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Abstract 
Physiological ageing is accompanied with an increase in systemic inflammatory 
mediators (inflammageing), a functional decline of the immune system 
(immunesenescence), altered endocrine function (adrenopause) and reduced 
physical activity which predisposes the elderly to increased risk of disease. Little is 
known about the interplay between physical activity, inflammageing, adrenopause 
and immunesenescence and what impact interventions may have in the elderly. This 
thesis identified the consequences of inflammageing and its association with 
immunesenescence and the impact physical activity plays on limiting the severity of 
inflammageing. 
Cytomegalovirus drives immunesenescence but was not associated with 
inflammageing. Instead inflammageing was associated with reduced physical activity 
and increased body fat. Furthermore, inflammageing and adrenopause was 
associated with increased frailty and mortality risk over a ten-year period.  
Accelerometer defined physical activity levels in healthy elders revealed a reduced 
inflammatory profile and improved neutrophil migration towards interleukin-8. Acute 
exercise revealed an enhanced inflammatory profile indicative of positive tissue 
adaptation. Furthermore there was a reduced ratio of cortisol to 
dehydroepiandrosterone sulphate which was accompanied by enhanced neutrophil 
and monocyte bactericidal function. Subsequently ten-weeks of high-intensity 
interval training, which was more than half the time commitment of regular aerobic 
training, revealed similar reduced inflammation and improved neutrophil and 
monocyte bactericidal capacity. 
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Chapter 1: Introduction 
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1.1 The Ageing Population 
 
Life expectancy in the developed world is increasing and has done so over the past 
150 years [1]. Advances in sanitation, medical care and socio-economic 
circumstances mean more people are now living longer than at any time in history. 
Current predictions suggest that by 2035 nearly one-quarter of the UK population will 
be aged sixty-five years or over and within those the number of over 85 year olds will 
have doubled [2]. On a global scale it is predicted that those over sixty years old will 
account for twenty-one percent of the population and equate to around two billion 
people [3].  
Recently it has been recognised that although lifespan is increasing there are clear 
disparities between this and time spent towards the end of life in a healthy condition 
(Healthspan) [4]. Currently in the UK, women and men can expect to spend the last 
eleven and eight years, respectively, in poor health. The impact of these unhealthy 
years is obvious in terms of a significant increase in health care costs as well as 
reduced quality of life in the ageing population [5].  Subsequently the need to 
improve healthspan by identification of risks to health in old age earlier and using 
economic, personalised non-invasive interventions is paramount. 
A common biological definition of ageing is: “Increasing frailty of an organism with 
time that reduces the ability to deal with stress, resulting in increased chance of 
disease and death”. Frailty is a syndrome associated with the elderly and confers a 
reduced capacity of a number of integral psychological, sociological, medical and 
physiological components [6-8]. Notably the clinical definition of frailty includes 
decrements in musculoskeletal function assessed by limitations to walking speed, 
ability to rise from a chair unaided and balance control, with compromised cognitive 
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capacity affecting the ability to carry out activities of daily living [7, 9, 10] . Broader 
definitions of age-related frailty extend to loss of cardiovascular and immune function 
[11, 12].  
This reduced functional capacity ultimately leads to the increased prevalence of 
adverse health outcomes due to an inability to effectively deal with or provide 
resistance against cumulative stressors and ensuing loss of homeostasis [8].   As 
individuals become frail it is apparent that they may present no life-threatening 
illnesses, thus frailty does not always include frank disease [6]. Furthermore, 
apparently healthy elders may not register as frail, yet have underlying significant 
health conditions which would suggest they are not in a healthy state. Subsequently 
the ‘Healthy Ageing Phenotype’ (HAP) has recently been proposed in order to bring 
together the multiple disciplines of gerontology and incorporate frailty and disease in 
a comprehensive definition of healthy ageing, Figure 1.1 [13].  Together, definitions 
of healthy ageing and frailty are becoming important tools for gerontological science 
and medicine which allows for better understanding of how to treat poor healthspan 
and intervene before health deteriorates beyond recovery.  
Although ageing research includes extending lifespan this tends to be in animal 
models [14, 15]. Human ageing research instead is focused on improving the health 
status of the elderly and improving their healthspan. In order to accomplish this it is 
necessary to gain insight into the risk and progression of disease as well as which 
factors can influence disease and promote healthspan. The HAP suggests that the 
underlying cause of age-related chronic disease states is due to a combination of 
genetic predispositions and lifestyle influences such as stress, smoking, alcohol and 
physical activity [13]. Importantly, there are factors associated with ageing and 
chronic disease which may be susceptible to interventions. Low grade chronic 
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systemic inflammation is one such factor which not only provides relatively accurate 
predictive measurements of disease but is also directly associated with behavioural 
lifestyle choices which are modifiable [16].  
In light of this the general aims of this thesis are two-fold. Firstly; assess the causes 
and consequences of systemic inflammation in elderly individuals. This will entail 
focussing on such things as lifestyle choices indicative of physical activity levels. 
Furthermore, focus will include assessment of latent viral infections which are 
capable of driving the immune system towards a dysregulated functional state, which 
increases risk of morbidity and mortality. Secondly; this thesis aims to assess the 
effects of physical activity in older individuals on both immune function and systemic 
inflammation.    
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Fig. 1.1: The Healthy Ageing Phenotype. This figure highlights the common underlying pathways of the major chronic conditions 
which are lifestyle and age dependent. In particular highlighting the vicious circle of pathways which leads first to conditions that 
may be reversible by modifying lifestyle factors before irreversible damage is done where management of these conditions is the 
only option. This irreversible situation is then associated with increased frailty and mortality in the elderly. Taken directly from 
Franco et al. [13]. 
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1.2 Low Grade Chronic Systemic Inflammation (Inflammageing) 
 
1.2.1 Inflammageing and health 
Physiological ageing is associated by a chronic sub-clinical systemic inflammatory 
state, termed inflammageing [17], characterised by elevated levels of serum pro-
inflammatory mediators such as interleukin (IL) 6, IL-1β and TNFα and acute phase 
proteins such as C-reactive protein (CRP). Further, the levels of mediators that 
counteract the inflammatory state, such as IL-10, are reduced with age compounding 
the inability to maintain immune homoeostasis [18]. Importantly, chronic low-grade 
inflammation is now accepted as a key pathogenic factor in the development or 
worsening of several age-related pathologies including cardiovascular disease [19], 
Alzheimer’s disease, sarcopenia, dementia and type-2 diabetes [20]. Furthermore 
inflammageing has been recognised as an independent risk factor for frailty and all-
cause mortality [16]. Table 1.1 highlights the key age-related inflammatory 
mediators, their cellular sources and relations with disease. Interestingly, studies in 
centenarians show that these extremely long-lived individuals maintain the cytokine 
profile of younger adults and do not develop inflammageing [21].  
 
Epidemiological and experimental studies have identified a number of biological 
markers which are associated with inflammation which predict both morbidity and 
mortality in the elderly . Increased concentrations of circulating inflammatory 
cytokines such as TNFα, IL-6, IL-1 and their cognate receptors function in a complex 
network where the role of one cytokine may be modified by another. It has become 
clear recently hyper-production of these cytokines are strong independent risk 
factors of infection, disease and mortality. Furthermore increased cytokine 
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production results in the increase of other inflammatory biological mediators such as 
chemokines like MCP-1, IL-8 and MIP-1α and acute phase proteins such as CRP.  
 
What is clear is that with age the functional balance of inflammatory versus anti-
inflammatory mediators is weighted towards an inflammatory state. IL-10 is the 
typical anti-inflammatory type 2 cytokine which acts to dampen and resolve 
inflammation by directing its actions against potent type 1 (Th1) cytokines such as 
TNFα. Although some have suggested IL-10 may not be reduced in the elderly the 
ratio of TNFα to IL-10 is often markedly increased. Mooradian and colleagues 
assessed the impact of TNFα concentrations of elderly nursing home residents 
(average age 89 years) and showed it was associated with significant mortality after 
only 4 months [22]. In this study the comparison group showed no detectable TNFα, 
highlighting the difficulty in measuring these cytokines which are usually only present 
with underlying disease.  
 
TNFα however is linearly associated with both IL-6 and CRP concentrations, both 
contributors to the inflammatory state [23]. IL-6 stimulates the hepatic production of 
CRP, an acute phase protein released primarily in response to infection and aids the 
immune response by binding to pathogens for immune recognition [24]. Ageing has 
been shown to increase CRP concentrations and has furthermore been associated 
with increased risk of metabolic disorders such as insulin resistance and diabetes 
[25, 26]. Additionally when in combination with IL-6 and IL-1 receptor antagonist 
(RA), CRP is associated with low strength and poor physical performance. Cesari 
and colleagues assessed 1020 individuals from Italy as part of the InCHIANTI study 
and found after adjustment for covariates IL-6 and CRP levels associated with low 
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grip strength and self-reported physical performance [27], both elements of the frailty 
index. Similar findings have been found by several groups and highlight the 
association with inflammatory imbalance and frailty. Chronic low-grade IL-6 
production has been suggested to inhibit the production of insulin-like growth factor 1 
(IGF-1), a potent anabolic growth factor even in the elderly, and can cause reduced 
muscle mass and lead to poor physical functioning [28, 29]. Not only has increased 
IL-6 and reduced IGF-1 been associated with reduced muscle function and mobility 
but in combination with TNFα was associated with increased mortality [30].  
 
Inflammatory cytokine production is accompanied by an anti-inflammatory response 
which is designed to aid resolution of inflammation. The association of IL-10 with 
frailty was not significant in the InCHIANTI study, but this cytokine is now being 
included in more longitudinal studies and may turn out to be an influence on ageing.  
The predictive value of inflammatory/anti-inflammatory biomarkers compared to 
traditional risk factors such as cholesterol and blood pressure is gaining more 
acceptance in gerontological research and medicine. It is recognised that there is a 
reduced validity with increasing age of such traditional physiological biomarkers, 
especially in cardiovascular disease assessment.  Therefore the combination of 
assessing inflammatory and anti-inflammatory biomarkers with traditional clinical 
checks will enhance the early detection of frailty and disease risk in the elderly. 
Furthermore understanding the causes of chronic systemic inflammation could lead 
to mechanisms which can be targeted and treated before long term damage to 
health occurs.  
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Table 1.1: Inflammatory mediators of the elderly. Typical cytokines, chemokines and growth factors measured in the elderly, 
their source and place of activity, adapted from De Martinis et al. [31]. 
 
IL (interleukin), TNFα (Tumour necrosis factor – α), CRP (C - reactive protein), IFN-γ (Interferon-γ), GM-CSF 
(Granulocyte/monocyte – colony stimulating factor), IGF-1 (Insulin like growth factor-1), NK (natural killer). 
Inflammatory Biomarker Cellular Source Target Actions Effect of Age on 
Production
Associations with age-related disease
IL-1β Macrophages Dendritic Cells 
Endothelia Epithelia Stromal
Endothelium, 
hepatocytes, 
hypothalamus
Enhances immune response, fever, 
sickness, acute phase protein release
Increased Frailty, autoimmune disease, emphysema
IL-2 T-cells T-cell, B-cell, NK-
cell
Activation, proliferation Decreased Autoimmune disorders
IL-6 Macrophages Dendritic Cells T-
cells Endothelia Adipocytes 
Stromal
Liver, B-cells Acute phase protein release, cellular 
proliferation
Increased Insulin resistance, Alzheimers, Cerebrovascular Disease
IL-8 Monocytes, Macrophages, 
Stroma, Endothelia
Neutrophils, T-cells Activation , chemotaxis Increased Atherosclerosis, Cancer
IL-10 Macrophages, T-cells T-cells, mast cells, 
B-cells
Inhibits cytokine release, costimulator for 
proliferation
Decreased Cancer, autoimmune disorders
IL-17 T-cells Nuetrophils, 
monocytes, 
stroma, endothelia
Enhances immune responses, promotes a 
pro-inflammatory environment
Increased Autoimmune disorders
TNFα Macrophages, T-cells, 
Monocytes, Neutrophils, NK-
cells
Most cells Celll Death, Activation Increased Sarcopenia, Anaemia, Osteoperosis
CRP Hepatocytes Most cells Enhances immune responses, promotes a 
pro-inflammatory environment
Increased Cardiovascular disease
IFNγ T-cells, NK-cells All cells except 
erythrocytes
Enhances immune responses, antiviral, 
promotes a pro-inflammatory environment
Increased Autoimmune and Autoinflammatory disorders
GM-CSF T-cells, Macrophages, 
Endothelia, Stroma
All myeloid cells 
and endothelia
Growth factor, chemoattractant Decreased Rheumatoid Arthritis
IGF-1 Stroma, Endothelia Adipocytes, 
muscle cells, 
epithelia, stroma
Growth Factor, Proliferation, Mitogenic Decreased Frailty, Sarcopenia, Osteoperosis, Cancer
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1.2.2 Causes of Inflammageing 
The exact causes of inflammageing are variable between individuals and result from 
a combination of factors. In particular accumulation of adipose tissue and a 
dysfunctional immune system are suggested to be two primary and interlinked 
mediators of inflammageing [32]. Furthermore, the interactions with a dysregulated 
endocrine function, immunesenescence and obesity have led to suggestions that the 
endocrine system may play an integral role in the severity of systemic inflammation. 
Senescent cells are also pro-inflammatory and may make a contribution [33]. 
 
1.2.2.1 Adipose Tissue Derived Inflammation 
Obesity and its associated poor health conditions have had an enormous impact on 
the health of the global population. Along with ageing, obesity is now considered a 
major worldwide health issue and is positively correlated with increasing age [34]. As 
with ageing, obesity predisposes individuals to increased risk of a number of 
diseases including type-2 diabetes, atherosclerosis, liver disease and certain types 
of cancer. Recently, obesity and many of its negative effects have been attributed to 
a close link between metabolism and the immune system [35]. Advances in our 
understanding of obesity have revealed a complex network of cells within the fatty 
tissue which secrete a range of inflammatory mediators and direct many localised 
and systemic cellular interactions. Adipocyte tissue is thus no longer considered 
simply as an energy storage tissue but a complex endocrine organ [36].   
 
Adipose tissue derived bioactive mediators have been characterised and are known 
as adipokines (Table 1.2) [36, 37]. The anti-inflammatory adiponectin and pro-
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inflammatory leptin are the most abundant of adipokines produced directly from 
adipocytes and their ratio is associated with the occurrence of insulin resistance [38]. 
Along with increased production of cytokines (IL-6 and TNFα), chemokines (MCP-1 
and CXCL5), and mediators of fibrinolysis (PAI-1), obesity is associated with a 
persistent low-grade chronic inflammation [39].  
 
Adipose tissue consists of a number of cell types which together contribute to 
increased systemic inflammation. Lean adipose tissue consists primarily of small 
volume adipocytes, anti-inflammatory or alternatively activated M2 macrophages and 
CD4+ T-cells [40]. Obesity progression is characterised by increased uptake and 
storage of triglycerides in the adipocyte causing significant hypertrophy. There is 
also a progressive shift in the phenotype of resident immune cells as adipose 
infiltration of pro-inflammatory M1 macrophages and cytotoxic CD8+ T-cells 
increases [40, 41]. This combination causes an increase in soluble pro-inflammatory 
mediators released from the various cells. As obesity progresses the adipocyte 
volume further increases, M1 to M2 macrophages shifts further towards a 
predominance of M1 and inflammation and hypoxia mediated vascular dysfunction 
occurs causing adipocyte necrosis [42]. At this stage the metabolic control of the 
adipose tissue is severely impaired and the pro-inflammatory state can further 
increase dramatically. Critically the adipose tissues sensitivity towards insulin and its 
production of the adipokines adiponectin and leptin are altered [43]. 
 
1.2.2.2 Adiponectin 
Adiponectin is the most abundant adipokine released from adipocytes circulating in 
excess of 5 mg.ml-1 and exhibits mainly anti-inflammatory effects  [44]. Adiponectin 
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binds to two cellular receptors (ADIPOR1 and ADIPOR2) causing activation of AMP-
activated protein kinase (AMPK) and peroxisome-proliferator-activated receptor-α 
(PPARα) [45] . AMPK activation can increase fatty acid oxidation and glucose 
transporter type-4 (GLUT4) translocation and ultimately reduces insulin resistance 
through a non-insulin dependent uptake of glucose [46]. Furthermore, by blocking 
the actions of nuclear factor-κB (NF-κB) adiponectin can reduce the synthesis of pro-
inflammatory cytokines such as TNFα and IFN-γ in macrophages whilst increasing 
production of anti-inflammatory cytokines such as IL-10 and IL-1 receptor antagonist 
(IL-1RA) from monocytes, macrophages and dendritic cells [47, 48]. Recently 
adiponectin has been shown to reduce neutrophil apoptosis and production of IL-8 
via an AMPK dependent manner [49]. Furthermore, due to the structure of 
adiponectin which is homologous to complement factor C1q, adiponectin can 
associate to form multimeric oligomers and bind to apoptotic cells and facilitate their 
removal by macrophages [50]. Early uptake of apoptotic cells promotes an M2 
phenotype in macrophages and can protect against inflammation [36].  
 
Adiponectin expression is inhibited by the actions of TNFα, IL-6, hypoxia and 
oxidative stress which could explain why obese individuals have lower plasma levels 
than non-obese [51-53]. As ageing is accompanied by systemic increases in IL-6 
and TNFα, even in the absence of obesity, this could have major consequences for 
adiponectin derived protection in the elderly. Subsequently low adiponectin levels in 
the elderly may contribute to the dysregulation of the production of pro-inflammatory 
cytokines leading to elevated systemic inflammation as well as immune dysfunction 
[54].  
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1.2.2.3 Leptin 
Leptin has the primary function of regulating feeding behaviour through its actions on 
the central nervous system. Leptin concentrations are increased in order to stop the 
desire and requirement to feed; therefore leptin resistance has been associated with 
both obesity and insulin resistance. Indeed leptin concentrations directly correlate 
with adipose mass and can be assessed as a measure of stored energy. Leptin has 
directly opposite effects from adiponectin being generally pro-inflammatory. Leptin 
shares structural similarities to the pro-inflammatory cytokines IL-2, IL-6, IL-12 and 
granulocyte colony stimulating factor (G-CSF) [37]. Subsequently, leptin can directly 
stimulate monocytes and macrophages to increase production of IL-6 and IL-12 as 
well as chemokines such as MCP-1 [55]. Leptin can stimulate proliferation of 
monocytes via the IL-2 receptor and also activates neutrophils enhancing their 
superoxide production [56, 57]. Leptin also has regulatory effects on NK-cells and T-
cells through mediating proliferation, differentiation and cytotoxic functions [55, 58]. 
Therefore leptin has many beneficial effects especially during acute infection by 
mediating the inflammatory response towards pathogens. However, as obesity 
increases elevated production of leptin and reduced adiponectin contribute to an 
uncontrolled inflammatory overload [59]. This imbalance leads to heightened adipose 
driven systemic inflammation through both immune and metabolic perturbations. 
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1.2.2.3 The Obesity Paradox 
Although it is clear that obesity is a major driving force behind systemic inflammation 
and that inflammation can act to reduce production of anti-inflammatory mediators 
from adipocytes there is a paradox suggesting otherwise [60]. Recent studies have 
suggested that metabolically healthy obese individuals have reduced inflammatory 
profiles similar to non-obese individuals. In their recent study Phillips and Perry 
measured metabolic health as defined by a number of criteria including blood 
pressure, insulin sensitivity, cholesterol and triglycerides [61]. They found that from 
2047 men and women aged 45 - 74, individuals who were metabolically healthy and 
obese had reduced levels of IL-6, CRP, PAI-1 and increased adiponectin compared 
to metabolically unhealthy obese individuals. Furthermore these values were 
comparable to non-obese individuals even after accounting for age, gender, 
medication and other confounding factors. Although this study could not confirm 
causality it has been recently estimated that the prevalence of metabolically healthy 
obesity is as much as thirty five percent [61]. Therefore obesity driven inflammation 
may be overestimated in the general population and only account for a small 
percentage of systemic inflammation observed in the elderly. 
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Table 1.2: Adipose tissue derived biomarkers, their cellular source and primary 
function. Adapted from Ouchi et al. [36] 
 
RBP4 (Retinol binding protein-4), ANGPTL2 (Angiopoietin-related protein-2), TNFα 
(Tumour necrosis factor alpha), IL (Interleukin), CCL2 (Chemokine (c-c motif) ligand 
2), CXCL5 (C-X-C motif chemokine 5), MCP-1 (Monocyte chemotactic protein-1), 
PAI-1 (Plasminogen activator inhibitor-1), NAMPT (Nicotinamide 
phosphoribosyltransferase), SFRP5 (Secreted frizzled-related protein 5).  
Adipokine Primary Cellular Source Primary Function
Leptin Adipocytes Appetite control
Adiponectin Adipocytes Insulin sensitizer and anti-inflammatory
Resistin PBMCs Promotes macrophage production of IL-6 
and TNFα causing insulin resistance
RBP4 Liver, adipocytes, macrophages Implicated in sytstemic insulin resistance
Lipocalin 2 Adipocytes, macrophages Promotes adipocyte production of TNF 
causing insulin resistance
ANGPTL2 Adipocytes Local and vascular inflammation
TNFα Stromal vascular cells, adipocytes Inflammation, antagonsim of insulin 
signalling
IL-6 Adipocytes, stromal vascular cells, 
liver, muscle
Changes with source and target tissue
IL-18 Stromal vascular cells Broad-spectrum inflammation
CCL2 Adipocytes, stromal vascular cells Monocyte recruitment
CXCL5 Macrophages Antagonsim of insulin signalling via JAK-
STAT pathway interference
MCP-1 Adipocytes, macrophages Immune cell recruitment
PAI-1 Adipocyte, endothelia Inhibits fibrinolysis
NAMPT Adipocytes, macrophages Monocyte chemotactic activity
SFRP5 Adipocytes Suppression of pro-inflammatory WNT 
signalling
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1.2.2.4 Endocrine Dysregulation with Age 
There is a functional modification of the endocrine system with age that can 
influence the severity of inflammation [62]. The hypothalamic-pituitary-adrenal (HPA) 
axis serves as the primary neuroendocrine unit and is one of the most studied 
endocrine components affected by ageing. The HPA axis consists of the 
hypothalamus, pituitary gland and adrenal glands and is responsible for regulating 
the stress response in humans. Physiological and psychological stress stimulates 
the secretion of corticotrophin releasing hormone (CRH) which directs its actions on 
the anterior pituitary gland to produce adrenocorticotropic hormone (ACTH). ACTH 
exerts its actions on the zona fasciculata to produce cortisol and the zona reticularis 
to produce dehydroepiandrosterone (DHEA) which are then released into the blood 
stream. The HPA axis has a negative feedback mechanism involving cortisol 
mediated reduction in ACTH which in turn reduces cortisol secretion [63]. DHEA on 
the other hand does not have this mechanism and is subsequently the most 
abundant hormone in the body [64]. Following synthesis DHEA is distinctively 
sulphated (DHEAs) and released into the blood where it is converted back to DHEA 
and its steroidal metabolites in the tissue. 
Ageing is associated with a severe decline in the synthesis and release of DHEAs 
which peaks around 20 – 30 years old before reducing to around 10% of original 
concentrations after the age of 60 years [65]. Cortisol changes with age are less 
dramatic with some studies showing increases, others showing no change and some 
decreasing [66-68]. Deuschle and colleagues suggested that there is an increase in 
nocturnal cortisol production with age which results in an overall increase in 24 hour 
cortisol levels [66]. As cortisol is a diurnally controlled hormone which peaks during 
the night and is at its lowest following waking in the morning methodological 
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differences explain much of the variance observed in cortisol concentrations. 
Regardless of cortisol changes there is an age-associated increase in the ratio of 
cortisol to DHEAs which has profound effects for health [69]. With respect to 
immunity cortisol is immune suppressive, whereas DHEAs is immune enhancing 
[70]. As the elderly have a dysregulated immune function which increases their 
susceptibility to infection it is thought the increased ratio of cortisol to DHEAs may 
contribute to immunesenescence [71, 72]. Neuroendocrine dysfunction has also 
been associated with sarcopenia, osteoporosis, mental wellbeing and prevalence of 
frailty in the elderly [73, 74] . 
  
Exposure to physiological and psychological stress increases with age and is 
accompanied by hyperactivation of the HPA-axis resulting in elevated cortisol 
production. Cortisol is typically an anti-inflammatory hormone and increased cortisol 
levels have been associated with reduced T-cell function during healthy ageing [75]. 
However it appears that with time repeated exposure of T-cells to glucocorticoids 
(GC) causes an age associated resistance which would result in a heightened 
inflammatory response and may explain the paradox of inflammageing in the 
presence of a raised cortisol:DHEAs ratio [76, 77]. A recent study in young 
individuals infected with rhinovirus revealed those who had increased resistance to 
GC were more likely to develop an infection and had increased pro-inflammatory 
cytokine production [78]. It is unclear however whether GC resistance is present in 
innate immune cells of the elderly. 
DHEAs is the natural endogenous antagonist of cortisol yet its production is severely 
reduced with age [70]. DHEAs is considered immune enhancing and recently it has 
been shown that DHEA supplementation improved natural killer cell cytotoxic 
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function and increased IL-2 production leading to improved proliferation whilst 
reducing IL-6 concentrations [79]. DHEAs is also able to increase neutrophil 
superoxide generation in vitro [80]. DHEA is associated with improved immune 
responses and reduced systemic inflammation and is now considered a primary 
candidate as a supplement to improve immunity in elderly people [70, 81, 82].  
 
1.2.2.5 Chronic Antigenic Challenge 
Ageing is accompanied by increased exposure to clinical and sub-clinical infections 
as well as continuous exposure to latent viral infections due to immunesenescence, 
discussed in chapter 1.2.4. Repeated exposure to infection stimulates the growth of 
memory and effector immune cells which occupy a significant proportion of the 
available immune space. Repeated antigenic challenge is the primary reason for 
exhaustion of the immune system and driving it towards a state of dysregulation and 
dysfunction, known as immunesenescence [83]. Undoubtedly increased antigenic 
challenge can increase chronic systemic inflammation in the elderly and one of the 
dominant theories of inflammageing is that it is driven in large part by the sustained 
efforts of the immune system to control infections, primarily chronic viral infections 
[17].  
 
1.2.2.6 Cytomegalovirus 
Persistent latent viral infections are believed to be a primary cause of both 
immunesenescence and inflammageing, most notably the herpes virus 
cytomegalovirus (CMV) [84]. CMV is a highly prevalent virus of the herpes family 
which also includes Epstein-Barr virus (EBV) and varicella-zoster virus (VZV). CMV 
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is one of the most studied of all herpes viruses and infects 60–85% of the Western 
population and approximately 80–90% of those over 65 years [85]. CMV infects cells 
primarily of the myeloid lineage. Monocytes are one of the main cells infected by 
CMV which alters their phenotype to increase adhesion and migration potential [86]. 
Upon migration to a suitable tissue the virus can replicate and seed in the local 
endothelial and stromal environment. It is here the virus remains latent due to 
continual immune surveillance until local and/or systemic immunity is compromised 
and reactivation occurs [87].  
 
Infection with CMV has been shown to dramatically alter the T-cell phenotype and 
function in both young and older adults [88]. In particular there is a CMV associated 
reduction in the diversity of the T-cell receptor (TCR) repertoire which is 
accompanied by increased proportions of pro-inflammatory effector memory cells 
[89]. Comparisons between age and health matched seropositive (CMV+) and 
seronegative (CMV-) individuals have shown that there is an expansion of the CD8+ 
cells and to some extent the CD4+ memory T cell compartment in CMV+ individuals 
[89]. Phenotypic alterations in T cells from CMV+ individuals demonstrate a reduced 
ability for antigen presenting cell co-stimulation and activation due to reduced 
expression of the cognate receptor for CD80/CD86, CD28 [90, 91]. Furthermore 
CMV stimulation has been shown to upregulate the production of IL-10, the classic 
anti-inflammatory cytokine, which acts directly on reducing program death ligand on 
dendritic cells allowing for viral evasion from the immune response [92].  These 
mechanisms may act to preserve the viral lifespan by evading the immune response 
developed to combat reactivation. Interestingly stimulation of T cells from CMV+ and 
CMV- individuals with CMV protein epitopes reveals that there is an elevated 
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production of IL-6 and TNFα not only from T cells but also NK cells and 
macrophages from CMV+ individuals [93]. Hyper-production of inflammatory 
cytokines by CMV may act to prolong the viral lifespan. Recently it has been shown 
that elevated levels of TNFα in elderly individuals can attenuate the IL-2 proliferative 
response of T cells which would confirm this [94].  
 
Ageing is associated with both an increased prevalence of CMV infection, 
reactivation and its consequent immune alterations [95]. Furthermore, CMV infection 
has been suggested to increase the risk of all-cause mortality in the elderly and is a 
component of the Immune Risk Profile (IRP), a set of immune markers associated 
with increased mortality on older adults [96]. In light of this it is reasonable to assume 
that CMV infection promotes chronic systemic inflammation through remodelling of 
the immune system and increasing risk of mortality from novel or more severe 
infectious episodes. As the elderly are exposed to signs of immune dysfunction the 
failure to control CMV infection is increased, however the exact mechanism of age-
related CMV associated mortality has not been elucidated.  Recently it has been 
shown that CMV may infect monocytes and utilise their mobility to seed in tissues 
such as vascular cells, liver and lungs [87]. CMV infected monocytes can alter the 
phenotype of monocytes and adopt a pro-inflammatory phenotype which causes 
them to be increase cellular adhesion. It has also been speculated that CMV 
infection may lead to atheroma plaque formation by adhesive monocyte infiltration in 
the vascular endothelial bed resulting in foam cell generation [97, 98].  
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1.2.2.7 Cellular Senescence  
One of the most noticeable consequences of latent viral infection is its ability to drive 
oligoclonal expansion and subsequently the prevalence of senescent T-cells specific 
to the virus [99, 100]. Not limited to immune cells, cellular senescence is the state of 
irreversible growth arrest following multiple rounds of clonal expansion believed to be 
induced by oncogenic insults [101-103].  Since the discovery of replicative 
senescence some fifty two years ago it is now thought that senescence occurs in 
order to limit the risk of cancer development [104-106]. Therefore it is of no surprise 
that with ageing the frequency of senescent cells increases in all tissues and in 
mouse models the elimination of senescent cells delays age associated dysfunction 
highlighting this intricate relationship [107, 108]. Although it has been shown that 
increased cellular senescence is associated with heightened risk of age-related 
diseases and physical dysfunctions it remains unclear the specific mechanisms.  
 
Senescence is believed to be induced by a number of causes including repeated cell 
division, telomere shortening, DNA damage responses (DDR) inducing double 
strand breaks, protein aggregation, strong mitogenic signals and increased reactive 
oxygen species production [33, 109]. These senescence inducers create a 
phenotype which is characterised by such things as cell cycle arrest, increased 
activity of senescence-associated β-glactosidase activity and synthesis and 
secretion of pro-inflammatory mediators. Activation of the p53 and the p16INK4a 
tumour suppressor pathways are believed to be the primary, but not exclusive, 
pathways responsible for inducing a senescent response. Subsequently activation of 
the NF-κB pathway occurs and results in increased pro-inflammatory mediator 
production [110]. Therefore as inflammageing is associated with an absence of 
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detectable pathogens it is likely that inflammageing is in part driven by the 
accumulation of senescent cells [33]. Consequently, the senescence-associated 
secretory phenotype (SASP) has been coined detailing this phenomenon [111, 112]. 
The SASP has been shown to produce a number of inflammatory mediators capable 
of modifying cells and tissue function, including MMP3, TNFα, IL-6, IL-8, MCP-1, IGF 
binding proteins and PAI-1 [113, 114]. What is clear is that the SASP is not limited to 
one cell type or tissue and can be found at varying degrees in tissues such as 
adipose and immune [115]. Although cell senescence can be viewed as an example 
of antagonistic pleiotropy by promoting protection in younger age, the accumulation 
that occurs is thought to promote an increased incidence of cancer and other age 
related disorders [116]. Interestingly the SASP may not only be limited to 
chronological age accumulation but has been recently suggested to promote 
neighbouring cells to become senescent and adopt the SASP [117, 118]. Therefore 
geriatric and medical sciences are striving to implement interventions which can 
specifically target cell senescence and the SASP.    
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1.2.3 Consequences of Inflammageing 
As described in section 1.2.1 inflammageing is associated with increased mortality 
and age-related frailty. The increase in mortality is due to a broad range of effects of 
increased inflammation on physiology. 
 
1.2.3.1 Severity of Infections and Disease in the Elderly 
Inflammageing can influence the severity and prevalence of infections and disease in 
older adults [119]. Respiratory diseases and influenza infection are the fourth major 
contributors to mortality in the elderly. Pneumonia in the elderly can account for as 
much as thirty percent of hospitalised elders whilst ninety percent of influenza deaths 
are in the over 65 year olds. Mortality data of elderly individuals compared to young 
individuals suggests that fifty percent more will die from sepsis infection whilst there 
is a 400 fold increase in elderly deaths from gastrointestinal infections [120]. 
Furthermore, one in seven deaths of over 85 year olds can be attributed to bacterial 
diseases, highlighting the progressive age associated inability to mount an immune 
response and control inflammation [121].  
The increased incidence of these infections is due in large part to the ageing of the 
immune system, termed immunesenescence, which includes reduced functioning of 
innate immune cells such as neutrophils and NK cells [122-124]. These cells act as 
the front line defence against bacteria and viruses respectively and the age-related 
reduction in the microbicidal function influences the increased susceptibility to 
infection in the elderly. The basal increase in production of cytokines by monocyte 
and macrophages is paradoxically combined with a reduced inflammatory response 
to pathogens, compromising the innate response to infection [125]. The reduced 
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ability to generate an anti-inflammatory response, notably IL-10 production, means 
that inflammation is not resolved promptly. This contributes to the increased frailty 
and mortality seen in elders after infections such as influenza [126].  
 
1.2.3.2 Inflammageing and chronic age-related diseases 
Inflammageing has also been suggested to be an underlying mechanism behind 
many of the major age-related chronic diseases [127]. Not only have inflammatory 
biomarkers such as CRP and IL-6 been associated with increased risk of metabolic 
dysfunction, including insulin resistance, but they and TNFα are independently 
associated with cardiovascular disease (CVD), Alzheimers disease and type-2 
diabetes amongst others [31]. Chronic diseases are becoming increasingly prevalent 
in the elderly with approximately thirty percent of all deaths attributable to CVD 
including coronary heart disease and stroke. Furthermore, fifty percent of people with 
diabetes will die from CVD [128]and over 800,000 elderly individuals suffer from 
Alzheimers disease in the UK [129].  
 
1.2.3.3 Insulin Resistance 
Many of the tissues which are affected by ageing are also affected by obesity, 
vascular, heart, skeletal muscle, liver etc. Insulin is a pancreas derived hormone 
which regulates the uptake, oxidation and storage of metabolic fuels in tissues such 
as the liver, skeletal muscle and adipose tissue. Recently it has been shown that 
immune cells such as adipose resident macrophages also require the use of insulin 
[41, 130].  Over time resistance to the actions of insulin develop which leads to 
increased inflammation and vascular endothelial dysfunction. With ageing, there is 
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often an increase in circulating concentrations of insulin (hyperinsulinaemia) which is 
a result of both increased glucose concentrations due to poor diet, and the inability to 
uptake glucose as a fuel due to the prevalence of insulin resistance [131]. Insulin 
resistance has been shown to have a clear link with increased TNFα production. 
TNFα binding to cells can disrupt insulin receptor (IR) activity by activation of NF-κB 
and c-Jun amino-terminal kinase (JNK) which causes phosphorylation of the IR [37]. 
Yuan and colleagues suggested that over-expression of inhibitor of nuclear factor 
kapp-B kinase subunit beta (IKKβ) can attenuate TNFα induced insulin resistance by 
reducing the expression of NF-κB [132]. Therefore hyper-production of TNFα as with 
ageing results in insulin resistance and a lack of glucose uptake by cells. This can 
have detrimental effects as the cell switches energy metabolism in order to survive 
and produces elevated free radicals in the process [133]. Insulin resistant cells may 
become necrotic requiring an inflammatory mediated clearance. In summary 
systemic insulin resistance can perpetuate heightened inflammation through altered 
metabolic function leading to cell death. 
 
1.2.3.4 Frailty and Physical Dysfunction  
Frailty can be viewed as the stage where complete homeostasis may be lost or 
compromised and progression towards disease is rapid leading to death [31]. 
Therefore predicting those who are becoming frail has become a major health care 
challenge of recent times. Defining frailty is complex due to the methods utilised to 
measure it, however a few criteria have been validated and are clinically relevant. 
The Fried Frailty Criteria is the most widely implemented objective approach to 
characterising and classifying frailty [134]. Fried and colleagues defined frailty on the 
basis of muscle weakness, exhaustion, slow walking speed, weight loss and low 
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activity status [7]. These measures are easy to assess in clinic and at home and can 
be converted into objective quantifiable scores and frailty is defined as having 3 out 
of 5 of these conditions. The Fried Frailty Score is also relatively robust in that if 
some of the measures are not able to be assessed, e.g. weight loss in a specific 
time, alternative measurement criteria can be adopted. Prevalence of frailty has 
been recently estimated at around four percent for men and nine percent for women 
among community dwelling elders (64 – 74 years) in the UK [135].  This percentage 
and total number of the population is expected to significantly increase due to our 
ageing population.  
Frailty has an underlying inflammatory phenotype with cross sectional studies 
associating CRP, IL-6, IGF-1, DHEAs and white blood cell subtypes with progression 
and severity of frailty [136-138]. Cross sectional analysis does not determine 
causality and only a few studies have assessed the longitudinal associations 
between inflammation and frailty [139]. Therefore identification of inflammatory 
biomarkers to predict frailty in the elderly is critical to providing interventions that 
prevent frailty.  
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1.2.4 Immunesenescence and Inflammation 
It is clear that the increased susceptibility to disease and severity of infection is 
associated primarily with a dysfunctional immune response. Immunesenescence is 
the age-related changes of the immune system which can be defined by 
modifications in immune tissue development, innate and adaptive cell number, 
phenotype and function [85, 125]. The intimate relationship with immunesenescence 
and chronic systemic inflammation in the elderly and are now considered a major 
cause of age-related disease driven morbidity and mortality. 
 
1.2.4.1 Adaptive Immunesenescence 
Consisting primarily of naive and antigen specific B and T lymphocytes the adaptive 
arm is responsible for elimination of pathogen infected cells and conveying lifelong 
protection (memory) against re-infection. However due to increased antigenic 
exposure with age and as the adaptive arm has limited self-renewal capabilities, it 
eventually becomes dysfunctional leading to increased risk of infection and immune-
related disease [140-142]. Table 1.3 outlines some of the common adaptive immune 
changes with age.  
 
Ageing is accompanied by a severe involution of the thymus which is characterised 
by a gradual replacement of functional stromal cells with fat and fibrous tissue [143]. 
Although thymic involution can result in functional mass being 10% of that of a young 
person the overall size of the peripheral T cell pool is unchanged with age [85]. 
Maintenance of the T-cell pool number is achieved by expansion of circulating cells, 
including naive and antigen experienced memory T cells. Contributing to this 
expansion is the activation of memory T cells by previously encountered antigens 
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and latent viruses such as CMV. In the case of CMV this can lead to up to 15% of 
peripheral CD8+ T cells being CMV specific, reducing the ability to respond to new 
pathogens or vaccines [141]. The reduced output of naive T cells and a concomitant 
increase in memory T cells results in a profound contraction of the diversity of the 
TCR repertoire.  
 
Although the adaptive immune system shows a broad range of changes with age 
(Table 1.4) it is the innate immune system changes with age which are believed to 
exert the greatest impact on systemic inflammation [144].  
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Table 1.3: Adaptive immune changes associated with increased age 
 
TCR (T-cell receptor), CD (Cluster of differentiation), KLRG (Killer cell lectin-like 
receptor subfamily G1). 
1.2.4.2 Innate Immunesenescence 
The innate immune system is the immediate non-specific first line of defence against 
infection which is responsible for recognition and clearance of pathogens and 
consists of both humoral and cellular components. Few studies have shown defects 
in the humoral arm, though complement proteins such as C1q are increased with 
age [145]. 
 
The cellular components of innate immunity consist of a diverse group of cells 
including neutrophils, monocytes, macrophages, dendritic cells and NK-cells. These 
cells are responsible for control of pathogenic invasion via a number of direct 
cytotoxic properties and resolution through secretion of a number of regulatory 
cytokines and chemokines which can direct the adaptive immune response. 
Alteration with age
T-cell Thymic Involution
Reduced T cell repertoire
Impaired TCR sensitivity
Reduced Naïve cell numbers
Increased memory and effector memory numbers
Inverted CD4: CD8 ratio
Loss of costimulatory molecules CD27 and CD28
Increase of negative regulatory receptors KLRG, CD57
Increased inflammatory cytokine production
B-Cell Reduced numbers of B cells
Increased monoclonal production
Increased somatic hypermutation
Telomere Shorter telomeres and suppressed telomerase
Cellular Senescence Increased expression of p16
ink4a
Stem Cell Progenitors Reduced lymphoid lineage
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Therefore a dysfunctional innate immune response impacts on both immediate 
responses and immune memory. Furthermore, there is a growing consensus that 
activation of the cellular innate immune system with age significantly contributes to 
the dysregulated inflammatory state [146]. Thus dysregulated inflammation is also a 
consequence of increased levels of basal inflammatory products and impaired 
immune responses. The age-related changes to innate immunity are shown in Table 
1.4. 
Table 1.4: Innate immune changes associated with increased age 
  
NET (Neutrophil extracellular traps), MHC (Major histocompatibility complex), TLR 
(Toll-like receptor), CD (Cluster of differentiation).  
Alteration with Age
Neutrophils ↔ Numbers, adherence & TLR expression
↓Chemotaxis
↓Phagocytosis
↓Superoxide production
↓Apoptosis
↓Lipid raft formation
↓NET production
Monocyte/Macrophages ↔ Numbers
↓Chemotaxis
↓Phagocytosis
↓Superoxide production
↓Apoptosis
↓Lipid raft formation
↓MHC-II expression
↓Stimulated cytokine production
↓TLR expression
↑Prostaglandin synthesis
↑Basal cytokine production
↑Pro-inflammatory phenotype
Dendritic Cells ↓Antigen presentation
↓TLR signalling
↓Chemotaxis
↓Decreased IFN production
NK-cells ↑Cytotoxic CD56dim population
↓Cytotoxicity
↓Proliferation
↓Chemokine production
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1.2.4.2.1 NK cells 
NK cells represent 10-15% of peripheral blood lymphocytes and are responsible for 
defence against tumour and virally infected cells [147]. NK cells constitutively 
express activating (e.g. NKp30 and NKp46) and inhibitory (e.g. KIR and CD94) 
receptors and can be distinguished by their surface density of CD56 and lack of 
expression of CD3. CD56bright NK cells are termed immunoregulatory and produce a 
range of cytokines whilst the CD56dim population which accounts for 90% of the NK 
cells are cytotoxic effector cells [148]. Ageing is associated with a reduced 
percentage of CD56bright cells and increased cytotoxic CD56dim cells [149]. This shift 
in phenotype towards a predominantly mature state is associated with altered 
expression of NK receptors but reduced cytotoxic capacity with age. Recently it has 
been shown that NK dysfunction with age is due to the reduced release and binding 
of the pore-forming molecule perforin [149]. Furthermore, NK cells from the elderly 
have been consistently shown to have reduced chemokines and cytokine production 
which will elongate the infection resolution process and inflammation [125, 146].  
 
1.2.4.2.2 Dendritic Cells 
Dendritic cells (DCs) are professional antigen presenting cells, sitting at a crucial 
interface between innate and adaptive immunity and are responsible for priming the 
T-cell mediated immune response. DCs can be categorised into two distinct types; 
plasmacytoid DCs (pDCs) and myeloid DCs (mDCs). pDC’s are critical to host 
defence against pathogenic invasion, particularly viral, by producing type I and III 
interferon via TLR ligation in order to direct the immune response. They are capable 
of initiating an NK-cell response whilst also activating T-cells via antigen 
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presentation. mDCs on the other hand are responsible for cytokine production that 
initiates a Th1 cytotoxic response against pathogenic challenges.  
 
mDCs from the elderly have reduced primary functions such as endocytosis, 
chemotaxis and activation of T-cells [150, 151]. Basal levels of pro-inflammatory 
cytokines are increased in mDCs from the elderly due to aberrant reduced 
expression of PI3K which can stimulate NF-κB dependent production of IL-6 and 
TNFα [150]. Studies have shown with stimulation that elderly mDC pro-inflammatory 
cytokine production to be increased, decreased or unchanged [150, 152, 153]. pDCs 
from the elderly appear to have reduced production of inflammatory cytokines 
following activation via TLR7 and 9 with viral DNA [152]. This reduced TLR function 
has been attributed to a reduced expression and aberrant signalling. Furthermore, 
the dysfunctional TLR responses of pDCs can be directly associated with reduced 
priming of T-cells and production of IFN [154]. Therefore dysfunctional TLR 
responses of pDC’s will elongate the infectious episode and stimulate heightened 
inflammation in the long run.  
 
1.2.4.2.3 Monocytes and Macrophages 
Although monocytes represent a relatively small proportion of circulating leukocyte 
numbers (approximately 5 - 10%) they are key mediators of the immune response to 
infection by responding to inflammatory signals and differentiating into antigen 
presenting cells such as macrophages or dendritic cells. Monocytes are capable of 
providing direct cytotoxicity through phagocytosis and oxidative killing of pathogens 
as well as processing and presenting them to the adaptive immune arm via human 
leukocyte antigens (HLA). Monocytes are heterogeneous and can be identified by 
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the differential expression of CD14 and CD16, with 2 distinct subsets identified, 
classical CD14++/CD16- and pro-inflammatory (non-classical) CD14+/CD16+ [78]. 
These cells differ in their expression of toll-like receptors (TLRs), adhesion 
molecules and chemokine receptors with CD16 expressing monocytes having 
greater surface density than the CD16 negative monocytes [155]. Recently, the pro-
inflammatory population has been subdivided into 2 groups, CD14+dim/CD16++bright 
and CD14++bright/CD16+dim and are characterised by pro-inflammatory capacity and 
elevated expression of PRRs such as TLR2 and TLR4 [156, 157]. Agonists against 
TLRs cause NF-κB activation resulting in pro-inflammatory cytokine production.  
Inflammatory cytokine production from monocytes in the elderly is either increased or 
decreased depending on the particular TLR which is stimulated . Both TLR1 and 
TLR2 expression and stimulation of TLR2 results in reduced cytokine production in 
the elderly, though TLR4 responses are increased [125, 158]. Additionally adherent 
monocytes from the elderly which are predominantly CD16+ show an increase in 
TLR5 (bacterial flagellin components) stimulated production of IL-6 [159]. Therefore 
monocytes from the elderly appear to have reduced inflammatory potential which 
negates adaptive immune response whilst constitutively producing more TNFα from 
CD16+ monocytes. 
Monocytes migrate from the peripheral blood towards sites of infection in a similar 
manner to neutrophils except for the detection of chemokines which is controlled by 
other chemokines. Migration in the elderly is impaired and in chronic inflammatory 
conditions such as atherosclerosis there is an elevated concentration of MCP-1, the 
ligand for the monocyte chemokines receptor CCR2 and to a lesser extent CCR4 
[160].  Both systemic MCP-1 and CCR2 expression on monocytes are increased 
with age suggesting that dysfunctional migration may be due to downstream signals 
Page | 34  
 
associated with MCP-1/CCR2 activation. Migration to sites of inflammation results in 
macrophage differentiation and resolution of infection, however aged monocytes 
have reduced CX3CR1 expression which is necessary for tissue transmigration 
[161]. 
Because of their critical role in macrophage and DC homeostasis and inflammation, 
monocyte changes with ageing may have a significant impact on immune 
dysregulation and heightened inflammation. Recent studies have identified an age-
related shift from a classical to non-classical phenotype and suggest a systemic 
activation status [162, 163]. Ageing has been consistently shown to increase both 
numbers and percentages of non-classical monocytes at the expense of classical 
monocytes. Furthermore, adhesion molecule expression is decreased for CD62L but 
not CD50, the receptor for lymphocyte function-associated antigen 1 (LFA-1), 
although CD50 surface density is increased [162]. Additionally the expression of 
human leukocyte antigen DR (HLA-DR), the human homolog to MHC-II, is 
decreased and ultimately reduces antigen presentation to CD4+ T-cells [163].  
Age associated changes of the monocyte are thus indicative of promoting systemic 
aberrant inflammation through basal output of cytokines and an inability to maintain 
immune surveillance.  
 
1.2.4.2.4 Neutrophils 
Neutrophils account for 50-60% of all leukocytes and are primarily responsible for 
the clearance and control of opportunistic bacteria, yeast and fungi as well as 
regulation of innate and adaptive immune interactions [123, 125]. Neutrophils are 
one of the first cells to engage foreign pathogens and attempt to resolve infection. To 
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do this they have an anti-microbial arsenal which includes phagocytosis, reactive 
oxygen species (ROS) production, extracellular DNA trap formation (NETS) and 
secretion of antimicrobial molecules and peptides such as the protease elastase and 
the defensin human neutrophil peptide-1 [164]. Furthermore, neutrophils are able to 
mediate the immune response via production of cytokines, chemokines and growth 
factors including TNFα, IL-8, CCL3, IP-10, MIP-1α, IL-12, VEGF and others [164, 
165].  
 
Reduced neutrophil functions have the potential to contribute to chronic systemic 
inflammation through each of the above dysregulated functions. During acute 
infection the neutrophilia observed is similar between young and elderly individuals 
suggesting that granulopoiesis is unaltered with age [123]. However, recent evidence 
suggests that elevated numbers of neutrophils is associated with all-cause mortality 
in the elderly [166]. The process of migration towards the site of infection is complex. 
Neutrophils are required to adhere to activated endothelium, a process mediated by 
the interactions of endothelial ligands such as intercellular adhesion molecule 1 
(ICAM-1) and their cognate receptors on the surface of the neutrophil. The 
expression of the integrins CD11a, CD11b and CD18 appear to be unchanged 
between healthy elders and young individuals [167]. Adhesion to the endothelium 
leads to detection of chemokines produced by the infected site and ultimately 
transmigration across the vascular endothelium. Receptors specific for chemotactic 
agents are unchanged with age yet in vitro analysis has revealed that the elderly 
have reduced chemotaxis [146, 168, 169]. Age associated reduced chemotactic 
ability is a consequence of constitutive activation of signalling pathways involving 
phosphoinositide 3 kinase (PI3K) [168]. Dysfunctional chemotaxis by neutrophils 
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may promote systemic inflammation due to collateral tissue damage caused by 
aberrant migration. In order to move through tissue to the site of infection neutrophils 
release the protease elastase which breaks down elastin and collagen in connective 
tissue. This causes elevated tissue damage and promotes an inflammatory response 
that may be above and beyond the initial inflammatory response from the infection. 
Elderly individuals have been recently shown to have increased systemic elastase, 
although it is not clear the exact source in this study [170]. Furthermore in recent 
animal studies assessing neutrophil function following burn-induced lung injury it was 
shown that there were elevated inflammatory responses in the old mice compared to 
the young [171]. This effect was mediated by increased expression of ICAM-1 in the 
lung and reduced expression of CXCR2 on the neutrophil.  
 
Neutrophils are professional phagocytes and therefore express a plethora of 
receptors responsible for the detection of, adhesion to and uptake of pathogenic 
microbes. Neutrophil phagocytic capacity in the elderly has been consistently shown 
to be impaired, although only when opsonised components are used [172, 173]. 
Phagocytosis incorporates two main variables affected by ageing, the percentage of 
cells able to phagcytose and the numbers of microbes ingested on a per cell basis. It 
has been suggested that these impairments are due to signalling defects and/or 
reduced expression of receptors such as CD16 on the neutrophil cell surface [172]. 
TLR agonist stimulation on neutrophils has been shown to increase a number of 
functions including cytokine release and superoxide generation whilst reducing 
migratory capacity. Although the expression of TLR4 on neutrophils appears 
unchanged whether there is an age related effect for TLR function remains to be 
determined. 
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Following phagocytosis pathogens are contained within phagosomes which combine 
with lysosomes to form the phagolysosome. It is here pathogens are exposed to 
microbicidal killing by an oxidative burst consisting of superoxide (O2-). Depending 
on the pathogenic challenge neutrophils from the elderly show either a reduced 
[Staphyloccocus aureus (S. Aureus)] or unchanged [Escherichia coli (E. Coli)] 
production of O2- [174]. This may in part be due to the mechanisms recruited to deal 
with pathogens, such as complement and Fc receptor-mediated responses for gram-
positive bacteria, LPS binding by CD14/TLR4 or fMLP ligation with its receptor which 
is further increased on exposure to TNFα. Signal transduction of a number of effector 
functions have been shown to be impaired. These include pro-survival responses to 
GM-CSF via the Janus kinase signalling pathway and reduced expression of 
suppressor of cytokine signalling 1 (SOCS1) and SOCS3 [175].The latter signalling 
pathway mediates the production of cytokines, chemokines and reactive oxygen 
species (ROS). Neutrophil function in the elderly is thus impaired primarily due to 
modifications of signalling pathways that reduce microbicidal activity whilst 
elongating lifespan and increasing inflammatory cytokine production. It is unclear 
whether these modifications happen in the bone marrow during development or 
occur in the peripheral tissue in response to micro-environmental changes. 
 
One factor that complicates interpretation of neutrophil data is the short-lifespan and 
subsequent release from the bone marrow (BM) of ‘new’ neutrophils, which results in 
a mixed population of potentially functionally different cells. As neutrophils are known 
to lose their function as they age [176], it is plausible that these cells are residing in 
the circulation for longer in older adults. To date, no study has been able to 
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determine the percentage of newly released neutrophils and neutrophils close to the 
end of their life in the peripheral blood. In vitro studies culturing isolated neutrophils 
have identified phenotypic differences in expression of CXCR2 and CXCR4 [177, 
178]. CXCR4 functions as the receptor to keep newly matured neutrophils in the BM 
and return of aged neutrophils back to BM. As ageing is associated with increased 
low-grade systemic inflammation, which lengthens neutrophil survival time, 
neutrophil composition may be significantly different between young and old. 
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1.2.5 Interventions to attenuate Inflammation and Immunesenescence 
1.2.5.1 Therapeutics  
As inflammageing is associated with increased morbidities it represents a target that 
could reduce morbidity in elders. Metformin is prescribed to reduce hepatic glucose 
production and reduce cardiovascular disease risk by improving insulin sensitivity 
[179]. This drug works by stimulating a range of cell processes via activation of AMP 
kinase, including autophagy [180]. Recently metformin has been associated with 
reduced inflammation by inhibiting NF-κB activation and reducing CRP levels and 
has improved survival of patients with type-2 diabetes [181]. Furthermore, metformin 
has been shown to alter T-cell biology by potentially improving cell generation and 
protective immunity in cancer patients [182]. 
 
Recently it has been proposed that all elderly people be placed on statin therapy 
regardless of health status [183]. Statins are typically prescribed to combat 
hypercholesterolemia but have also been shown to have anti-inflammatory and anti-
hypertensive actions [179]. Indeed epidemiological studies suggest that the benefits 
of statin therapy may be mediated primarily through its anti-inflammatory actions 
[184]. Recent unpublished data from our group suggests that statins can repair the 
migratory and functional defects of neutrophils from the elderly (E. Sapey personal 
communication) suggesting not only anti-inflammatory benefits but also immune 
enhancing effects. 
 
However, the cost of prescribing statins and metformin to all elderly individuals is 
considerable and a small proportion of individuals have negative side effects to statin 
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therapy [185]. Thus there is a need for a cost-effective, safe and efficacious 
intervention to reduce inflammation driven morbidity. 
 
1.2.5.2 Exercise and Health 
Maintenance of regular physical activity throughout life is associated with a number 
of major health benefits including, reduced risk of cardiovascular disease, diabetes 
and stroke as well as reduced physical disability (sarcopenia) and mortality [186]. 
However, after the age of 45 years there is a progressive and sharp decline in both 
time and intensity of physical activity participation which has been attributed primarily 
to a lack of available time [187]. Reduced physical activity, especially in the elderly, 
is known to lead to sarcopenia, reduced endurance capacity and a concomitant 
increase in visceral adiposity, with the latter contributing to inflammation [188, 189]. 
The anti-inflammatory and immune enhancing effects of exercise have been 
extensively researched in young healthy and non-healthy individuals but until 
recently few studies have assessed the impact in the elderly.  
 
The anti-inflammatory effects of exercise have received significant attention in the 
last few years and are summarised in Table 1.5 [190]. The mechanism by which 
exercise acts appears to be primarily through modifications of the main contributors 
to inflammageing; altered adiposity and modified immune function. Exercise has 
known thermogenic properties which increases energy expenditure and can reduce 
adipose tissue by utilising the abundant energy contained within. As part of this 
process exercise alters the blood lipid profile by decreasing low-density lipoprotein 
(LDL) particles and increasing high-density lipoprotein (HDL) particles [191].  
Therefore exercise reduces the risk of obesity by utilising triglycerides as an 
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abundant energy source and offering protection from CVD by improving the 
cholesterol clearance transport mechanism (LDL: HDL) [192].  
Increased adipose tissue results in elevated concentrations of pro-inflammatory 
adipokines leading to persistent low-grade systemic inflammation [130]. Regular 
exercise has been shown to consistently reduce the amount of both abdominal and 
visceral fat regardless of age and gender [193]. Consequently there is a shift in the 
ratio of pro to anti-inflammatory adipokine secretion characterised by elevated 
adiponectin and reduced leptin as well as IL-6 and TNFα. Therefore a reduction in 
adipocyte mass will directly reduce the pro-inflammatory production of adipokines 
whilst increasing the anti-inflammatory phenotype. However, as much as 30% of 
circulating IL-6 is known to be produced from adipose tissue with only 10% of this 
being directly from the adipocyte [194]. The remaining IL-6 is produced primarily 
from resident macrophages suggesting that exercise itself has an impact on 
macrophage adipose infiltration and differentiation. 
IL-6 release is intrinsically and transiently linked with exercise duration and intensity 
and is specifically expressed at higher levels of intensity [195]. However in this 
context it acts as an anti-inflammatory stimulator which can reduce production of 
systemic TNFα. Muscle synthesis of IL-6 in response to exercise has been well 
documented and accounts for a large portion of systemic concentrations. Muscle 
derived IL-6 has been shown to increase production of the anti-inflammatory 
cytokines IL-10 and IL-1RA as well as the anti-inflammatory glucocorticoid cortisol. 
Thus it appears that muscle derived IL-6 may act as an anti-inflammatory effector 
[196].   
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1.2.5.3 The Myokine Paradigm 
Recently skeletal muscle has been identified as a major endocrine organ capable of 
producing a large amount of pro-inflammatory cytokines, chemokines and growth 
factors [197]. Until recently the production of such inflammatory mediators has led 
many to suggest that certain intensities, durations and modes of exercise may in fact 
be chronically damaging and not suitable for patients with inflammatory mediated 
disease. This would seem counterintuitive as exercise is associated with a plethora 
of health benefits. Collectively termed as myokines, their release from contracting 
skeletal muscle may in fact play a role in exercise induced protection from chronic 
disease and morbidity [198]. Typical pro-inflammatory cytokines and chemokines are 
now being considered as anti-inflammatory and tissue protective following exercise-
induced release from skeletal muscle.  
 
Although IL-6 was the first myokine identified as being synthesised and secreted by 
contracting skeletal muscle recent data suggests muscle can secrete around forty 
different cytokines, growth factors and metalloproteinases [190]. IL-6 is generally and 
persistently produced from a number of cells including immune, adipocyte and 
endothelial, however during exercise the majority of IL-6 found systemically is 
produced by the skeletal muscle [199]. Importantly the magnitude of the muscle 
derived IL-6 response, and other cytokines, is highly dependent on intensity and 
duration of exercise.  One of the major differences between exercise induced and 
infection induced IL-6 responses is the dynamics of the preceding and following 
cytokine release. In response to infection, TNFα is one of the first cytokines released 
which magnifies the inflammatory response by increasing systemic temperature and 
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directing both immune and humoral responses to the infection. Following TNFα 
release the rest of the inflammatory milieu including IL-1, IL-6, IL-8 and IL-10 are 
secreted.  In contrast the response to exercise does not induce a TNFα response 
(unless exercise is extremely severe) in the muscle or systemically, instead IL-6 is 
one of the first cytokines consistently produced followed by the anti-inflammatory IL-
1RA and IL-10 and the chemokine IL-8 [197]. 
 
Classified typically as a pro-inflammatory cytokine having a severe impact on 
progression and severity of chronic diseases such as cardiovascular disease and 
diabetes, IL-6 is often cited as the ‘geriatric cytokine’ due to its presence in most age 
related diseases [200, 201]. From a number of observations, IL-6 is suggested to 
have a causal role in developing insulin resistance and promoting metabolic disease 
in the elderly [31]. Indeed chronic IL-6 production can disrupt insulin binding and 
signalling via increased expression of intracellular SOCS3. SOCS3 expression is 
also increased upon leptin binding and as leptin is homologous to IL-6, at elevated 
levels both disrupt the insulin receptor substrate-1 (IRS-1) pathway following insulin 
binding [202]. However, during exercise IL-6 is released from the muscle and does 
not activate intracellular SOCS3, instead bypassing it directly to AMPK activation 
and subsequent increased expression of GLUT-4 [203]. This exercise-mediated 
increased expression of GLUT-4 is independent of insulin signalling, however due to 
the reduced IRS-1 inhibition, insulin also stimulates GLUT-4 translocation to the cell 
membrane and allows efficient uptake of glucose.  
 
Furthermore, IL-6 can act to dampen the inflammatory effects of other pro-
inflammatory cytokines. As mentioned previously TNFα can directly reduce insulin 
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sensitivity through inhibiting tyrosine phosphorylation of IRS-1 via impaired Akt 
signalling. IL-6 infusion has been shown to reduce the endotoxin mediated TNFα 
response in vivo and although immune cell function was not assessed it does 
highlight systemic reductions in TNFα [204]. Importantly the IL-6 infusions in this 
study had comparable TNFα responses to those individuals who had undertaken an 
exercise session. This study highlights that it is most likely not the IL-6 cytokine itself 
which is different between exercise and basal conditions but more the ratio of IL-6 to 
TNFα. Therefore in the case of elderly individuals who may have significantly more 
systemic TNFα present, IL-6 at varying concentrations can act to reduce a TNFα 
mediated response. This mechanism is most probably through reducing TNFα 
induced insulin resistance. In light of this the current hypothesis suggests that 
exercise-induced IL-6 production is in fact an energy sensing mechanism that allows 
the muscle to replenish glycogen stores [190, 199]. 
 
In addition to IL-6 another typically pro-inflammatory mediator IL-8 is acutely 
responsive to exercise [205, 206]. IL-8 is typically a pro-inflammatory chemokine 
produced by macrophages and endothelial cells during infection to attract neutrophils 
and other immune cells to the site of inflammation. IL-8 mRNA expression and 
protein in muscle has been shown to increase in response to exercise [205]. 
However IL-8 may be influenced to a greater degree by the intensity, duration and 
mode of exercise than IL-6. Typically, increased IL-8 is observed following 
exhaustive eccentric or muscle damaging exercise such as running and not 
moderate concentric exercise like cycling. However others have shown small but 
significant increases in IL-8 following concentric exercise bouts suggesting that IL-8 
release has a dual role in exercise induced adaptations [207]. During muscle 
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damaging eccentric or high intensity exercise IL-8 has been suggested to be 
released as an inflammatory mediator attracting immune cells to mediate the 
damage response and promote repair [208]. In non-damaging exercise sessions 
however immune cell infiltration in muscle is not observed suggesting an alternative 
role. Indeed in recent studies it has been shown that exercise increases expression 
of the IL-8 receptor CXCR2 on microvascular endothelial cells promoting IL-8 
induced angiogenesis [209, 210]. Therefore exercise induced IL-8 can act to 
promote damaged muscle cell healing as well as stimulating vascular growth and 
increasing blood and nutrient supply to the muscle [208]. 
 
Clearly muscle acts as an endocrine organ enhancing its own protection and 
adaptation. Over time and with a lack of stimulation these actions may be impaired 
but with the introduction of even small amounts of exercise, the muscle can provide 
the potential to reduce systemic inflammation and improve quality of life in elderly 
individuals. 
 
1.2.5.4 Exercise Mediated Immune Changes  
Exercise induced effects on the immune system have received considerable 
attention over the last 25 years and are summarised in Table 1.5. Ever since it was 
recognised that physical activity load was associated with altered immune function 
there has been a goal to determine the beneficial effects of exercise on immunity. 
Individuals who perform moderate bouts of structured exercise appear to be at a 
reduced risk of infectious episodes suggesting that exercise can mediate the 
immune response to infection [211, 212]. Acute exercise has consistently been 
shown to alter the circulating numbers and percentages of subtypes of immune cells 
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[213-216]. Chronic exercise training does not always confirm these findings 
suggesting that functional alterations may be an epigenetic effect. Much of the work 
assessing exercise and immune function has been carried out in young healthy 
individuals; however a growing number of studies are assessing the impact of 
exercise in the elderly and those with chronic disease, particularly inflammatory 
related diseases.   
1.2.5.4.1 Adaptive Immunity 
The majority of studies assessing immune function alterations in response to 
exercise have been conducted on the adaptive arm of the immune system. These 
studies have focused on such things as the phenotype changes, proliferative 
capacity, co-stimulatory potential and cytokine shift of T-cells [217]. Acute exercise 
has been shown to alter the phenotype of T-cells circulating in both young and 
elderly individuals as well as improving their proliferative capacity [218, 219]. 
Unfortunately this effect appears to be transient and is not observed following 
longitudinal exercise interventions in both young and old volunteers [211, 220, 221].  
Active elderly individuals have been shown to have reduced IL-2 receptor expression 
which may relate to functional changes [222]. Secretion of cytokines by T-cells in 
response to exercise has shown some promise and it has been suggested that 
exercise may shift T-cells in the elderly towards a Th2 anti-inflammatory/humoral 
response rather than the pro-inflammatory Th1, although the mechanism and 
consequences of this remain elusive [223-225].  
1.2.5.4.2 Innate Immunity 
Innate immunity and the effect chronic and acute exercise has received considerably 
less attention than the adaptive arm. The majority of studies have assessed the 
effects on NK-cells and monocytes. 
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Like most other immune cells there is an intensity and duration dependent 
redistribution of NK-cell numbers, specifically increased proportions of the CD56bright 
regulatory NK-cell population. Exercise induced functional changes have yielded 
inconsistent findings [219, 226]. NK-cell cytotoxicity has been shown to be increased 
in response to 6 months of aerobic training in elderly individuals but another study 
showed no differences in NK-cell function after aerobic training in elderly women 
[227, 228]. Infection with CMV has been shown to alter the phenotype of NK-cells by 
increasing the expression of CD57 on the cell surface [229]. Acute exercise has 
been shown to mobilise NK-cells to a tremendous degree yet CMV infected 
individuals NK-cells were less responsive [230] 
Dendritic cells from the elderly have been suggested to have reduced TLR-induced 
cytokine production but increased basal inflammatory state and production of TNFα 
and IL-6 [152]. The effect of exercise on elderly dendritic cell function is not well 
researched. Studies have shown that acute exercise can mobilise myeloid and 
plasmacytoid DC’s in relation to catecholamine production, and prolonged exercise 
can alter the balance of DC subtypes [231]. However as DC function is conducted in 
tissue understanding the relevance of this in humans is difficult. Recently 5 weeks of 
aerobic training in rats was shown to increase antigen presentation capability via the 
HLA-DR homolog MHC-IA/IE, leukocyte activation and IL-12 production of bone 
marrow isolated DC’s [232]. Although this study was conducted in young adult rats 
using in vitro differentiated DC’s the alterations suggest heightened immune 
functioning and potential anti-tumour activity via IL-12 production from aerobic 
training. Replication of these findings in aged humans would yield an incredible 
insight into immune self-tolerance deficiencies and tumour recognition which could 
both be restored by exercise.  
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Migration of peripheral blood monocytes and the subsequent differentiation towards 
adipose tissue is critical to the development of sustained inflammation. Whether 
exercise can moderate this process and reduce inflammation in the elderly is 
unknown. As exercise reduces the size of adipocytes it has been suggested that the 
production of chemokines (MIP1α and MCP-1) responsible for macrophage 
infiltration is reduced [233]. Vascular adhesion molecules such as ICAM-1 are 
increased with ageing and chronic disease but have been shown to be reduced with 
6 months of aerobic exercise [234]. Therefore it is plausible that exercise reduces 
the migratory capacity of monocytes into adipose tissue. Macrophages with the 
inflammatory phenotype (M1) are preferentially associated with inflamed adipose 
tissue [235]. The effects of exercise on macrophage phenotype in humans remains 
to be determined, however in mice it has been recently shown that exercise induces 
a phenotypic switch of M1 to M2 macrophages in the adipose tissue as well as 
reducing M1 infiltration [236].   
As the monocyte and its differentiated forms are intrinsically linked with increased 
systemic inflammation the impact of exercise on monocyte function may be critical to 
reduced inflammation. In response to acute bouts of exercise monocyte numbers are 
increased with the CD16+ population accounting for the largest percentage change 
[156, 157]. Although following acute exercise the numbers and percentages of 
subtype’s return to normal base levels there is a marked reduction in CD16 
expressing monocytes after exercise training interventions [156]. Timmerman 
showed that elderly active individuals had lower percentages of CD16+ monocytes 
than inactive age and sex matched individuals [237]. Furthermore, 12 weeks of 
aerobic training resulted in both reduced percentages of CD16+ monocytes as well 
as LPS stimulated TNFα monocyte production in the inactive group. Although this 
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study showed no changes in TLR4 expression others have suggested that TLR2 and 
TLR4 expression are reduced by chronic exercise training in the elderly [238, 239]. 
Indeed following prolonged acute exercise TLR expression is reduced for several 
hours. Mechanisms behind the exercise induced reduction in TLR expression are 
unknown however it has been suggested that anti-inflammatory cytokines and/or 
glucocorticoid production may have an impact [240]. Additionally, 12 weeks of both 
strength and aerobic training resulted in an increase in the monocyte expression of 
CD80 [241]. Reduced expression of CD80 on monocytes has been shown to relate 
to poor vaccine responses in the elderly due to reduced activation potential of T-cells 
and antigen presentation capabilities [242]. Phagocytosis of pathogens is reduced 
with ageing however the effects of exercise have received little attention. To date the 
only study to assess phagocytosis was in middle aged men and showed no changes 
following 12 weeks of training [243].  
The majority of neutrophil functions are impaired with age and can contribute to 
systemic inflammation through secondary mechanisms such as reduced pathogen 
clearance and aberrant migration and collateral tissue damage. Studies in 
overweight women (53 ± 9.8 years) have shown reduced neutrophil numbers 
following six weeks training which was associated with reduced BMI and insulin 
sensitivity however it is unclear if these are directly linked [244]. The effects of 
neutrophil numbers in response to acute exercise are dependent on the intensity and 
duration of the bout. High intensity exercise has been shown to cause increased 
numbers of neutrophils and this is further increased over several hours, thought to 
be controlled by increased glucocorticoid production [245]. Lower intensity exercise 
shows a typical leukocyte biphasic response with an initial increase followed by a 
return to baseline in the immediate hours following cessation. Some studies have 
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shown no differences between active and inactive elders for neutrophil numbers 
which suggests differences may be due to underlying inflammatory morbidities in the 
inactive groups [226].  
Even fewer studies in the elderly have assessed neutrophil function in response to 
exercise. Yan and colleagues showed that although lower than the young, neutrophil 
phagocytosis was maintained better in active elderly men [226]. Oxidative killing of 
bacteria in response to exercise has to date not been assessed. Migratory capacity 
of neutrophils is critical to resolution of infection, 4 weeks of moderate aerobic 
exercise was shown to improve and maintain migration towards infection in young 
healthy individuals [246]. 
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Table 1.5: Inflammatory and Immune findings from cross-sectional and randomised control trials examining associations 
between exercise training statuses in elderly adults. 
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1.2.5.5 Exercise and cortisol and DHEAs 
Due to the associations between the cortisol to DHEAs ratio, immunesenescence 
and inflammation, in the elderly research has focused on whether there is exercise 
induced protection of adrenal function in the elderly.  Ravaglia and colleagues [247] 
showed that older men (~67 years) had reduced DHEAs concentrations than middle-
aged men (~58 years). However when the two age groups were split for physical 
activity levels, both middle-aged and elderly active men had increased DHEAs 
concentrations compared to inactive elderly men. Furthermore the active elderly men 
were comparable to the inactive middle-aged men. Similarly aerobic capacity has 
been associated with increased DHEAs in women and men. Heaney and colleagues 
[248] recently showed that although there was no difference in concentrations of 
cortisol, DHEAs or their ratio with increasing levels of physical activity in elderly 
individuals, a short exercise bout caused significant reductions in cortisol but not 
DHEAs.  
1.3 Summary and Aims of Thesis 
 
Elderly individuals have an increased incidence and severity of infection and chronic 
disease than the young. This is accompanied by multi-system functional declines 
including an increased incidence of sarcopenia, osteoarthritis, cardiovascular 
function and dementia. An underlying factor contributing to this phenomenon is the 
increase in low-grade chronic systemic inflammation (inflammageing) characterised 
by elevated levels of pro-inflammatory and reduced anti-inflammatory mediators. 
Factors contributing to inflammageing are complex and not completely understood; 
however the dominant mechanisms are believed to be lifelong antigenic challenges 
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resulting in immune dysfunction (immunesenescence), reduced levels of physical 
activity and increased prevalence of obesity, age-related loss of anti-inflammatory 
sex steroids and hyperactivation of the HPA axis. Taken together obesity, sedentary 
behaviour and immune mediated inflammation contributes to the majority of 
morbidities and mortality observed in the elderly.  
Physical activity and exercise offers a mechanism by which immune dysfunction, 
obesity and subsequently inflammation can be attenuated in the elderly. Exercise 
both acute and chronic is energy demanding and subsequently utilises adipose 
tissue as an energy source reducing the risk of obesity. Similarly exercise can modify 
the number and function of circulating immune cells to reduce the risk of infection 
and modify cytokine output by muscle and adipose tissue. However, until recently 
few studies have assessed the impact of physical activity on inflammation and 
immune function in the elderly.  
 
In light of this, the aims of this thesis were to: 
1. Identify the consequences and causes of inflammageing, focussing on 
lifestyle and CMV serostatus, in healthy elderly individuals. 
 
2. Assess the effects of physical activity as an intervention on inflammation and 
immunesenescence. 
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Chapter 2: General 
Materials and Methods 
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As each chapter has different participant groups and slightly different approaches to 
methodology, the general methods will be described below whilst specific study 
methods included before the pertinent results. Therefore, this section will include 
primarily the analytical analyses conducted on blood serum and plasma to determine 
inflammatory mediator responses. Furthermore, all immune function components will 
be included here.  
 
2.1 Blood cell counts and preparation of serum and plasma 
 
Blood was taken from healthy volunteers by venepuncture. All studies were 
approved by the relevant local research ethics committee and all participants gave 
written informed consent. All blood samples were processed immediately. Plasma 
was obtained by centrifugation of EDTA treated blood at 3000 rpm (5804 Eppendorf 
centrifuge, Eppendorf UK Ltd., Stevenage, UK) for 10 minutes at 4°C. Serum was 
obtained by the same centrifugation of clotting factor treated blood following 30 
minutes standing upright to clot. Plasma and serum were snap frozen and stored at -
80°C for later analysis.  
Complete blood differentials, including leukocyte counts were completed using EDTA 
treated whole blood immediately after sampling on a fully automated CoulterTM 
ACTdiff haematology analyser (Beckman-Coulter, High Wycombe, UK). All samples 
were analysed in triplicate. 
 
 
 
Page | 56  
 
2.2 Analysis of serum and plasma biomarkers  
 
2.2.1 Luminex based assays 
Detection of serum free cytokines was measured using commercially available XMap 
multiplex Luminex kits (Bio-Rad, Hemel Hempstead, UK) according to 
manufacturer’s instructions. One kit was specific for type 1 cytokines which 
contained combinations of the following cytokines (IL-1b, IL-4, IL-6, IL-8, IL-10, IL-13, 
IL-17A, TNFα, GM-CSF, MCP-1 and VEGF) whilst the second kit measured ICAM-1, 
VCAM-1 and MIF.  Briefly, antibody coupled magnetic beads were added to a 96-
well greiner NUNC plate. Serum was first centrifuged at 10,000 x g to remove 
platelets and cell debris and then diluted 1:4 with assay specific buffer before 
addition of 50 μl of sample and standards to each well. Plates were then sealed, foil 
covered and incubated for 30 minutes on an orbital shaker at 350 rpm. Following 
incubation, washing was performed 3 times before addition of the biotinylated 
detection antibody and incubated as before. Following incubation, washing was 
performed and streptavidin-RPE, which binds the detection antibody, was added and 
incubated as before but for exactly 10 minutes. Following washing and re-
suspension plates were read on a Luminex200 instrument (Luminex Corp, Austin, TX, 
USA). The system identifies and quantitates cytokines based on bead colour and 
RPE fluorescence. The concentration of the cytokines is determined and 
automatically calculated by the Bio-Plex ManagerTM (Bio-Rad, Hemel Hempstead, 
UK) software using a standard curve derived from the recombinant cytokine 
standard. 
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2.2.2 ELISA 
All ELISA’s were performed using commercially available pre-validated kits and 
according to manufacturer’s guidelines except for CMV which was an in house pre-
validated gift from Prof. Paul Moss (School of Cancer Sciences). All standards, 
controls and test samples were assessed in duplicate. Test sample concentrations 
were determined from the standard curve produced from the recombinant standards 
provided. All ELISAs were quantified on a Synergy-2 microplate reader (BioTek, 
Bedfordshire, UK) within 10-minutes of adding stop solution. Standard curves and 
value extrapolation were conducted using GraphPad Prism® software v5 (GraphPad 
Software, La Jolla, USA). Intra-assay coefficient of variation was less than 5% for 
each ELISA. 
2.2.2.1 CRP: Detection of serum free C-reactive protein (CRP) was determined by a 
commercially available high-sensitivity ELISA (IBL International, Hamburg, 
Germany). Serum samples were centrifuged at 2,500 xg for 10 minutes to remove 
platelets before being diluted 1:1000 in kit dilution buffer. Wells pre-coated with 
monoclonal anti-CRP antibodies were incubated with 100 µl of either test serum or 
standards (0 – 10 mg.L-1). Plates were covered with adhesive film and incubated for 
30 minutes. Following incubation, plates were washed 3 times using kit wash buffer. 
After patting excess fluid from the plate 100 µl of CRP conjugated to horseradish 
peroxidise (HRP) was added and incubated for 30 minutes at RT. Wells were 
washed as before and 100 μl of chromogen solution containing 3,3’,5,5’-
tetramethylbenzidine (TMB) was added and incubated for 10 minutes at RT in the 
dark. Following incubation 50 µl of the stop solution containing 0.5M sulphuric acid 
(H2SO4) was added to each well. 
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2.2.2.2 Cortisol and DHEAs: Detection of serum cortisol and DHEAs was 
completed independently using commercial ELISA kits (IBL International, Hamburg, 
Germany). Briefly, wells pre-coated with anti-cortisol or anti-DHEAs rabbit polyclonal 
antibodies were incubated with duplicates of 20 µl (cortisol) or 25 µl (DHEAs) of 
either test serum, standards (cortisol: 0 – 2208 nmol.L-1 and DHEAs: 0 – 26000 
nmol.L-1) or high and low controls in the presence of 200 µl of cortisol or DHEAs 
conjugated to HRP. Plates were covered with adhesive film and incubated for 60 
minutes. Following incubation, plates were washed 4 times using the kit wash buffer. 
After patting excess fluid from the plate 100 µl of substrate solution containing TMB 
was added and incubated for 15 minutes at RT in the dark. Following incubation 100 
µl of the stop solution containing 0.5M H2SO4 was added to each well. 
2.2.2.3 Adiponectin, Leptin and IFNγ: Detection of plasma adiponectin/Acrp30 and 
leptin and serum IFN-γ were completed independently using sandwich ELISA kits 
(R&D Systems, Abingdon, UK). Briefly, mouse anti-human adiponectin, leptin or IFN-
γ capture antibodies were diluted in sterile PBS to working concentrations of 2, 4 and 
4 µg.ml-1 respectively. Wells were incubated overnight at RT with 100 µl capture 
antibodies. Following incubation wells were washed 3 times in 400 µl wash buffer 
(PBS/0.05% Tween® 20). Non-specific binding was reduced by blocking the wells 
with 300 µl of reagent diluent [PBS + 1% protease free BSA (Fisher Scientific, 
Loughborough, UK)] for 1 hour at RT. Following blocking plates were washed as 
before 3 times. Leptin (0 – 2000 pg.ml-1) and adiponectin (0 – 4000 pg.ml-1) 
standards and test plasma were diluted in reagent diluent before incubating 
duplicates of 100 µl for 2 hours at RT. Plates were then washed as before 3 times. 
Biotinylated mouse anti-human adiponectin, IFN or leptin detection antibodies were 
diluted in reagent diluent and 100 µl per well incubated for a further 2 hours at RT. 
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Following incubation the washing was repeated before incubating wells with 100 µl of 
HRP conjugated Streptavidin for 20 minutes at RT in the dark. Following incubation 
the washing was repeated before addition of 100 µl TMB substrate solution and 
incubated for 20 minutes at RT in the dark. Reactions were stopped by addition of 50 
µl 2N H2SO4 (Sigma-Aldrich). 
2.2.2.4 PAI-1: Detection of plasma plasminogen activator inhibitor-1 (PAI-1) was 
completed using a sandwich ELISA kit (Life Technologies). Briefly, wells pre-coated 
with anti-PAI-1 antibodies were incubated with 100 μl of standards and samples 
diluted 1:2 in the appropriate buffer provided, covered and incubated for 2 hours at 
RT. Following incubation, plates were washed 4 times using the kit wash buffer. After 
patting excess fluid from the plate 100 µl of biotinylated human PAI-1 biotin 
conjugate solution was added to each well (except the blank) and incubated for a 
further 2 hours as before. Plates were washed again before 100 μl of streptavidin-
HRP working solution was added to each well and plates again covered and 
incubated at RT for 30 minutes. Following a similar wash, wells were incubated with 
100 μl of chromagen solution in the dark for 30 minutes at RT before stopping the 
reaction with 100 μl of stop buffer.  
2.2.2.5 Insulin: Detection of plasma insulin was completed using a sandwich ELISA 
kit (Life Technologies). Briefly, wells pre-coated with anti-insulin antibodies were 
incubated with 50 μl of standards, controls and samples as well as 50 μl of anti-
insulin-HRP conjugate for 30 minutes at RT. Following incubation, plates were 
washed 3 times using the kit wash buffer. Following washing 100 μl of TMB 
chromagen solution was added to each well and incubated for 15 minutes at RT in 
the dark. Following incubation the reaction was stopped by adding 100 μl of acidic 
stop solution. 
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2.2.2.6 MIF and Endothelin-1: Detection of serum macrophage migration inhibitory 
factor (MIF) and plasma Endothelin-1 were completed independently using sandwich 
ELISA kits (Abcam®, Cambridge, UK).  Briefly, wells pre-coated with anti-MIF or 
Endothelin-1 antibodies were incubated with 100 μl of standards and samples diluted 
1:2 in the appropriate buffer provided, covered and incubated for 1 hour at RT. 
Following incubation, plates were washed 5 times using the kit wash buffer. After 
patting excess fluid from the plate 100 µl of HRP conjugated MIF or Endothelin-1 
working solution was added to each well and plates again covered and incubated at 
RT for 30 minutes. Following a similar wash, wells were incubated with 100 μl of 
chromagen solution in the dark for 30 minutes at RT before stopping the reaction 
with 100 μl of stop buffer. 
2.2.2.7 CMV: Detection of serum CMV specific IgG antibodies was completed using 
an in-house validated indirect ELISA (gratefully received from Prof. Paul Moss, 
School of Cancer Sciences; University of Birmingham, UK). Briefly, MRC-5 
fibroblasts were infected with human CMV strains AD169 (G. Wilkinson, Cardiff, UK) 
or Towne1125 at a multiplicity of infection (MOI) of 4:1 for 4 hours. Mock infections 
were also conducted to eliminate non-specific IgG binding. Supernatants were 
harvested and centrifuged to pellet the virus before quantification by stimulation of 
PBMC’s from CMV positive donors. Viral or mock lysate (50 µl) diluted to 1:4000 
from stock in carbonate-bicarbonate buffer (Sigma-Aldrich) were then bound to an 
ELISA NUNC plate overnight at 4°C. Plates were washed 3 times in 200 µl of wash 
buffer (PBS/0.05% Tween® 20) on an automated plate wash. Following this 25 µl of 
donor serum samples [pre-diluted 1:150 in dilution buffer (PBS/0.05% Tween® 20 + 
1% BSA)] and 50 µl of standards (0 – 1000 Au) were added in duplicate to both viral 
and mock lysate wells alongside 75 µl and 50 µl of dilution buffer respectively. 
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Following a 1 hour incubation at RT, plates were washed as before and then 
incubated for an additional 1 hour at RT with 100 µl of goat anti-human IgG HRP 
conjugated secondary antibody (pre-diluted 1:8000 in dilution buffer; Southern 
Biotech, Alabama, USA). Following incubation, plates were washed as before 3 
times before addition of 100 µl TMB substrate solution and incubated for 10 minutes 
at RT in the dark. Reactions were stopped by addition of 100 µl 2N H2SO4 (Sigma-
Aldrich) and OD recorded at 450 nm and 570 nm within 10 minutes on a Synergy-2 
microplate reader (BioTek). Analysis was completed by subtracting the average 
mock lysate readings from the average viral lysate readings. Values greater than 10 
Au were considered to be CMV positive. 
2.2.2.8 Vitamin D: Plasma samples (500 µl) were sent to the University Hospitals 
Birmingham clinical analysis laboratory for determination of vitamin D 
concentrations. Samples were analysed in duplicate for concentrations of vitamin D2 
and D3 using tandem mass spectrometry under clinical settings. 
2.3 Measurement of Metabolic Biomarkers  
 
Serum and plasma fasting glucose, glycerol, total triglycerides, total cholesterol and 
HDL-cholesterol (Instrumentation Laboratories Ltd., Warrington, UK) and non-
esterified free fatty acids (Randox, UK) were assessed independently using an ILab-
600 semi-automated clinical spectrophotometric analyser (Instrumentation 
Laboratories Ltd.). Analyis was conducted in collaboration with UoB department of 
Sport and Exercise Sciences. Briefly, the analyser was quality control checked for 
each metabolite to be measured before 300 μl of either serum or plasma was added 
to an individual spectrophotometric vial. Samples were placed in the machine and 
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assayed independently in duplicate. Results were calculated automatically by the 
analyser using iLAB-600 software (Instrumentation Laboratories Ltd.). 
2.4 Assays of Immune cell function 
 
2.4.1 Neutrophil Isolation 
Neutrophils were isolated from heparin treated whole blood by discontinuous 
centrifugation. Blood was transferred into a sterile 50 ml FalconTM and diluted 6:1 
with 5% (w/v) dextran (Amersham Biosciences, Uppsala, Sweden) reconstituted in 
0.9% saline and erythrocytes allowed to sediment for 30-45 minutes at room 
temperature (RT). The leukocyte rich buffy coat was carefully removed and layered 
on top of a discontinuous gradient in a 15 ml FalconTM consisting of 5 ml 56% 
Percoll® (Sigma-Aldrich, Dorset, UK) and 2.5 ml 80% Percoll®. Gradients were 
prepared by diluting 1x Percoll® (45 ml) with 5 ml of sterile 9% (w/v) sodium chloride 
(NaCl: Sigma-Aldrich) before dilution of 40 ml of this working stock with 10 ml sterile 
0.9% (w/v) NaCl to create an 80% Percoll® stock. The 56% Percoll® stock was 
created by dilution of 28 ml working stock with 22 ml of sterile 0.9% (w/v) NaCl and 
the 56% Percoll® carefully layered on the 80% Percoll®. 
Gradients were centrifuged at 110 x g for 20 minutes at RT with no brake in a 
benchtop centrifuge. Following centrifugation, neutrophils suspended at the interface 
of the 80-56% Percoll® were carefully removed and placed into a sterile 50 ml 
FalconTM and washed once at 400 xg for 10 minutes in RPMI-1640 media 
supplemented with 2mM L-glutamine, 100 U/ml penicillin and 100 µg/ml streptomycin 
(GPS: all Sigma-Aldrich). The supernatant was discarded and cells resuspended in 
RPMI-1640 supplemented with GPS and 0.15% (volume/volume (v/v)) bovine serum 
albumin (Sigma-Aldrich) to a final concentration of 2x106.ml-1. Purity was determined 
Page | 63  
 
by cytospin and differential staining using a commercially available Geimsa stain 
(Diff-Qik: Gentaur Europe, Brussels, Belgium). Neutrophils consistently comprised 
≥98% of the cell population.  
2.4.2 Neutrophil Chemotaxis 
Neutrophil migration was assessed using an Insall Chamber (Weber Scientific 
International Ltd, Teddington, UK) and has been described previously [249]. Briefly, 
glass coverslips were coated with 7.5 % endotoxin free bovine serum albumin 
(Sigma) and isolated neutrophils incubated for 20 minutes at RT to allow cells to 
adhere. Coverslips were then inverted onto the Insall chamber and the chamber 
filled with either the RPMI as a control or RPMI containing 100nM IL-8. Neutrophil 
migration was then immediately recorded using a Zeiss Axiovert-100 microscope 
and a FAST Mono-12bit QICAM digital camera. Recording lasted 12 minutes with 
images taken every 20 seconds using Improvision OpenLab software. After 
recording, ten randomly selected cells were tracked and analysed using Image-J 
software (Wayne Rasband, NIH, MD, USA). All videos were analysed in duplicate by 
two independent researchers blinded to participant characteristics. 
Neutrophil migration was assessed using 3 parameters. Average cell speed 
(chemokinesis) of movement (μm.min-1) was measured from the distance travelled 
between frames in any given direction over time. Average cell velocity (chemotaxis), 
defined as the speed in a constant direction was also measured in μm.min-1. As the 
Insall chamber allows the formation of a stable chemoattractant gradient with a 
defined constant direction on the y-axis only distance travelled on this axis was 
calculated for chemotaxis. Finally accuracy (chemotactic index) was calculated by 
the cosine of the angle between the cells direction and the orientation of the 
chemoattractant gradient at each time frame. This formed a vector analysis of 
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movement which was expressed on a comparative scale (CS) ranging from -1 to +1 
where +1 represents movement directly towards the chemoattractant source. 
2.4.3 Monocyte Isolation 
PBMCs were isolated from heparin treated whole blood by density gradient 
centrifugation. Blood was transferred into a sterile 50 ml FalconTM and diluted 1:1 
with sterile phosphate buffered saline (PBS). Blood mixtures were layered over 
Ficoll-PaqueTM PLUS (GE Healthcare, Uppsala, Sweden) at blood: Ficoll ratio of 4:3 
ml and centrifuged at 400 x g for 30 minutes at RT with no brake. Following 
centrifugation, mononuclear cells suspended at the interface of the Ficoll and plasma 
were removed and washed twice, 400 x g for 10 minutes, in PBS. Cells were 
counted and viability assessed by trypan blue exclusion before being suspended in 
1ml of PBS for magnetic isolation of monocytes. PBS was prepared by dissolving 
one PBS tablet (Sigma-Aldrich) per 200ml of distilled water and sterilised by 
autoclaving. 
CD14+ monocytes were isolated from PBMCs using the EasySepTM Human 
Enrichment Kit (Stem Cell Technologies, Grenoble, France). PBMCs (15x106.ml-1). 
PBMCs were placed in a 5 ml (12 x 75 mm) polystyrene tube on ice and washed, 
250 x g for 10 minutes at 4°C, in 2 ml cell sorting buffer (PBS containing 1mM 
Ethylenediamine-Tetraacetic Acid (EDTA) and 2% bovine serum albumin (BSA)). 
Cell pellets were resuspended in 0.5 ml sorting buffer before addition of 15 µl of the 
EasySepTM monocyte enrichment cocktail and incubated at 4°C for 10 minutes. 
Following incubation, 15 µl of EasySepTM magnetic particles were added and 
incubated at 4°C for 5 minutes. Cell suspensions were then made to a total volume 
of 2.5 ml with sorting buffer and placed inside a Purple EasySepTM Magnet for 2.5 
minutes at RT. Following incubation, the cell suspension containing CD14+ and 
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CD16+ monocytes was poured into a 5 ml polystyrene tube and washed twice (250 
xg for 10 minutes) in Hank’s balanced salt solution (HBSS) supplemented with 
calcium and magnesium (Gibco®, Life Technologies, Paisley, UK). Cell pellets were 
resuspended in RPMI supplemented with GPS at a final concentration of 2x106.ml-1 
ready for migration analysis. 
2.4.4 Monocyte Migration 
Monocyte migration was measured using 5µm transwell chambers (Corning Costar, 
Amsterdam, Netherlands) towards monocyte chemoattractant protein-1 (MCP-1: 
R&D systems, UK) or RPMI supplemented with GPS as a control in sterile 
conditions. Chamber membranes were pre-wet with RPMI supplemented with GPS 
and placed into the 24-well plate containing either 900 µl of RPMI supplemented with 
GPS or 900 µl of RPMI supplemented with GPS containing 10nM MCP-1. Plates 
were incubated at 37°C in a sterile humidified 5% CO2 atmosphere for 1 hour. 
Following incubations chambers were removed and immersed 3 times in PBS before 
fixing with 3.7% (w/v) formaldehyde for 2 minutes at RT. Chambers were immersed 
3 times again in PBS and permeabilised in 100% methanol for 20 minutes before 
immersion in PBS again. Differential staining using a commercially available Giemsa 
stain (Diff-Qik: Gentaur Europe) was conducted by incubation of chambers in the 
dark for 15 minutes. Giemsa staining was washed off with PBS and inside chambers 
gently cleaned with cotton wool buds to remove any non-migrated cells and 
chambers left to dry for a minimum of 30 minutes. Once dry, chambers were viewed 
under a light microscope and adherent monocytes counted in five fields of vision at 
20x magnification.  
To determine if any monocytes had detached from the chamber membrane and 
passed into the chemoattractant each 900 µl sample was removed into a 5 ml 
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polystyrene tube. Wells were then incubated for 10 minutes at 37°C in 100 µl of 2% 
(w/v) trypsin (Sigma-Aldrich) before addition of 400 µl cold PBS supplemented with 
1% BSA and transferred to a 5 ml polystyrene tube. Cells in both samples were 
counted by flow cytometry. Using an AccuriTM C6 flow cytometer (BD Biosciences), 
50 µl of each sample was extracted and cells counted in the leukocyte gating applied 
on the forward v side scatter. Cell numbers were then added to the appropriate 
membrane counts and total monocyte migration calculated by subtracting the 
average number of monocytes per field plus flow cytometry counts in the control 
from the MCP-1 sample. 
2.4.5 Determination of Monocyte Production of Pro-Inflammatory Cytokines 
Monocyte cytokine production was evaluated by exposing heparin treated whole 
blood to lipopolysaccharide (LPS). Blood was diluted 1:1 in 5 ml polystyrene tubes 
with Iscove’s Modified Dulbecco’s Medium (IMDM) supplemented with GPS. LPS 
(Sigma-Aldrich) was added at a final concentration of 10 ng.ml-1, or the same volume 
of IMDM as a negative control, in the presence of 3 µg.ml-1 of Brefeldin A and 
incubated at 37°C in a sterile humidified 5% CO2 atmosphere for 4 hours. Following 
incubation samples were placed on ice and washed twice, 250 x g for 10 minutes at 
4°C, with 2 ml cold PBS supplemented with 1% BSA. Samples were then 
resuspended in 100 µl of PBS supplemented with 1% BSA and incubated on ice with 
appropriate surface antibodies or their concentration-matched isotype control (Table 
2.1) for 30 minutes in the dark. Samples were then washed as before in PBS 
supplemented with 1% BSA before resuspending the pellet in 2 ml of 1x BD FACSTM 
lysis buffer (reconstituted in distilled water) for 10 minutes at RT in the dark. Samples 
were then washed twice as before fixing and permeabilising cells using a 
commercially available fix and perm kit (Life Technologies). Fixation was completed 
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by incubating the cell pellet in 100 µl Reagent A for 15 minutes at RT in the dark. 
Following a single wash the cell pellet was permeabilised by incubating in 100 µl 
Reagent B and addition of the appropriate intracellular cytokine antibody or their 
concentration-matched isotype control for 30 minutes in the dark on ice. Samples 
were then washed twice as before and resuspended in PBS supplemented with 1% 
BSA and stored in the dark on ice until flow cytometric determination of monocyte 
cytokine production. 
 
Table 2.1: Anti-human primary antibodies used for monocyte analysis 
 
 
2.4.6 Flow Cytometry for Immune Cell Phenotyping 
Neutrophils were analysed from isolated cells whilst monocyte phenotype was 
assessed from isolated PBMCs. Briefly, 200 µl of isolated cells (1x106.ml-1) were 
dispensed into 5 ml polystyrene tubes and washed twice (250 x g for 5 minutes at 
4°C) in PBS supplemented with 1% BSA before supernatants discarded and cells 
resuspended in 100 µl PBS supplemented with 1% BSA containing surface specific 
antibodies or their concentration-matched isotype control (Table 2.2). Following 30-
minute incubation in the dark on ice, cells were washed twice as before and 
Antigen Fluorochrome Isotype Dilution Clone Supplier
CD14 PcB IgG2a 1:100 M5E2 BD Bioscience
CD16 FITC IgG1 1:25 3G8 BD Bioscience
CCR2 APC IgG2b 1:10 48607 R&D Systems
CCR4 APC IgG2b 1:10 205410 R&D Systems
TLR2 APC IgG2a 1:20 TL2.1 BD Bioscience
TLR4 APC IgG2a 1:20 HTA125 eBioscience
HLA-DR PE-CF594 IgG2a 1:50 G46-6 BD Bioscience
CD11b APC IgG1 1:20 ICRF44 BD Bioscience
CD18 PE IgG1 1:20 6.7 BD Bioscience
TNFα PE IgG1 1:100 MAb11 eBioscience
IL-6 PE IgG1 1:25 MQ2-13A5 eBioscience
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resuspended in 300 µl PBS supplemented with 1% BSA for flow cytometric analysis. 
All flow cytometry was performed using a CyAnADP bench top flow cytometer 
(DAKO). Neutrophil and monocyte proportions were determined by gating of 10,000 
and 5,000 cells, respectively, on the forward scatter (FS) versus side scatter (SS) 
flow cytometry dot-plot. Cells were then excluded for doublets before appropriate 
gating strategies applied to determine the percentage and surface density of each of 
the measured antigens.  
 
Table 2.2: Anti-human primary antibodies used for neutrophil analysis 
 
 
2.4.7 Neutrophil and Monocyte Phagocytosis and Superoxide Generation 
Neutrophil and monocyte phagocytosis and superoxide generation were assessed in 
whole blood immediately after sampling using commercially available kits according 
to manufacturer’s instructions (BD Biosciences, Oxford, UK). For all samples, the 
volume of blood tested was adjusted to ensure that neutrophil and monocyte 
concentrations in respect of bacteria were consistent across the three time-points.  
Briefly, phagocytosis was assessed in heparin treated whole blood which had been 
cooled on ice for 10 minutes. Samples were then incubated for 10 minutes on ice 
Antigen Fluorochrome Isotype Dilution Clone Supplier
CD16 FITC IgG1 1:25 3G8 BD Bioscience
CD16 APC IgG1 1:100 CB16 eBioscience
CXCR1 FITC IgG2b 1:50 8F1-1-4 eBioscience
CXCR2 PE IgG1 1:50 5E8-C7-F10 eBioscience
CXCR4 APC IgG2a 1:50 12G5 eBioscience
CD11b APC IgG1 1:20 ICRF44 BD Bioscience
CD18 PE IgG1 1:20 6.7 BD Bioscience
TLR2 APC IgG2a 1:20 TL2.1 BD Bioscience
TLR4 APC IgG2a 1:20 HTA125 eBioscience
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(control) or in a 37°C (test) water bath with 20 µl of pre-opsonised FITC-labelled 
E.Coli. Phagocytosis was halted by the addition of 2 ml ice cold phosphate buffered 
saline (PBS; Sigma-Aldrich, UK) whilst cell surface bound FITC was quenched by 
adding 100 µl of the kit trypan blue solution. Unbound free bacteria were removed by 
washing twice in 2 ml PBS at 250 x g for 5 minutes at 4°C. The supernatant was 
gently removed and erythrocytes lysed and leukocytes fixed by adding 2 ml of 1x 
erythrocyte lysis buffer, containing 1% paraformaldehyde, and incubated for 20 
minutes in the dark at RT. Samples were washed twice as before in PBS before 
staining leukocyte DNA by addition of 200 µl propidium iodide (PI) provided in the kit 
for 10 minutes in the dark at RT before flow cytometry analysis was performed.  
Superoxide generation was assessed in heparin treated whole blood which had been 
cooled in a 5 ml polystyrene tube on ice for 10 minutes. Samples were then 
incubated for 10 minutes at 37°C with 20 µl of opsonised E.Coli (test) or PBS 
(control) in a water bath. 20µl of solution containing dihyrdorodamine-123 (DHR-
123), which is converted to rodamine-123 (R-123) in the presence of reactive 
oxidants, was incubated for another 10 minutes at 37°C. Superoxide activity was 
halted by removing samples from the 37°C, placing on ice and adding 2 ml of 1x 
erythrocyte lysis buffer, containing 1% paraformaldehyde, and incubated for 20 
minutes in the dark at RT. Samples were washed twice at 250 x g for 5 minutes at 
4°C in 2ml PBS before staining leukocyte DNA as before for 10 minutes in the dark 
at RT before flow cytometry analysis was performed.  
Phagocytosis and superoxide analysis was determined on a Cyan ADP430 flow 
cytometer (Beckman-Coulter, High Wycombe, UK) equipped with 3 solid-state lasers 
emitting light at 405nm (Argon), 488nm (Violet) and 642nm (Red). FITC and R-123 
were detected in FL1 whilst PI was detected in FL2 using the Argon laser. To ensure 
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only leukocytes were analysed, samples were first gated on their PI positive profile. 
This gate was then applied to the forward/side scatter profile to enhance typical 
neutrophil and monocyte identification. 10,000 neutrophils and 5,000 monocytes 
were acquired for analysis. Phagocytic and superoxide capacity was determined by 
the relative increase in percentage and median fluorescent intensity (MFI) in FL1 
compared to negative controls. Gating strategy is depicted in Figure 2.1. Data were 
analysed using Summit v4.3 (DAKO, Cambridgeshire, UK).  
 
Fig. 2.1: Gating strategy to identify bactericidal function. DNA dye identifies 
leukocytes (A) before applying this gate to the forward/side scatter which enables 
clear identification of the monocyte and neutrophil populations (B). Individual 
populations are then gated on before identifying and eliminating cells which have 
joined together using size v width (C). This population of single cells is then applied 
to a dot plot of DNA (PE) versus phagocytosis/superoxide (FITC) in which electronic 
compensation is applied to ensure no overlap of the two fluorochromes (D). 
Histograms are then generated which represent the negative control (E) and the 
positive test (F) allowing for quantification of cell function. 
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Chapter 3: Systemic 
Inflammation in the 
Elderly: Causes and 
Consequences 
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3.0 Introduction 
 
A number of studies have suggested that increased low-grade chronic systemic 
inflammation (inflammageing) occurs in the elderly and is associated with negative 
health outcomes such as depression, reduced physical mobility, cardiovascular 
disease, type-2 diabetes and Alzheimer’s disease [31]. The consequences of 
inflammageing are therefore profound in respect to being a causative mechanism of 
poor health, frailty and mortality in the elderly [82, 134]. It remains unclear the exact 
causal mechanisms of inflammageing although possible factors include increased 
adiposity, reduced physical activity, alterations to the HPA axis, notable the 
increased cortisol:DHEAs ratio,  and reduced production of sex steroids [32, 190, 
250]. However one of the dominant theories is that inflammageing is driven by the 
sustained efforts of the immune system to control infections [251].  
Ageing is associated with increased incidence and severity of infectious episodes, 
due in large part to the age-related decline in immunity, termed immunesenescence 
[252]. The changes in the immune system with age are not simply a decline in 
function; instead the response is remodelled, with innate cells such as macrophages 
producing pro-inflammatory cytokines in the resting state but showing a 
compromised response when exposed to pathogens. Therefore with age the immune 
system adopts a heightened pro-inflammatory status but reduced functional 
responses upon challenge leading to reduced pathogen clearance. Several age-
related changes to the immune system have been shown to be associated with 
increased mortality, termed the immune risk profile (IRP) [96]. Individuals who are 
infected with latent viral infections of the herpes family, specifically Cytomegalovirus 
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(CMV) are more likely to show accelerated immunesenescence and other elements 
of the IRP [89].  
CMV is a prevalent β-herpes virus infecting 60-90% of the population and undergoes 
intermittent reactivation requiring the adaptive immune system to contain and control 
it [95]. Although in healthy individuals CMV infection is asymptomatic it can lead to 
severe disease and death in those who are immune compromised. Furthermore, 
CMV has been shown to stimulate the production of pro-inflammatory cytokines from 
the immune system [93]. These observations have led to the suggestion that CMV 
infection is a primary driver of inflammageing and that this effect can contribute to 
increased morbidity including reduced physical functioning and mortality.  
In light of this, the aims of this chapter were to: 
1. Use a longitudinal cohort analysis to assess the contribution of systemic CMV 
infection on the progression of inflammation and adrenopause. 
2. Investigate the relationship between systemic inflammation, adrenopause and 
ageing over a ten year period. 
3. Determine lifestyle factors which influence systemic inflammation and 
adrenopause. 
4. Determine the consequences of systemic inflammation and adrenopause on 
frailty and mortality. 
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3.1 Study protocol: The Hertfordshire Ageing Study 
 
3.1.1 Participants 
The Hertfordshire Ageing Study (HAS) has been described previously and the 
protocol for recruitment of participants is presented in Figure 2.1 [253]. Briefly, 6803 
birth certificates dated between 1920 and 1930 were recovered and following 
investigation by the National Health Service Central Register 2621 subjects were 
found to be alive in the UK, of which 1428 were still residing in Hertfordshire. Home 
interviews and clinical assessment for a wide range of ageing characteristics and 
peripheral blood samples were obtained on 717 participants in 1993/94. Ten years 
later (2003/5) home interviews and clinical assessment including peripheral blood 
samples were conducted on 294 of the original 717 participants. Mortality was 
ascertained between these assessments and revealed 17% of participants were 
deceased. Table 3.1 shows the data available and measurements taken by 
researchers and trained research nurses during both clinical assessment and home 
interviews.  
Intravenous blood samples were collected and processed by research technicians 
for whole blood differentials, erythrocyte sedimentation rate (ESR), albumin, thyroid 
stimulating hormone (TSH), free T4 (T4), testosterone, sex hormone-binding globulin 
(SHBG), and peripheral blood mononuclear cell (PBMC) DNA isolation. Serum was 
snap frozen and stored at -80°C until analysis was conducted.  This project was 
given access by the MRC Human Epidemiology Unit, Southampton University, to the 
stored serum for analysis of various components as described above and the 
associated lifestyle data and physiological measurements made on the cohort. 
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Fig. 3.1: Recruitment of participants into the HAS study. Adapted from Sydall et 
al [253] .  
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Table 3.1: Data available from the HAS. Adapted from Syddall et al. [253]. 
 AH4 (Alice Heims-4), MMSE (Mini mental state examination), FEV (Forced 
expiratory volume), FVC (Forced vital capacity), SF36 (Short-Form 36).  
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3.1.2 Statistical Analysis 
All analyses were conducted using either Stata 11 (Stata Statistical Software, 
StataCorp 2009) or PASW version 18.0 (Chicago, IL, USA) and all data are 
presented as mean ± SD unless otherwise stated. Normality was assessed using 
Kolmogrov-Smirnov analysis; natural log transformation of distributed variables 
violating normality was completed. Independent sample T-tests were conducted to 
assess differences of variables between men and women at baseline and follow-up. 
Three categorical groups were created based on CMV infection over time and 
represented as either being negative (CMV-/-), positive (CMV+/+) or having 
converted from negative to positive (CMV-/+) over time. Data were then analysed 
using repeated measures ANOVA to assess the effect of time on inflammation and 
then its interaction with CMV status and gender. Following this, BMI and smoking 
status were included in analyses as covariates to adjust for potential confounding 
variables. The assumption of sphericity was tested using Mauchley’s method and 
any violations corrected for using the Greenhouse-Geisser method. Partial η2 is 
reported as a measure of effect size. Post-hoc pair wise analysis with Bonferroni 
correction was conducted to assess inflammatory variable differences over time in 
each CMV group. Linear regression analysis of the log-normalised data was used to 
test for significant associations between lifestyle factors either baseline and follow-up 
and inflammatory mediator’s. Individual lifestyle components were entered 
individually as independent variables (model 1); following this, any significant related 
lifestyle factors were entered together (model 2) to assess their mutually adjusted 
associations with cytokine levels. Follow-up time was calculated as the time elapsed 
in decimal years between the 1994/5 baseline and 2003/5 follow-up clinics. 
Pearson’s correlation coefficients and principal components analysis were used to 
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explore the interrelationships between biomarkers. Cox’s proportional hazards 
models and logistic regression models were used to analyse associations between 
the 1994/5 baseline panel of biomarkers and all-cause mortality and between data 
collection points and Fried frailty at the follow-up, respectively. Analyses were 
conducted with and without adjustment for the potential confounding effects of 
gender, follow-up duration (for logistic models for frailty only), and 1994/5 baseline 
age, height, BMI, smoking status, alcohol consumption, social class in adulthood, 
walking speed and number of systems medicated. Receiver operating characteristic 
(ROC) curves were used to explore the ability of the baseline biomarkers to 
discriminate between frailty at follow-up. Data were principally analysed for men and 
women combined, but analyses were repeated for men and women separately. A 
5% significance level was principally used to identify statistically significant 
associations, but a Bonferroni correction was also applied to enable identification of 
significant associations after allowance for multiple comparisons. Statistical 
significance was accepted at p<0.05. 
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3.2 Results 
 
3.2.1 Participant Characteristics  
Participant characteristics are presented in Table 3.2 for the 411 men and 306 
women recruited into the study at the baseline (1994/5) clinic. The average age was 
67.5 years for both men and women. Typical differences were evident between men 
and women for height (p<.001) and weight (p<.001) but not BMI (p=.703). Significant 
gender differences were evident for lifestyle choices. Men smoked more (p=.035), 
drunk more alcohol (p<.001), travelled more often in cars (p<.001) and carried more 
heavy loads (p<.001) while women watched more hours of TV (p=.004). Clinical 
measurements were all within the normal ranges however women had higher ESR, 
SHBG, TSH and lower free thyroxine (T4) values (all p<.001) than men (Table 3.2). 
Inflammatory profiles were all within normal ranges and showed men having higher 
IL-10, TNFα and lower IL-1β (all p<.001) than women. Endocrine profiles revealed a 
typical profile of men having higher DHEAs concentrations (p<.001) than women 
which resulted in a lower cortisol:DHEAs ratio (p<.001). Of the participants at 
baseline, men were at a greater mortality risk [HR: 1.51 (1.03 -2.21), p=.03] than 
females which was evident by 81 men (19.7%) and 40 women (13.1%) dying before 
the 2003/5 follow-up clinic.  
As the total white cell count (WCC) is made up from the differentials of 
predominantly neutrophils, monocytes and lymphocytes there were strong inter-
correlations ranging from 0.62 to 0.95  between WCC and each of the cell types (all 
p<.001). Neutrophils and monocytes correlated with each other (r=0.61, p<.001) 
whilst CRP correlated with WCC, neutrophil, monocytes and ESR (r range = 0.33 to 
0.37, p<.001 for all). Cortisol and DHEAs were correlated with each other (r=.091, 
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p=.016) and the ratio. Cortisol and DHEAs did not correlate with any of the other 
biomarkers measured (range: r=0.01 to 0.18, p>.05 for all). Principal component 
analysis of the measured biomarkers confirmed these associations with the first 
component accounting for 21% of the variation in the data and was a weighted 
average of WCC, neutrophils, monocytes, lymphocytes and CRP. The second 
component accounted for 13% of the variation in the data and was a contrast 
between cortisol and DHEAs. 
Of those individuals measured at baseline, 254 returned (153 men) for assessment 
at the 2003/5 follow-up and were measured for frailty status (Table 3.3). At follow-up 
women were more likely to be frail (p=.05) with a frailty prevalence of 11.9% 
compared to 5.2% for men. The average age of men was 66.9 years whilst women 
were 67.3 years old and were followed up 10.4 and 9.9 years respectively. Similar 
social, clinical, inflammatory and endocrine characteristics were evident between 
males and females from this group as those in the baseline assessment (Table 3.2). 
At follow-up 34% and 29% of men and women were respectively negative for CMV 
infection while 10% of men and 5% of women had converted to being positive for 
CMV during the time between measurements.  
Inter-correlations between biomarkers were similar in these participants except for 
cortisol and DHEAs which were independent of each other (r=.0.01, p=.90) but not 
the ratio as this is a component of the two. Cortisol and DHEAs did not correlate with 
any of the other biomarkers measured (range: r=0.02 to 0.15, p>.05 for all). Principal 
component analysis of the measured biomarkers confirmed these associations with 
the first component accounting for 19% of the variation in the data and was a 
weighted average of WCC, neutrophils, monocytes, lymphocytes and CRP. The 
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second component accounted for 12% of the variation in the data and was a contrast 
between cortisol and DHEAs. 
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Table 3.2: Characteristics of men and women assessed at baseline clinic 
 
Data are mean (SD) unless indicated. aNumber and percentage; bDefined as weekly 
alcohol consumption of ≥ 11 units for men and ≥ 8 units for women; cDefined as 
classes I, II, IIINM of the 1990 OPCS coding of social class; dVariable was positively 
skewed; median and inter-quartile range shown; eDefined as those who climb stairs 
daily or several times per day as opposed to never, occasionally or once a week; 
fAssessed as those who regularly travel in a car; gDefined as those who carry heavy 
loads either daily or several times per day; hAssessed as either being negative or 
positive at both baseline and follow-up or having converted from negative to positive 
from baseline to follow-up. *p<.05, **p<.01, ***p<.001 different from males   
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Table 3.3: Baseline characteristics of participants assessed at follow-up clinic 
 
Values are mean (SD) unless indicated. aNumber and percentage. bDefined as 
weekly alcohol consumption of ≥ 11 units for men and ≥ 8 units for women. cDefined 
as classes I, II, IIINM of the 1990 OPCS coding of social class. dVariable was 
positively skewed; median (25th and 75th percentile). eDefined as those who climb 
stairs either daily or several times per day as opposed to never, occasionally or once 
a week. fAssessed as those who regularly travel in a car as opposed to not regularly 
travelling by car. gDefined as those who carry heavy loads either daily or several 
times per day. hAssessed at the follow-up clinic. *p<.05, **p<.01, ***p<.001 different 
from males. 
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3.2.2 Evidence for Inflammageing  
Analysis of serum CRP and pro- and anti-inflammatory cytokines revealed a profile 
of increased systemic inflammation during ageing in line with previous observations 
[254]. There were significant main effects of ageing for IL-6, TNFα, CRP, IL-10 and 
IL-1β (Fig. 3.2). IL-6 (Fig. 3.2A) concentrations increased 2.3-fold over time [F(1,154) = 
117.3, p<.001; η2=.432], whilst TNFα (Fig. 3.2B) showed a 4.3-fold increase over the 
10-year period [F(1,104) = 126.5, p<.001; η
2=.549]. CRP (Fig. 3.2C) levels increased 
modestly 1.2-fold from baseline to follow-up [F(1,240) = 5.0, p=.026; η
2=.021] and IL-1β 
(Fig. 3.2F) decreased modestly by from baseline to follow-up [F(1,147) = 10.46, 
p=.002; η2=.066]. IFNγ (Fig. 3.2D) did not change over time [F(1,199) = 1.7, p=.188; 
η2=.009]. In addition levels of the anti-inflammatory cytokine IL-10 (Fig. 3.2E) were 
reduced by 65% over the 10-year period [F(1,53) = 42.8, p<.001; η
2=.447].  
3.2.3 Impact of Cytomegalovirus Infection on Inflammageing 
The analysis was repeated for the three different CMV groupings: those who were 
CMV seronegative at both time points (CMV -/-), those who were seronegative at 
baseline and converted during the 10 year period (CMV -/+) and those who were 
seropositive at both time points (CMV +/+). Similar increases were found in both IL-6 
(Fig. 3.3A) and TNFα (Fig. 3.3B) between baseline and follow-up in all three groups. 
IL-6 showed a 2.4-, 2.2- and 2.4-fold increase in the CMV-/+ (p=.03), CMV-/- 
(p<.001) and CMV+/+ (p<.001) groups, respectively. There was a corresponding 6.0, 
4.2- and 4.1-fold increase in TNFα in the CMV-/+, CMV-/- and CMV+/+ groups 
respectively (all p<.001).  CRP (Fig. 3.3C) concentrations did not change over time in 
the CMV-/+ (p=.541) or the CMV-/- (p=.736) but did increase significantly in the 
CMV+/+ (p=.004). In contrast IL-1β (Fig. 3.3F) concentrations did not change over 
time in the CMV-/+ (p=.975) or the CMV-/- (p=.517) but did decrease significantly in 
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the CMV+/+ (p<.001). IL-10 (Fig. 3.3E) concentrations were reduced 0.8- and 0.5-
fold in the CMV-/- (p=.001) and the CMV+/+ (p=.01) groups respectively, and a trend 
towards a reduction in the CMV-/+ (p=.07) was seen. Concentrations of IFNγ (Fig. 
3.3D) did not change over the 10-year period in the group as a whole (p=.188) and 
no change was seen in any of the three CMV groupings, CMV-/+ (p=.928), CMV-/- 
(p=.401) and CMV+/+ (p=.474). 
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Fig. 3.2: Evidence of Inflammageing. Cytokines IL-6 (A), TNFα (B), IFNγ (D),  IL-10 (E) and IL-1β (F) and CRP (C) in serum at 
baseline and 10 year follow-up in participants from the Hertfordshire Ageing Study. Data are mean ± S.E.M. analysed by mixed 
model repeated measures ANOVA. *p<.05, **p<.01, ***p<.001 for Baseline compared with Follow-up. 
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Fig. 3.3: CMV and Inflammageing. Impact of CMV serostatus and ageing on serum cytokine and CRP concentrations. At baseline 
(Black Bars) and 10-year follow-up (White Bars)   participants were grouped by CMV serostatus as either negative at baseline and 
positive at follow-up (CMV-/+), negative at both time points (CMV-/-) or positive at both time points (CMV+/+). Serum IL-6 (A), TNFα 
(B), CRP (C), IFNγ (D) , IL-10 (E) and IL-1β (F), were measured at baseline and 10 year follow up. Data are mean ± S.E.M. 
analysed by mixed model repeated measures ANOVA with Bonferroni corrected pair wise comparisons. *p<.05, **p<.01, ***p<.001 
for Baseline compared with Follow-up. 
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3.2.4 Evidence for Adrenopause with Ageing 
Endocrine dysfunction with age is associated with an imbalance of anti-inflammatory 
cortisol and the immune enhancing androgen DHEAs. The ratio of cortisol to DHEAs 
has been previously associated with morbidity and mortality in the elderly and 
therefore may play a role in systemic inflammation. As CMV infection was found not 
to be driving systemic inflammation its relationship with cortisol and DHEAs was 
determined. Interestingly, CMV is known to infect functional adrenocortical cells 
causing an increased and persistent production of cortisol. It is suggested that CMV 
increases cortisol in order to reduce the immune response against it and also to 
propagate replication.  
Analysis of serum cortisol and DHEAs revealed a profile of altered adrenal cortex 
function during ageing in line with previous observations (Fig. 3.4). There were 
significant main effects of ageing for concentrations of cortisol and DHEAs and the 
ratio of cortisol:DHEAs. Cortisol (Fig. 3.4A) concentrations increased by 29% over 
time [F(1,263) = 48.08, p<.001; η
2=.155] whilst DHEAs (Fig. 3.4B) concentrations 
decreased by 21% over time [F(1,259) = 14.80, p<.001; η
2=.054]. At both time points 
males had higher DHEAs concentrations than females (p<.001) and subsequently 
the reduced DHEAs concentrations were driven by male participants. Because of 
these opposite effects over time the ratio of cortisol:DHEAs (Fig. 3.4C) increased by 
179% over the 10-year time period [F(1,259) = 7.80, p=.006; η
2=.029]. 
3.2.4 Impact of Cytomegalovirus Infection on Adrenopause 
When the analysis was repeated for the three CMV groupings similar patterns of 
change for cortisol (Fig. 3.4D), DHEAs (Fig. 3.4E) and the ratio of cortisol:DHEAs 
(Fig. 3.4F) were observed. Cortisol showed a 30%, 37% and 24% increase in the 
CMV-/+, CMV-/- and CMV+/+ groups respectively (all p<.001). There was a 
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corresponding 32%, 32% and 13% decrease in DHEAs concentrations in the CMV-
/+, CMV-/- and CMV+/+ groups respectively (all p<.001). Consequently, 
cortisol:DHEAs ratios increased by 81%, 150% and 202% for the CMV-/+ (p=.009), 
CMV-/- (p<.001) and CMV+/+ (p<.001) groups respectively.    
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Fig. 3.4: Adrenopause and CMV Infection. Impact of ageing and CMV serostatus on serum cortisol and DHEAs concentrations. 
Serum concentrations of cortisol (A), DHEAs (B) and the cortisol:DHEAs ratio (C) were determined at baseline (Black Bars) and 10-
year follow-up (White Bars).   Participants were grouped by CMV serostatus as either negative at baseline and positive at follow-up 
(CMV-/+), negative at both time points (CMV-/-) or positive at both time points (CMV+/+) for Cortisol (D), DHEAs (E), or the ratio of 
cortisol to DHEAs (F). Data are mean ± S.E.M. analysed by mixed model repeated measures ANOVA with Bonferroni corrected 
pair wise comparisons. **p<.01, ***p<.001 for Baseline compared with Follow-up. 
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3.2.5 Impact of Behavioural Lifestyle Choices on Inflammageing 
As CMV did not appear to be driving systemic inflammation or adrenal alterations 
over time in the elderly, behavioural lifestyle choices were assessed for associations 
with observed changes in inflammation and adrenal function. Table 3.4 highlights the 
relationship between baseline lifestyle choices, social status, body composition and 
baseline serum IL-6, CRP, TNFα, IL-1β, IL-10 and the cortisol:DHEAs ratio. No 
associations were evident for IFN-γ (data not shown). Of all the independent 
variables assessed only social class did not influence any of the biological markers 
assessed suggesting that unlike the prevalence of a number of diseases, 
socioeconomic status does not have an influence on inflammageing. The data 
suggest that increased CRP levels were associated with lifestyle factors consistent 
with sedentary behaviours such as more hours watching TV (p<.001) and less 
walking distance (p<.001), as well as an unhealthy lifestyle consisting of smoking 
(p=.025) and being overweight [increased BMI and waist to hip ratio (both p<.001)]. 
Following mutually adjusted analyses all of these lifestyle factors remained 
significant except for waist:hip ratio. Around 13% of the increase in CRP 
concentrations can be attributed to being overweight, reduced walking speed and 
increased hours watching TV. These data suggest that both body composition and 
physical activity levels account for raised CRP concentrations in elderly individuals.  
CRP is synthesised in response to IL-6 production, in this model IL-6 concentrations 
were positively associated with BMI (p=.004) highlighting its relationship with body 
composition and CRP production. TNFα concentrations were associated with more 
hours watching TV (p=.016) and a lack of climbing stairs regularly (p=.032), which 
after mutual adjustment remained significant. These data suggest that increased 
TNFα concentrations in healthy elderly are mainly associated with physical inactivity 
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and less so with body composition. IL-1β had an unexpected association which 
implied that drinking (p=.016) may protect against increased concentrations whilst 
having an increased waist:hip ratio (p<.001) was also associated with reduced 
concentrations. However, physical inactivity was associated with increased 
concentrations of IL-1β indicated by more travelling in cars and increased hours 
watching TV (both p<.001). Following mutual adjustment both physical inactivity 
associations remained highly significant whilst waist:hip ratio was severely 
attenuated (p=.043) and alcohol drinking was completely attenuated.  
Interestingly unadjusted analysis of IL-10 concentrations revealed that waist:hip ratio 
(p<.001), alcohol consumption (p=.001) and carrying heavy loads (p=.003) were 
positively associated with increased concentrations whilst watching more TV was 
negatively associated. These data would suggest that IL-10 concentrations would be 
reduced in physically inactive individuals but be increased if they were overweight.  
Following mutual adjustment, physical inactivity measures were attenuated and were 
not significant (p=.838 and p=.811 respectively) whilst waist:hip ratio (p<.001) 
remained significant suggesting IL-10 is influenced more by body composition in the 
elderly than physical activity levels.  
The ratio of cortisol:DHEAs has been suggested to be a good predictor of morbidity 
in both young and elderly individuals. The cortisol:DHEAs ratio was influenced by 
both body composition and physical activity levels. Increased ratios were associated 
with those that watched more TV (p=.039) and carried few heavy loads (p<.001), 
whilst lower ratios were observed in those who smoked (p=.001), drank more alcohol 
(p=.007) and had increased waist:hip ratios (p<.001).  Increased alcohol intake 
(p=.791) and watching TV (p=.094) were attenuated with mutual adjustment analysis 
and lost significance, but the relationship with cortisol:DHEAs ratio remained 
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significant for carrying loads (p=.025), smoking (p=.008) and waist: hip ratio 
(p<.001).  
Taken together it is clear that at an average age of 67 ± 2 years leading a sedentary 
lifestyle accounts for heightened systemic inflammation and reduced anti-
inflammatory potential. The R2 values in Table 3.2 show that mutually associated 
sedentary lifestyle choices and body composition contributed to around 2%, 13%, 
2% and 7% of elevations in inflammatory IL-6, CRP, TNFα and IL-1β respectively. 
Almost 20% of reduced anti-inflammatory potential (IL-10) was associated with 
sedentary lifestyles while also accounting for 2% of the elevations in the 
cortisol:DHEAs ratio. 
Table 3.5 highlights the relationship between baseline behavioural lifestyle choices, 
social status, body composition and the 10-year follow-up serum concentrations of 
IL-6, CRP, TNFα, IL-1β, IL-10 and the cortisol:DHEAs ratio. As previously shown 
ageing was associated with increased levels of IL-6, CRP, TNFα and cortisol:DHEAs  
ratio, whilst IL-10 and IL-1β were reduced in those who were assessed at both time 
points. Therefore, baseline biomarker values were included in the model to eliminate 
the bias that having higher concentrations at baseline resulted in higher 
concentrations at the 10-year follow-up.  
No associations were evident for IFN-γ (data not shown).  CRP was elevated 10-
years after baseline if participants had a higher BMI (p=.007) and drunk more alcohol 
(p=.008). Following mutually adjusted analysis it was revealed that CRP increases in 
later life were mainly driven by body composition and is most likely a reflection of 
elderly individuals becoming more inactive. Interestingly IL-6 had a similar pattern of 
association as before, relating to BMI (p=.018) along with CRP, however those that 
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carried more heavy loads were likely to have reduced IL-6 concentrations (p=.032). 
Associations remained following mutual adjustment suggesting that being active in 
younger life can lower the risk of elevated IL-6 in later life. The fact there was no 
association with CRP and load carrying suggests that the reduced IL-6 levels 
associated with load carrying is enough to impact the IL-6 stimulation of CRP.  
No associations were observed for TNFα however there was a trend for individuals 
who drank more alcohol to have higher TNFα (p=.073) whilst IL-1β was positively 
associated with smoking (p=.041). Although at baseline individuals who had higher 
waist:hip ratios were likely to have elevated IL-10  concentrations this association 
was lost at follow-up (p=.771), instead those who travelled more in cars (p=.006) 
were more likely to have reduced IL-10 concentrations.  The cortisol:DHEAs ratio 
showed no association of baseline lifestyle factors affecting the future 
concentrations. 
Although these data could not assess whether those who completed the follow-up 
assessment maintained their physical activity parameters during the ten year period 
it is clear that behavioural lifestyle choices can significantly influence systemic 
inflammation ten years later. The R2 values in Table 3.5 show that mutually 
associated sedentary lifestyle choices and body composition at baseline contributed 
to around 3%, 4% and 2% of future elevated IL-6, CRP and IL-1β concentrations 
respectively. Almost 10% of reduced anti-inflammatory potential (IL-10) at follow-up 
was associated with travelling more in a car 10-years earlier. Taken together the 
data in Tables 3.4 and 3.5 suggest that leading a sedentary lifestyle can account for 
considerable proportions of future heightened systemic inflammation and reduced 
anti-inflammatory potential.  
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Table 3.4: Lifestyle factors and inflammation. Relationship between lifestyle factors at baseline and the level of serum 
inflammatory, anti-inflammatory and endocrine biomarkers at baseline for the 717 HAS participants. 
 
Linear regression analysis of the log-normalised data was used to test for significant associations between lifestyle factors at 
baseline sampling and the level of baseline inflammatory, anti-inflammatory and endocrine biomarkers. Individual lifestyle 
components were entered individually as independent variables (model 1); following this, any significant related lifestyle factors 
were entered together (model 2) to assess their mutually adjusted associations with cytokine levels. Values which are highlighted 
and bold represent significant associations.  
Model Predictor β t p R
2
β t p R
2
β t p R
2
β t p R
2
β t p R
2
β t p R
2
1 Body Mass Index (kg/m
2)
.295 7.662 <.001 .085 .146 2.920 .004 .019 .006 .136 .892 -.002 .029 .619 .536 -.001 -.085 -1.885 .060 .005 .039 .981 .327 .000
Waist: Hip Ratio .091 2.260 .024 .007 .053 1.054 .292 .000 -.035 -.731 .461 -.001 -.164 -3.576 <.001 .025 .443 10.883 <.001 .194 -.224 -5.773 <.001 .049
Alcohol (grouped) .027 .672 .502 -.001 -.064 -1.279 .202 -.002 -.039 -.827 .409 -.001 -.111 -2.416 .016 .010 .145 3.260 .001 .019 -.106 -2.703 .007 .010
Smoking .090 2.255 .025 .007 .000 -.004 .997 -.003 .000 .002 .998 -.002 .005 .116 .907 -.002 .072 1.589 .113 .003 -.132 -3.342 .001 .016
Social Class .074 1.838 .067 .004 -.022 -.435 .663 -.002 .001 .020 .984 -.002 -.022 -.462 .644 .002 -.012 -.265 .791 -.002 -.034 -.852 .395 .000
Total Walking -.126 -3.169 .002 .014 -.034 -.678 .498 -.001 .019 .407 .684 -.002 .047 1.012 .312 .000 .040 .877 .381 .000 -.014 -.341 .733 .001
Car Travel -.028 .687 .492 -.001 -.093 -1.840 .066 .006 .032 .673 .501 -.001 .176 3.884 <.001 .029 -.149 -3.337 .001 .020 -.060 1.512 .131 .002
Hours Watching TV .155 3.915 <.001 .023 .067 1.338 .182 -.002 .114 2.419 .016 .011 .162 3.543 <.001 .024 -.081 -1.800 .072 .005 .082 2.066 .039 .005
Climbing Stairs .031 .777 .437 -.001 -.028 -.554 .580 -.002 .101 2.145 .032 .008 .048 1.033 .302 .000 -.035 -.773 .440 -.001 .016 -.415 .678 .001
Carrying Heavy Loads .019 .472 .637 -.001 .009 .177 .860 -.002 .002 .041 .967 -.002 .001 .011 .991 -.002 .136 3.025 .003 .016 -.146 -.3716 <.001 .020
2 Body Mass Index (kg/m
2)
.285 7.129 <.001
Waist: Hip Ratio .027 .659 .510 -.101 -2.026 .043 .445 9.856 <.001 -.171 -3.956 <.001
Alcohol (grouped) -.033 -.676 .500 -.015 .217 .828 .018 .265 .791
Smoking .096 2.418 .016 -.108 -2.673 .008
Social Class
Total Walking -.102 -.2680 .008
Car Travel .134 2.853 .005 .008 .205 .838
Hours Watching TV .113 2.914 .004 .126 .113 2.420 .016 .137 2.994 .003 .066 .067 1.677 .094
Climbing Stairs .101 2.147 .032 .023
Carrying Heavy Loads .010 .240 .811 .196 -.091 -2.240 .025 .071
Cortisol: DHEAsCRP IL-6 TNF-α IL-1β IL-10
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Table 3.5: Lifestyle factors and future inflammation. Relationship between lifestyle factors at baseline and the level of serum 
inflammatory, anti-inflammatory and endocrine biomarkers at follow-up for the 254 HAS participants returning. 
 
Linear regression analysis of the log-normalised data was used to test for significant associations between lifestyle factors at 
baseline sampling and the level of follow-up inflammatory, anti-inflammatory and endocrine biomarkers. Lifestyle components were 
entered individually as independent variables (model 1); following this, any significant related lifestyle factors were entered together 
(model 2) to assess their mutually adjusted associations with cytokine levels. Values which are highlighted and bold represent 
significant associations. 
Model Predictor β t p R
2
β t p R
2
β t p R
2
β t p R
2
β t p R
2
β t p R
2
1 Body Mass Index (kg/m
2)
.167 2.724 .007 .028 .147 2.382 .018 .022 -.048 -.578 .564 .002 .066 .922 .357 .004 .024 .208 .836 .001 .042 .671 .499 .002
Waist: Hip Ratio .046 .736 .462 .002 .007 .117 .907 .000 .007 .088 .930 .000 .051 .715 .476 .003 .034 .292 .771 .001 -.051 -.814 .417 .003
Alcohol (grouped) .165 2.692 .008 .027 -.001 -.021 .984 .000 .149 1.805 .073 .022 .011 .152 .879 .000 .018 .154 .878 .000 -.019 .301 .763 .000
Smoking .076 1.230 .220 .006 .081 1.312 .191 .007 .069 .825 .411 .005 .146 2.061 .041 .021 -.082 -.709 .480 .007 -.056 -.907 .365 .003
Social Class .025 .392 .695 .001 .026 .417 .677 .001 -.079 -.950 .344 .006 -.016 -.215 .830 .000 -.138 -1.192 .237 .019 -.043 -.682 .496 .002
Total Walking .008 .133 .895 .000 .067 1.071 .285 .004 -.022 -.262 .794 .000 -.081 -1.141 .255 .007 .015 .133 .895 .000 -.040 -.644 .520 .002
Car Travel -.027 -.439 .661 .001 .055 .879 .380 .003 -.039 -.472 .638 .002 .028 .387 .699 .001 -.313 -2.834 .006 .098 -.021 -.334 .739 .000
Hours Watching TV .082 1.327 .186 .007 .102 1.646 .101 .010 .027 .325 .745 .001 .102 1.437 .152 .010 .168 1.466 .147 .028 .092 1.477 .141 .008
Climbing Stairs .014 .222 .825 .000 .036 .571 .569 .001 .123 1.483 .140 .015 .011 .155 .877 .000 -.005 -.039 .969 .000 .081 1.300 .195 .007
Carrying Heavy Loads -.051 -.817 .415 .003 -.133 -2.158 .032 .018 -.054 -.649 .518 .003 -.050 -.696 .487 .002 .128 1.110 .271 .016 .017 .270 .787 .000
2 Body Mass Index (kg/m
2)
.163 2.673 .008 .144 2.353 .019
Waist: Hip Ratio
Alcohol (grouped) .176 1.731 .085 .043
Smoking
Social Class
Total Walking
Car Travel
Hours Watching TV
Climbing Stairs
Carrying Heavy Loads -.130 -2.128 .034 .031
CRP IL-6 TNF-α IL-1β IL-10 Cortisol: DHEAs
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3.2.6 Associations with Inflammation, Adrenopause and Frailty 
To assess the consequences of systemic inflammation and adrenopause on the 
health of the elderly participants the baseline inflammatory associations with 
prevalence of frailty and all-cause mortality were assessed for the cohort. 
Determination of frailty in this cohort has been described previously [134]. 
The associations between the biological markers at baseline and frailty status at 
follow-up are outlined in Table 3.6. Unadjusted analyses of the increase [OR (95% 
CI) and p value] for WCC [2.51 (1.49, 4.24), p=.001], ESR [2.23 (1.28, 3.88), 
p=.005], neutrophils [2.17 (1.29, 3.65), p=.004], monocytes [3.22 (1.80, 5.74), 
p<.001], lymphocytes [2.00 (1.23, 3.25), p=.005], T4 [1.86 (1.11, 3.13), p=.002] and 
the cortisol:DHEAs ratio [1.78 (1.17, 2.72), p=.007] as well as a decrease in DHEAs 
[2.04 (1.30, 3.23), p=.002] levels were all associated with increased risk of being frail 
10-years later. CMV titre has been previously associated with progression to frailty; 
however there was no association here. Following Bonferroni correction (all p<.005) 
increases in WCC, monocytes and the reduction in DHEAs remained associated with 
frailty. Results were unaltered by adjustment for gender, baseline age and time 
between measurements. Results for ESR (p=.054) and T4 (p=.07) were attenuated 
by adjusting for height, weight, BMI, smoking, alcohol, social class and walking 
speed. Although results for neutrophils (p=.068) were attenuated by adjustment for 
co-morbidities, white cell count (p=.019), monocytes (p=.001), lymphocytes (p=.016), 
DHEAs (p=.023) and cortisol:DHEAs (p=.037) remained significantly associated with 
frailty 10-years after baseline clinical assessment.  
 
Figure 3.5 shows the associations of white cell count (Fig. 3.5A), neutrophils (Fig. 
3.5B), monocytes (Fig. 3.5C), lymphocytes (Fig. 3.5D), DHEAs (Fig. 3.5E) and 
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cortisol:DHEAs (Fig. 3.5F) when split into tertiles and assessed against the 
prevalence of frailty, revealing the clear associations with elevated biological blood 
markers and frailty in older age.  
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Table 3.6: Inflammation and frailty. Associations between Baseline biomarkers and Fried frailty status at Follow-Up for the 254 
HAS participants returning. 
 
OR: Odds Ratio, CI: Confidence Interval, p: probability value. a Unadjusted OR for frailty per standard deviation increase in 
biomarker. b OR adjusted for gender and baseline age. c OR adjusted as in footnote b as well as height, weight, BMI, smoking, 
alcohol, social class and walk speed. d OR adjusted as in footnote c as well as number of systems medicated as a marker of co-
morbidity. e Based on data for males only. 
Biomarker OR
a
95% CI p OR
b
95% CI p OR
c
95% CI p OR
d
95% CI p
Immune Composition
White Cell Count (x10
9.
L
-1
) 2.51 (1.49, 4.24) .001 2.85 (1.60, 5.07) <.001 2.36 (1.24, 4.51) .009 2.22 (1.14, 4.33) .019
Neutrophils (x10
9.
L
-1
) 2.17 (1.29, 3.65) .004 2.42 (1.37, 4.25) .002 1.92 (1.05, 3.52) .035 1.83 (0.96, 3.52) .068
Monocytes (x10
9.
L
-1
) 3.22 (1.80, 5.74) <.001 4.11 (2.11, 7.99) <.001 4.23 (1.94, 9.22) <.001 3.88 (1.73, 8.69) .001
Lymphocytes (x109.L-1) 2.00 (1.23, 3.25) .005 2.07 (1.26, 3.40) .004 2.00 (1.14, 3.53) .016 2.09 (1.15, 3.79) .016
Clinical
CMV Titre (Au) 1.10 (0.69, 1.75) .702 0.99 (0.61, 1.59) .956 0.96 (0.59, 1.58) .891 0.92 (0.57, 1.56) .910
ESR (mm
.
hr
-1
) 2.23 (1.28, 3.88) .005 2.36 (1.29, 4.30) .005 2.04 (0.99, 4.21) .054 1.77 (0.85, 3.65) .125
Albumin (g
.
L
-1
) 0.70 (0.44, 1.10) .123 0.66 (0.41, 1.06) .085 0.59 (0.34, 1.02) .058 0.48 (0.26, 0.91) .024
SHBG (nmol
.
L
-1
) 0.98 (0.63, 1.52) .936 0.90 (0.57, 1.40) .631 0.89 (0.51, 1.55) .678 0.88 (0.48, 1.61) .688
Testosterone (nmol
.
L
-1
)
e
1.54 (0.70, 3.42) .285 1.06 (0.44, 2.56) .892 4.06 (0.81, 20.39) .089 5.42 (0.95, 30.87) .057
Haemoglobin (g
.
L
-1
) 0.84 (0.52, 1.37) .495 0.84 (0.50, 1.42) .522 0.69 (0.39, 1.22) .203 0.82 (0.46, 1.48) .515
TSH (µU
.
L
-1
) 0.75 (0.48, 1.17) .202 0.72 (0.45, 1.16) .178 0.73 (0.42, 1.26) .254 0.68 (0.39, 1.20) .186
T4 (pmol
.
L
-1
) 1.86 (1.11, 3.13) .019 2.08 (1.16, 3.72) .014 1.78 (0.95, 3.32) .070 1.41 (0.74, 2.67) .296
Inflammation
IL-1β (pg
.
ml
-1
) 0.92 (0.51, 1.63) .764 0.94 (0.51, 1.72) .839 0.81 (0.43, 1.54) .525 0.76 (0.40, 1.44) .400
IL-6 (pg
.
ml
-1
) 1.75 (0.87, 3.54) .116 1.93 (0.90, 4.16) .092 1.65 (0.73, 3.76) .231 1.64 (0.71, 3.76) .243
IL-10 (pg
.
ml
-1
) 0.58 (0.29, 1.14) .116 0.55 (0.26, 1.18) .124 0.47 (0.17, 1.29) .142 0.63 (0.22, 1.83) .400
TNFα (pg
.
ml
-1
) 0.98 (0.61, 1.72) .545 0.99 (0.61, 1.74) .613 0.89 (0.48, 1.61) .435 0.81 (0.43, 1.55) .444
CRP (mg
.
L
-1
) 1.49 (0.88, 2.51) .138 1.59 (0.88, 2.86) .123 1.18 (0.58, 2.42) .649 1.04 (0.49, 2.18) .926
Endocrine
Cortisol (nmol
.
L
-1
) 1.04 (0.63, 1.74) .869 1.08 (0.63, 1.84) .789 1.07 (0.59, 1.94) .824 1.14 (0.60, 2.16) .699
DHEAs (nmol
.
L
-1
) 0.49 (0.31, 0.77) .002 0.45 (0.27, 0.74) .002 0.42 (0.23, 0.74) .003 0.50 (0.27, 0.91) .023
Cortisol: DHEAs ratio 1.78 (1.17, 2.72) .007 2.03 (1.25, 3.30) .004 2.02 (1.20, 3.41) .008 1.79 (1.03, 3.10) .037
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Fig. 3.5: Frailty and Inflammation. Prevalence of frailty measured by the Fried frailty index at Follow-Up for individuals 
according to the baseline distribution of White Cell Count (A), neutrophils (B), monocytes (C), lymphocytes (D), DHEAs (E) 
and cortisol:DHEAs (F) when data were split in to tertiles.  
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3.2.6 Associations with Inflammation, Adrenopause and Mortality 
Frailty has been previously associated with increased all-cause mortality [134, 255], 
therefore association between the same biological markers and mortality was 
assessed to understand the relationship between frailty, inflammation and mortality in 
this cohort. Table 3.7 shows the associations between measured biological markers 
for the 717 participants at the baseline and all-cause mortality during the period 
between baseline and follow-up clinics. Unadjusted analyses of increase [HR (95% 
CI) and p value] in levels of ESR [1.33 (1.11, 1.58), p=.002], neutrophils [1.33 (1.11, 
1.59), p=.002], monocytes [1.19 (1.00, 1.43), p=.005] and IL-1β [1.17 (1.00, 1.36), 
p=.004] were associated with increased all-cause mortality. Following Bonferroni 
correction (all p<.005) both increased ESR and neutrophils remain associated with 
mortality. Results were unaltered by adjustment for gender and baseline age 
however the associations between monocytes and mortality and IL-1β and mortality 
were attenuated after adjustment for height, smoking, alcohol, social class, walk 
speed and co-morbidities at baseline. 
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Table 3.7: Inflammation and mortality. Associations between Baseline biomarkers and all-cause mortality in the years prior to 
Follow-Up for the 122 HAS participants who died. 
 
HR: Hazard Ratio, CI: Confidence Interval, p: probability value. a Unadjusted HR for mortality per standard deviation increase in 
biomarker. b HR adjusted for gender and baseline age. c HR adjusted as in footnote b as well as height, weight, BMI, smoking, 
alcohol, social class and walk speed. d HR adjusted as in footnote c as well as number of systems medicated as a marker of co-
morbidity. e Based on data for males only 
Biomarker HR
a
95% CI p HR
b
95% CI p HR
c
95% CI p HR
d
95% CI p
Immune Composition
White Cell Count (x10
9.
L
-1
) 1.18 (0.98, 1.42) .081 1.17 (0.98, 1.41) .089 1.15 (0.96, 1.39) .133 1.15 (0.98, 1.41) .155
Neutrophils (x10
9.
L
-1
) 1.33 (1.11, 1.59) .002 1.31 (1.09, 1.57) .003 1.21 (1.00, 1.47) .046 1.21 (1.09, 1.57) .054
Monocytes (x10
9.
L
-1
) 1.19 (1.00, 1.43) .054 1.19 (0.99, 1.42) .064 1.13 (0.93, 1.36) .214 1.12 (0.99, 1.42) .235
Lymphocytes (x109.L-1) 1.10 (0.91, 1.32) .319 1.11 (0.93, 1.33) .261 1.06 (0.88, 1.28) .560 1.07 (0.93, 1.33) .490
Clinical
CMV Titre (Au) 0.97 (0.77, 1.22) .799 0.97 (0.77, 1.22) .713 0.96 (0.79, 1.22) .754 0.96 (0.78, 1.25) .789
ESR (mm
.
hr
-1
) 1.33 (1.11, 1.58) .002 1.31 (1.10, 1.56) .002 1.22 (1.01, 1.48) .037 1.22 (1.10, 1.56) .041
Albumin (g
.
L
-1
) 0.93 (0.77, 1.11) .401 0.92 (0.77, 1.11) .386 0.94 (0.78, 1.12) .480 0.94 (0.77, 1.11) .488
SHBG (nmol
.
L
-1
) 0.93 (0.77, 1.11) .411 0.93 (0.78, 1.11) .433 0.95 (0.79, 1.14) .587 0.98 (0.78, 1.11) .856
Testosterone (nmol
.
L
-1
)
e
1.18 (0.98, 1.42) .075 1.16 (0.97, 1.40) .108 1.15 (0.94, 1.40) .172 1.14 (0.97, 1.40) .193
Haemoglobin (g
.
L
-1
) 0.98 (0.78, 1.24) .894 0.98 (0.78, 1.24) .888 0.99 (0.76, 1.28) .937 1.00 (0.78, 1.24) .989
TSH (µU
.
L
-1
) 0.94 (0.78, 1.13) .521 0.96 (0.80, 1.15) .655 0.96 (0.80, 1.15) .643 0.97 (0.80, 1.15) .783
T4 (pmol
.
L
-1
) 0.95 (0.79, 1.14) .609 0.96 (0.80, 1.15) .664 1.00 (0.83, 1.20) .979 1.00 (0.80, 1.15) .987
Inflammation
IL-1β (pg.ml-1) 1.17 (1.00, 1.36) .044 1.18 (1.00, 1.38) .045 1.16 (0.98, 1.37) .085 1.14 (1.00, 1.38) .149
IL-6 (pg
.
ml
-1
) 0.97 (0.78, 1.20) .760 0.98 (0.79, 1.22) .857 0.96 (0.77, 1.19) .703 0.96 (0.79, 1.22) .706
IL-10 (pg
.
ml
-1
) 1.09 (0.87, 1.37) .431 1.09 (0.87, 1.37) .459 1.02 (0.81, 1.29) .846 1.02 (0.87, 1.37) .882
TNFα (pg
.
ml
-1
) 1.01 (0.99, 1.03) .072 1.01 (1.00, 1.03) .067 1.01 (1.00, 1.03) .060 0.89 (0.69, 1.14) .346
CRP (mg
.
L
-1
) 0.92 (0.78, 1.17) .655 0.95 (0.78, 1.17) .647 0.98 (0.80, 1.20) .834 0.98 (0.78, 1.17) .875
Endocrine
Cortisol (nmol
.
L
-1
) 1.08 (0.90, 1.31) .409 1.08 (0.89, 1.31) .426 1.09 (0.90, 1.32) .395 1.08 (0.89, 1.31) .430
DHEAs (nmol
.
L
-1
) 1.18 (0.97, 1.43) .091 1.19 (0.98, 1.44) .083 1.12 (0.92, 1.37) .262 1.10 (0.98, 1.44) .354
Cortisol: DHEAs ratio 1.04 (0.86, 1.26) .668 1.04 (0.86, 1.25) .710 1.02 (0.84, 1.24) .814 1.00 (0.86, 1.25) .978
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3.3 Discussion 
 
A well-controlled inflammatory response to infection and maintenance of protective 
inflammatory status is critical to the homeostasis of the individual. However with 
increased age there is an increase in low-grade chronic systemic inflammation, 
termed ‘inflammageing’ in the apparent absence of overt infection [256]. Systemic 
inflammation is associated with increased risk of chronic disease and infectious 
episodes in the elderly. Furthermore, systemic inflammation has been suggested to 
be a risk factor for frailty and all-cause mortality in elderly individuals [134, 251]. The 
cause of inflammageing remains unknown however there are strong associations 
with increased adiposity, physical inactivity and immunesenescence. The majority of 
studies investigating inflammageing and its causes have assessed these 
relationships in cross-sectional analyses with respect to differences between young 
and old individuals. These studies have limited power as in effect they are a ‘snap-
shot’ of two distinct and independent groups of individuals. 
 
 A number of longitudinal ageing studies have been and are being conducted, each 
with their own set of limitations. Probably one of the best known is the Baltimore 
Longitudinal Study of Aging (BLSA) which has collected over 50 years of ‘normal’ 
ageing research [257]. The BLSA is a comprehensive assessment of over 3000 
individuals as they age in an attempt to understand the interplay between ageing and 
health. It is one of the most successful of gerontological studies being conducted but 
like all longitudinal research suffers two inherent limitations. One is the people who 
take part are often healthier than the majority of a population and therefore less likely 
to suffer disease, plus the participants are from one small geographical area. This is 
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an important point especially with studies such as the OCTO and NONA studies as 
well as Japanese studies [258, 259]. These participants appear to be from areas in 
the world where advanced age is more frequent most likely due to diet and lifestyle 
choices. Regardless of these limitations each study does have the extremely 
valuable power of following a single group of individuals over time and therefore it is 
important for more studies to adopt this strategy. As each study population is made 
of demographically different and various environmental exposures the aim of 
longitudinal studies is finding a common pathway of outcome variables, in this case 
inflammageing, frailty and mortality.  
 
This study is the first to show that in a cohort of elderly individuals inflammageing is 
occurs independently of cytomegalovirus (CMV) infection [256] and thus does not 
support previous suggestions that the two are intrinsically linked. Behavioural 
lifestyle choices that are indicative of a sedentary nature appear to influence the 
progression of inflammageing to a greater degree. Furthermore, systemic 
inflammation and adrenal function and not CMV infection were predictive of frailty 
and mortality at the 10-year follow-up [134]. 
 
3.3.1 Cytomegalovirus Infection and Inflammageing 
Confirming findings from other groups comparing inflammatory differences between 
young and old individuals and between old individuals over time, ageing causes an 
increase in low grade systemic inflammation which is accompanied by a reduced 
anti-inflammatory potential [251]. It was shown here that levels of IL-6, TNFα and 
CRP were increased over a ten year period in relatively healthy elderly participants 
[256].  
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The longitudinal OCTO-Immune and NONA-Immune studies followed small cohorts 
of the very elderly (>85 years) for up to 6 years and correlated a number of immune 
markers with mortality [260, 261]. These studies were the first to define a set of 
parameters termed the “immune risk profile” (IRP) which was associated with 
increased mortality during follow up. Interestingly, these parameters included CMV 
sero-positivity and a profile of raised pro-inflammatory cytokines. However, these 
studies did not compare the inflammatory status of individuals who remained CMV-
sero-negative or who sero-converted in the 6 year study period. Similarly, Roberts et 
al conducted a prospective analysis of anti-CMV antibody titres and found that 
increased titre was associated with increased TNFα, IL-6 and raised mortality but did 
not consider longitudinal differences between CMV sero-negative and sero-positive 
individuals [262].  
 
CMV infection has the potential to increase the inflammatory milieu in a number of 
ways. Although it is predominantly dormant undergoing intermittent reactivation there 
is the underlying theory that the reactivation only occurs due to impaired immune 
control [263]. It has been shown that in times of physiological stress or during 
alternate infection requiring immune intervention CMV DNA can be readily detected 
in serum and urine [264, 265]. Indeed CMV is predominantly associated with 
mortality in immune suppressed individuals such as those undergoing stem cell 
therapy or those infected with HIV [266]. Therefore as the elderly are known to have 
impaired immune function it is reasonable to assume that CMV reactivation occurs 
more frequently. Indeed recent reports have suggested this is the case [267]. Thus 
CMV reactivation leads to persistent immune activation resulting in not only elevated 
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systemic inflammation but also immune exhaustion of the adaptive immune system, 
particularly CD8+ T-cells [267]. Furthermore, uncontrolled or reduced surveillance of 
CMV infection leads to localised tissue damage as the virus attempts to propagate 
itself whilst the immune system attempts to eliminate it. Therefore the current theory 
behind the association between CMV and increased mortality is that it drives a 
vicious circle reducing immunity in elderly individuals and increasing their risk of 
other infections whilst contributing to immune related tissue damage through 
dysregulated immune responses [84, 261]. To date no study has assessed the 
impact of CMV in the elderly on increased systemic inflammation over time 
accounting for individuals who are negative, positive and have converted from 
negative to positive during the time. This study is thus the first to address the impact 
of CMV serostatus on the increase in inflammatory markers during ageing and 
reveals that increased chronic systemic inflammation over a ten year period occurs 
independently of CMV infection [256]. These findings suggest that mortality 
associated with inflammation and CMV infection may in fact be independent of each 
other. Thus CMV infection does not appear to determine the age-related increase in 
serological markers of inflammation.  
 
In light of these findings other factors are likely responsible for systemic 
inflammation. Several genetic and environmental factors have been suggested to 
contribute to inflammageing. Although the current study was unable to assess 
genetic differences other studies have suggested associations. IL-6 polymorphisms 
(G174C) are associated with elevated IL-6 levels and increase in prevalence in the 
over 65 year olds [268], possibly reflecting an evolutionary benefit of a robust pro-
inflammatory response in early life which is not conducive to a healthy old age. 
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Indeed raised inflammatory cytokines such as IL-6 are not seen in centenarians or 
members of families with extended longevity, supporting the notion that an anti-
inflammatory genotype is beneficial in reaching extreme old age [269].  
 
Amongst lifestyle factors that could influence inflammageing are the age-related 
increases in adiposity, reduced physical activity, the loss of sex hormones during 
menopause and adrenopause which are all suggested to increase systemic 
inflammation [7, 82, 270]. Indeed, additional analyses of our data suggested that 
lifestyle factors such as levels of inactivity (hours watching TV, distance walked daily, 
level of car travel) and a higher BMI were contributing to elevated levels of circulating 
pro-inflammatory cytokines.  
 
3.3.2 Behavioural Lifestyle Choices and Inflammageing 
The elderly have been shown to reduce the amount of structured exercise; however 
there are many elders who augment this with increased levels of habitual physical 
activity such as DIY, walking and gardening [271]. Therefore the idea that reduced 
structured exercise results in reduced physical activity in the elderly is a misnomer 
and in fact some remain active throughout later life. However there remains good 
evidence that less than 1 in 5 older adults takes enough exercise to meet the Chief 
Medical Officers recommendation of 150 minutes per week aerobic exercise and 2-4 
bouts of resistance exercise [272]. 
 
A number of cross-sectional studies have assessed the relationship between 
physical activity and systemic inflammation in young, middle-aged and elderly 
cohorts [195, 273, 274]. Although each study assesses a different population with 
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varying degrees of inclusion criteria the general consensus is that physical activity 
attenuates systemic inflammation that can be explained in part by reduced adiposity 
[190]. In this study the data show the systemic effects of physical activity and some 
of the determinants which can affect these. The results show that behavioural 
choices which result in a more sedentary lifestyle are associated with increased 
systemic inflammation and also that sedentary behaviours are associated with 
chronic systemic inflammation some ten years later. In particular, increased levels of 
CRP, IL-6, TNFα and IL-1β were associated with being overweight, slow walking 
speed, travelling often by car, increased hours of watching TV and not carrying 
heavy loads.  
 
Structured exercise sessions have been shown to stimulate cytokines, chemokines 
and growth factor production from muscle known as myokines, even in the elderly, 
whilst reducing the size and function of adipose tissue [275]. Although these 
inflammatory mediators appear pro-inflammatory their actions are now considered 
tissue protective and ultimately anti-inflammatory [198]. This is down to the complex 
interactions of the dynamics of cytokine production. The classic exercise induced 
‘myokine’, IL-6 has been recently shown to not only stimulate glucose production in 
the liver but also improves the actions and sensitivity of insulin allowing energy 
utilisation to increase [203, 276]. Furthermore, exercise induced IL-6 promotes 
lipolysis within adipose tissue and ultimately reducing its size and pro-inflammatory 
macrophage content [203]. This is accompanied by reduction in TNFα and IL-1β 
production which is further enhanced by IL-6 reducing endotoxin production of TNFα 
[204]. Not only does exercise induced IL-6 promote reduced inflammatory cytokines 
but exercise also stimulates an anti-inflammatory environment consisting of IL-1ra 
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and IL-10 amongst others [277]. This so-called anti-inflammatory effect is the 
muscles way of protecting itself, repairing and adapting to the stresses involved with 
exercise.  
 
The fact that insulin sensitivity is improved in exercised muscle even in insulin 
sensitive individuals shows how robust this organ is in utilising energy. Additionally, 
habitual activity has been shown to increase adiponectin and reduce leptin, two 
adipose derived hormones suggesting that the function of the adipose tissue is also 
modified [278]. Although here there was no effect of physically active lifestyles on IL-
6 production walking and reduced car travel were associated with reduced TNFα and 
IL-1β whilst a similar effect was observed with CRP. Therefore although IL-6 was not 
directly affected by increased levels of activity it’s systemic effects were most likely 
influencing the production of other cytokines.  
 
Due to its abundance in the blood CRP is one of the most common biological 
markers measured and associated with various health conditions [279]. 
Subsequently reduced physical activity levels leading to a sedentary lifestyle are 
consistently associated with increased CRP concentrations [280, 281]. Longitudinal 
studies in younger individuals have suggested that physical activity induced 
reductions in CRP are independent of baseline CRP concentrations and body 
composition suggesting a dose dependent response of physical activity and CRP 
[239]. Here CRP concentrations in the elderly were associated with both activity 
status and body composition independent of each other but over time body 
composition influenced CRP to a greater extent. This is in contrast to a number of 
other studies which suggest that CRP production is dependent exclusively on body 
Page | 110  
 
fat content in the elderly [273]. However recently it has been shown that resistance 
type exercises which do not reduce body fat but increase muscle mass can stimulate 
large reductions in circulating CRP [281]. It was not possible to determine whether 
the individuals in this study were undertaking any form of resistance exercise. 
 
Physical activity has been shown to modulate and improve immune function leading 
to reduced pro-inflammatory potential. Studies have revealed a synergistic 
improvement in immune function and reduced inflammation with aerobic exercise 
and resistance exercise interventions [282]. It was not possible to determine immune 
function in this study and therefore assess the contribution it played in reducing 
systemic inflammation. Although it was shown that being active promotes a reduction 
in cortisol and the ratio of cortisol to DHEAs. Cortisol is typically an immune 
suppressing mediator whilst DHEAs is a precursor to sex hormones, improving 
muscle and other tissue functions but is also immune enhancing [70]. The ratio of 
these two endocrine products is associated with a number of adverse health 
conditions including frailty and mortality in the elderly which will be discussed in the 
following sections [134]. Therefore it is likely that the improved ratio of DHEAs to 
cortisol could infer enhanced immune function.  
 
It is clear that maintaining a reasonable physical activity status in later life can 
promote health benefits by reducing systemic inflammation and promoting endocrine 
function. Although it is not clear from this study what the exact mechanisms are, our 
observations are indicative of a number of different actions, particularly reduced 
adipose tissue induced inflammation and increased myokine production. 
Subsequently further epidemiological assessment is warranted to include such 
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factors as immune function and muscle mass in order to determine the dynamics of 
inflammatory biological  mediator reduction in the elderly. 
 
3.3.3 Consequences of Inflammageing 
Here higher baseline levels of total WCC, neutrophils, monocytes, lymphocytes, ESR 
and free T4, and lower levels of DHEAS as well as higher ratios of cortisol to DHEAS 
were all associated with an increased likelihood of being frail at ten year follow-up in 
a cohort of community dwelling older people. Furthermore higher baseline levels of 
ESR, neutrophils, monocytes and IL-1β were associated with increased likelihood of 
all-cause mortality across the ten years of the study. These findings complement and 
add to cross-sectional studies by Leng and colleagues [283] who showed that high 
neutrophil and monocyte counts were associated with frailty in disabled older women 
and Voznesensky and colleagues [284] demonstrated associations of frailty with 
DHEAS in community dwelling older people. These data also confirm findings from 
O’Hartaigh and colleagues [166] who suggested that increased neutrophil counts in 
particular were highly predictive of cardiovascular mortality in over three thousand 
elderly individuals.  
 
This is the first study to show longitudinal associations with frailty across both the 
immune and endocrine axis, suggesting that the age associated changes to the 
cellular immune system and hypothalamic-pituitary-adrenal (HPA) axis are central to 
the rate of development of age associated diseases and, as a consequence, to frailty 
and mortality. White blood cells are important co-ordinators of inflammation and the 
increase in their numbers could contribute to inflammageing and thereby increase 
frailty and mortality. Associations between interleukins or CRP and frailty have not 
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been shown in this study; this may reflect the complexities of inflammation which 
involves an inflammatory milieu of multiple proteins rather than a specific 
inflammatory protein. This would explain the positive associations between ESR and 
frailty and mortality in this study. ESR is a non-specific marker of inflammation which 
is characterised by increased rate of sedimentation of red blood cells [285]. During 
periods of heightened inflammation fibrinogen products are found in the blood which 
cause erythrocytes to clump together and subsequently sediment quicker. ESR is 
limited by the inability to define exactly what types of inflammatory proteins are 
present and subsequently where the inflammation may be originating. However it is 
perhaps a more powerful useful marker of general inflammatory status [286]. It may 
be that a single general marker of inflammatory status such as white cell count can 
be used to help identify people with a greater risk of frailty and mortality and to guide 
interventions.  
 
Both cortisol and DHEAS are products of the HPA axis; with ageing there is an 
imbalance between the two hormone levels, due to reducing DHEAS levels from age 
thirty years onwards, and relatively stable or slightly increased cortisol levels [120]. 
Here cortisol was increased whilst DHEAs was reduced over a ten-year period. The 
data suggest that the increase in cortisol could be due to CMV infection as it has 
been shown that CMV can infect cortisol producing cells promoting cortisol 
production in order to dampen the immune response towards it [287].  Raised levels 
of thyroid hormone are thought to further modulate the HPA axis through central 
changes in sensitivity to corticotrophin releasing hormone [288]. Furthermore, 
cortisol and DHEAs have direct effects on frailty via interaction with anabolic and 
catabolic pathways within myocytes [289]. Our own lab has recently shown that 
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following injury elderly individuals fair worse when they have increased cortisol to 
DHEAs ratio and have poorer physical function 6 months after their injury [290, 291]. 
Importantly, this ratio can be manipulated via pharmacological supplementation with 
DHEAs and potentially exercise interventions. A recent randomised controlled trail by 
Kenny and colleagues demonstrated that DHEAs supplementation reduced 
sarcopenia in already frail women involved in gentle exercise when compared to 
placebo [292]. 
 
Frailty is a dynamic process characterised by frequent transitions between frailty 
states over time. For individuals who are frail, the probability of transitioning to a pre-
frail state decreases over time and the probability of dying increases. Early 
identification is essential and there is ample opportunity for prevention and treatment 
with medical, nutritional and exercise interventions; pharmacological treatment is on 
the horizon. In addition to augmenting our understanding of frailty this study 
suggests a role for the use of biomarkers in screening populations to identify people 
with a greater likelihood of becoming frail before the syndrome has developed in 
order to facilitate targeted intervention. Furthermore, these biomarkers are simple, 
inexpensive and routinely used in clinical practice. This has exciting implications in-
terms of healthcare planning and policy making and high potential of significant 
social, economic and well-being benefits at both individual and global population 
levels.   
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3.4 Study limitations 
 
This study has some limitations. Firstly, it cannot completely exclude the effects of 
co-existing sub-clinical infections at the time of cytokine and endocrine analysis. 
However, participants were presumed fit and able to attend clinic appointments for 
data collection and results were screened prior to analysis for patterns suggestive of 
acute infection or haematological malignancy and four results removed from the data 
set. Secondly, consideration of the impact of other latent viral infections such as 
Epstein Barr Virus and Varicella Zoster Virus, which might possibly contribute to 
inflammation in the CMV negative participants.  Also, due to the relatively low 
seroconversion rate for CMV during the study period the size of the CMV-/+ group is 
quite small and the impact of seroconversion on serum markers should be 
addressed in a larger study.  
 
Study participants were lost to follow-up between the 1993/5 baseline and 2003/5 
follow-up clinics due to a variety of reasons (including 121 to mortality, loss to follow-
up, refusal to participate) and it has been previously shown that a healthy participant 
effect is evident in HAS.  In the current study, the 153 men who went on to have 
CMV status and frailty classified at the 2003/5 HAS follow-up were significantly 
(p<0•05) younger, less likely to be current smokers, were of higher social class, and 
had lower white cell count, ESR, neutrophil, monocytes, T4, IL-6 and CRP levels at 
the baseline clinic than the 258 men who only participated in the baseline study. 
Selection effects were less evident for women; the 101 women who were sampled at 
both time points were significantly (p<0•05) less likely to be current smokers and had 
lower neutrophil levels at the 1994/5 clinic than the 205 women who only participated 
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in the 1994/5 study, but were otherwise similar. These selection effects have the 
potential to bias results. However, the analyses were internal to the HAS sample; 
bias would only be introduced if the associations between CMV status, 
inflammageing, biomarkers and frailty were systematically different among those 
who participated in our study, and those who did not; this seems unlikely. Finally, 
there are numerous candidate biomarkers within the immune-endocrine axis that 
were not analysed and there is scope to widen this biomarker battery. However this 
may add unnecessary complexity and specifically chose readily available biomarkers 
to facilitate easy translation into the clinical environment. 
 
3.5 Future Work 
 
Future work is limited by the samples available and the data collected over the 
clinical assessments. Funding is being sought to bring back surviving participants 
and complete a third battery of tests. This would be of particular interest as it is 
thought that individuals who reach the age of eighty five or more may be genetically 
predisposed to having increased tolerance of inflammation and subsequently 
reduced inflammation. Therefore having three ten year assessments would allow us 
to reanalyse data and split them on genetic variation also.  Additionally it would be of 
interest to assess the metabolic profile of each of the participants. Recent evidence 
suggests that systemic inflammation is attenuated in obese individuals who are 
metabolically healthy. Although BMI was controlled for in the longitudinal analyses 
this was a statistical control and may not reflect the actual metabolic health of the 
individual. 
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Furthermore, it is clear there are intrinsic links between inflammageing and 
immunesenescence. This was evident in this study with inflammatory biomarkers 
being associated with rudimentary components of frailty and immunesenescence 
markers associated with frailty and mortality. Although CMV infection was not found 
to be driving inflammageing, future work should consider more than just one latent 
herpes virus in order to rule out such a link.  
  
3.6 Conclusions 
 
In conclusion, ageing is associated with an increased level of systemic pro-
inflammatory mediators consistent with the theory of inflammageing. CMV infection 
does not appear to drive the age-related increase in serum markers of inflammation. 
This suggests that interventions to control CMV infection incidence in the population 
would have little or no impact on the inflammatory profile of ageing individuals. 
However, it is well established that the cellular immune response against CMV is 
extremely immune-dominant and increases further in older adults, occupying 
valuable “immune space” and potentially impairing the response to other pathogens 
and to vaccinations in old age. However, we cannot rule out the impact CMV may 
have in conjunction with other latent viral infections such as EBV and VZV. 
Reactivation and immunodominance of these latent herpes infections are much less 
and therefore less likely to impact our findings to a great extent. Further 
epidemiological analyses of the impact of CMV infection on health status in the 
elderly thus remain warranted. 
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Lifestyle choices were associated with increased systemic inflammation at baseline 
and influenced inflammatory status ten years later. This suggests that behavioural 
modification through increasing physical activity levels from a younger age than 63 
years may attenuate inflammation at a later age. Importantly modifications over the 
age of 63 years when systemic inflammation is present may also attenuate increases 
in later life, although it is unclear to what extent these modifications will be and how 
exactly to change behaviour lifestyle choices.  
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Chapter 4: Habitual 
Physical Activity, 
Inflammation and Innate 
Immune Function 
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4.0 Introduction 
 
The previous chapter outlined the concept that systemic inflammation can be 
modulated by behavioural lifestyle choices associated with increased physical 
activity and reduced body fat. Although inflammation was predicted by body 
composition and activity levels independently of each other it is well known that 
physical activity can reduce body fat. Studies in obese individuals who have had fat 
removal surgery show altered inflammatory metabolic phenotypes with reduced 
serum leptin and IL-6 concentrations [293]. Therefore adipose tissue is a significant 
source of pro-inflammatory cytokines and reducing its mass will reduce inflammation. 
However muscle is also a major producer of cytokines such as IL-6 and termed a 
myokine. Their impact is context dependent but following exercise IL-6 levels 
increase and down regulate other pro-inflammatory cytokines such as TNFα, thus 
having an overall anti-inflammatory effect. This suggests that physical activity and fat 
mass modulate inflammation on parallel paths rather than the same path.  
Furthermore in the previous chapter systemic inflammation and endocrine 
dysfunction were found to be predictive of both frailty and mortality irrespective of 
body composition. Frailty is the concept of reduced physical functioning in the elderly 
and is measured by a composite score of physiological parameters. Many of the 
parameters used to assess frailty are related to physical functioning which can be 
modulated by physical activity. Strength measurement is assessed as a determinant 
of muscle loss/weakness but even in the elderly muscle maintenance is possible 
through regular exercise. Therefore maintenance of physical activity can attenuate 
the age-related increase in inflammation and reduce its impact on tissue damage 
and frailty. 
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Mortality due to a respiratory infection such as pneumonia is the fourth major cause 
of death in older adults, indicating a loss of immunity with age. In the previous 
chapter frailty and mortality were both predicted by immune components associated 
with the innate immune system. However if physical functioning was predictive of 
inflammatory cytokines it is likely that the more active individuals have a better innate 
immune response. Indeed previous studies in the elderly have shown that physical 
activity can improve innate immune function [294]. In particular monocytes and 
neutrophils which are key intermediaries in the inflammatory response have most 
often been shown to have improved function following physical activity assessment.  
In light of this literature, physical activity has the potential to modulate inflammation 
by reducing adipose mass and improving immune function thereby reducing aberrant 
systemic inflammation.  The majority of studies assessing inflammatory status in 
relation to physical activity in the elderly have assessed either systemic inflammatory 
cytokines or immune function independent of each other. This does not allow 
assessment of the larger picture showing the relationship with immunity and 
inflammation and the impact physical activity can have. Furthermore it is unclear the 
level of physical activity elderly individuals need to attain to gain inflammatory 
benefits. The majority of studies have assessed physical activity as a questionnaire 
or in distinct groups which may not be reflective of the majority of the population.  
Therefore the aims of this chapter were: 
1. To assess comprehensively the inflammatory phenotype and innate immune 
function in healthy elderly individuals who were habitually active or inactive. 
2. Determine whether habitual physical activity was predictive of frailty and to what 
extent. 
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3. Assess the impact of physical activity on innate immune function and its 
relationship with inflammation.   
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4.1 The Physical Activity and Healthy Ageing Study Methods 
 
4.1.1 Participants 
Participants were recruited via GPs from 54 primary care trusts (PCT’s) in and 
around the Birmingham and The Black Country area (Fig. 4.1). Search patterns 
revealed 3470 suitable candidates with GP’s assessing each candidate and signed 
as suitable according to the inclusion/exclusion criteria (Appendix I). Surgeries then 
sent each candidate a request to take part in research at the University of 
Birmingham from which 473 (13.6%) interested candidates returned pre-paid 
envelopes with their contact details. From this 202 (42.7%) candidates were 
recruited with another 15 recruited from an ageing conference held at the University. 
Recruits were booked into the Wellcome Trust Clinical Research Facility (WTCRF) at 
the Queen Elizabeth Hospital between 8:30 and 9:30am having fasted overnight. 
Inclusion/Exclusion criteria are shown in appendix 1. Ethical approval was obtained 
from Birmingham and Black Country LREC. 
Following consent participants had their blood glucose (Accu-check Performa) and 
‘office’ blood pressure (GH Pro2000 dinamap, USA) assessed to ensure there were 
no undiagnosed pathologies which would exclude them from the study. Six 
participants were excluded due to blood glucose concentrations of over 7mmol.L-1 
which was deemed to be at risk of undiagnosed diabetes.  
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Fig. 4.1: PAHA recruitment. Recruitment protocol of the 217 individuals enrolled 
in the study. 
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Upon satisfactory blood glucose and blood pressure results participants had their 
weight, height, waist and hip circumference measured. Following this blood samples 
were acquired by trained phlebotomists from a vein in the antecubital fossa. 
Peripheral blood (40 ml) was collected into vacutainers (Becton-Dickinson, Oxford, 
UK) containing lithium heparin or EDTA anticoagulants or clotting factor for serum 
isolation. Following this each participant received a small breakfast before having the 
questionnaires and accelerometer device explained to them in order to assess 
quantitative physical activity levels. 
4.1.2 Accelerometry 
Physical activity (PA) status was determined from seven continuous days of 
accelerometer (GT3X, Actigraph, FL, USA) wear. Participants wore the GT3X 
around the waist above the non-dominant leg continuously, except for when bathing 
(including water based activities). The GT3X was programmed to record data in 
three orthogonal planes (vertical (VT), antero-posterior (AP) and medio-lateral (ML)) 
every 60-seconds. Tri-axial vector magnitude (VM) was calculated from the total 
counts of each of the movement planes using the formula VM=√(VT2 + AP2 +ML2) 
and total steps and counts calculated. Total time and percentage of time spent in 
sedentary, light, moderate, vigorous and very vigorous activity levels was assessed 
using cut-offs previously described [295]. Other variables collected and computed by 
the software include energy expenditure and mean metabolic equivalents (METs). 
Sleep quality (SQ) was determined from seven continuous nights of GT3X wear. 
Participants were asked to remove the device from the waist each night when 
preparing for bed and position it snugly around the ankle. Participants recorded the 
times they were attempting to begin evening sleep and the time they fully awaken in 
the morning. Using these data and the ActiLife software actogram, individual  60-
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second epochs were used to determine sleep onset, latency, total sleep time (TST), 
wake after sleep onset (WASO), number of awakenings and efficiency from the 
Cole-Kripke algorithm [296]. 
4.1.3 Body Composition 
Body fat percentage, muscle mass, bone mineral density and estimated visceral fat 
mass were measured and analysed by trained NHS clinical research radiographers 
using dual energy x-ray absorptiometry (DEXA). 
4.1.4 Physical Functioning 
Physical functioning was assessed using a number of methods. Grip Strength was 
determined in both hands using the best score from three attempts using a Takei 
Grip-D TKK-5401 dynamometer. Timed-Up-and-Go was determined by the time 
taken to stand up from seated, walk six metres and return to seating. Participants 
were instructed to walk at their regular walking pace. Balance was assessed using 
the Berg Balance Score as previously described where a score out of 56 is 
associated with progress towards frailty [297]. Leg strength was assessed by trained 
NHS clinical research radiographers using a LeonardoTM GRFP jump mat with the 
best score from three two-legged jumps calculated. Sleep quality was assessed by 
the Pittsburgh Sleep Quality Index questionnaire as previously described. Anxiety 
and depression was assessed using the Hospital Anxiety and Depression (HADS) 
questionnaire as preciously described. 
Progression towards frailty was defined from composite scoring of quintiles of the 
following measurements: Arm and leg muscle density and grip strength adjusted for 
age, gender and BMI; Time to walk 6m adjusted for age, height and gender and 
energy expenditure adjusted for age and gender. All quintiles were scored so that a 
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score of 1 resulted in the best score and 5 the worst score. Together with the self-
reported functional limitations score (1-5) measurements were added together to 
give a continuous functioning score. Following this, scores were split into groups of 
three with the classifications as low functioning, high functioning and moderate 
functioning. 
4.1.5 Recall Analysis 
Following completion of the 211 participants; accelerometer data was analysed and 
split into quintiles of physical activity levels stratified for age and gender. Participants 
in the lowest activity quintile were then matched for gender, age and medication with 
participants from the highest activity quintile and invited back for further testing. 
Participants returned to the WTCRF at 8am having fasted overnight where they were 
consented again by a trained research nurse and similar blood glucose and blood 
pressure assessments conducted as well as anthropometric measurements. 
Participants were given the accelerometer to wear again for 7 continuous days to 
confirm they had not significantly changed their activity patterns since the first clinical 
assessment. Peripheral blood was taken as before with serum and plasma isolation 
processing described in section 2.1.  
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Fig. 4.2: Physiological functions examined during the PAHA study. 
 
4.2 Statistics 
 
Statistical analysis was performed similar to Chapter 3. Physical capability was 
defined from composite scoring of physical functions (grip strength, walk speed, berg 
balance score and) and split into tertiles to assess progression towards being frail 
with 1: High Functioning 2: Moderate Functioning and 3: Low Functioning. 
Multivariate ANOVA was then conducted to assess the association of age and 
physical activity scores on progression towards frailty. Linear regression analysis 
was then conducted to assess biomarker associations with physical capability. 
Analyses were conducted with and without adjustment for the potential confounding 
effects of age, gender, smoking, drinking and medications. Neutrophil migratory 
dynamic calculations were intrinsically linked to each other and therefore multivariate 
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ANOVA was conducted to assess the variation of physical activity status with 
migratory dynamics. Univariate ANOVA’s adjusting for potential confounding factors 
were then completed on all measured immune and inflammatory variables to assess 
differences between physical activity groups. Statistical significance was accepted at 
p<.05. 
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4.3 Results from the Whole Cohort 
 
4.3.1 Participant Characteristics 
Participant characteristics for the 100 men and 111 women who took part in the 
study are presented in Table 4.1. The average age was 67 for men and 65 for 
women. No differences were observed for BMI, however DEXA analysis revealed 
that women had significantly greater percentage of body fat but less estimated 
visceral adipose mass, bone mineral density (BMD) and waist: hip ratio than men (all 
p<.001). Although these values were different, BMI, body fat and BMD were all 
considered normal with the majority of participants considered overweight and not 
obese. No differences were observed for resting blood pressure, however women 
had a slightly higher resting heart rate than men (p=.002) but still within the normal 
range of 60 -84 bpm.  Men drank more alcohol (p=.030), were stronger according to 
jump power (p=.019) and grip strength (p<.001) which remained after adjustment for 
arm muscle density.  
No effects for gender were evident for physical activity levels or potential 
confounding factors such as smoking and alcohol consumption or medication. 
Furthermore, health status of these participants was unusually high with below 
average percentages for smoking (5%) and alcohol consumption. Furthermore, 
medication use was on average 57% for this cohort compared to recent studies 
suggesting medication use was 81% for over 60 year olds [298].  
Cortisol and DHEAs were lower in women but they had a slightly higher cortisol: 
DHEAs ratio (all p<.001), whilst IL-8 (p=.010) and MIF (p=.037) were the only 
biological biomarkers to be different between males and females. The metabolic 
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biomarkers leptin, adiponectin, cholesterol, free fatty acids and glycerol were all 
elevated in women compared to men (all p<.001). However, inflammatory 
phenotypes suggested good health with a number of lower than typically observed 
values for biological markers. In particular the cortisol: DHEAs ratio has been 
suggested to be closer to 1.0 in the elderly compared to a median value of 0.14 seen 
here [69]. Furthermore, levels of typical pro-inflammatory cytokines TNFα, IL-6 and 
IL-1β were virtually undetectable whilst CRP concentrations were mostly below the 
CVD risk value of 3.0 mg.L-1. In summary inflammatory phenotype was not 
considered clinically significant in any participants.  
Metabolic data was also indicative of good health. As diabetes and any metabolic 
disorders were considered exclusion criteria it was unsurprising to observe healthy 
values for glucose, insulin, leptin, adiponectin and cholesterol. Furthermore, physical 
functioning in the participants was excellent with balance scores and walking tests 
considerably better than the general population. Although women tended to have 
worse sleep than men (p=.037) and be slightly more anxious (p=.006) these values 
were not considered clinically significant.  
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Table 4.1: Participant characteristics for men and women  
 
Continued overleaf  
Male (n =100) Female (n =111)
Social Characteristics
Age (years)
a 67 (64, 71) 65 (63, 69)
BMI (kg
.
m
2
)
a 25.6 (23.4, 27.4) 25.0 (22.7, 27.8)
Waist: Hip
a 0.93 (0.90, 0.97) 0.82 (0.78, 0.88)***
Body Fat (%)
b 28.4 (6.0) 38.8 (6.6)***
Visceral Fat Mass (g)
a 1245 (741, 1904) 468 (315, 994)***
Bone Mineral Density (g
.
cm
2
)
b 1.2 (0.1) 1.1 (0.1)***
Systolic BP (mmHg)
b 137 (16) 134 (17)
Diastolic BP (mmHg)
b 80 (10) 78 (11)
MAP (mmHg)
b 99 (10) 97 (12)
Resting HR (bpm)
a 63 (57, 73) 68 (63, 76)**
Current Smoker
d 6 (6) 5 (5)
Drink Alcohol
d 94 (94) 94 (85)
Alcohol Consumption
b,e 6.3 (2.7) 5.1 (2.7)*
Activity Score
7-Day GT3X Accelerometer Wear
(Counts
.
hr
-1
)
b,c 61388 (18719) 65018 (18326)
(Vector
.
hr
-1
)
b,c 36089 (10746) 38448 (10660)
(Steps
.
hr
-1
)
b,c 500 (188) 490 (154)
Physical Activity Score (IPAQ)
a 22.8 (12.8, 40.8) 26.5 (13.2, 52.9)
Clinical
Medicated
d,f 55 (55) 66 (59)
Statin Use
d,g 18 (32) 15 (23)
Seasonal Vaccinated
d,h 34 (41) 30 (32)
White Blood Cells (x10
9.
L
-1
)
a 5.2 (4.2, 5.9) 4.9 (4.1, 6.3)
Neutrophils (x10
9.
L
-1
)
a 3.2 (2.6, 3.9) 2.9 (2.4, 3.8)
Monocytes (x10
9.
L
-1
)
a 0.35 (0.30, 0.50) 0.40 (0.30, 0.50)
Lymphocytes (x10
9.
L
-1
)
a 1.4 (1.1, 1.9) 1.5 (1.3, 1.9)
CMV Positive
d 57 (58) 71 (65)
CMV Titre (AU)
a 43.2 (3.7, 882.9) 58.0 (4.2, 1034.9)
Total Vitamin D (nmol
.
L
-1
)
a 54.0 (36.0, 70.5) 55.0 (40.0, 73.0)
 Vitamin D2 (nmol
.
L
-1
)
b 0 (0, 0) 0 (0, 0)
 Vitamin D3 (nmol
.
L
-1
)
a 53.0 (34.0, 69.5) 52.0 (39.0, 72.0)
Physical Functioning
Grip Strength (kg)
b 38 (8)    23 (4)***
Two-Leg Jump Power (max
.
kg
-1
)
b 33.7 (6.3) 26.0 (4.7)*
Berg Balance Score
a 56 (55, 56) 56 (55, 56)
Timed-Up-and-Go (sec)
b 8.1 (1.6) 8.0 (1.6)
Pittsburgh Sleep Quality Index
a 5 (4, 7)   6 (5, 7)*
Hospital Anxiety Depression Score
a 0.29 (0.14, 0.50)   0.43 (0.21, 0.57)*
Anxiety Score
a 0.43 (0.14, 0.71)    0.57 (0.29, 0.86)**
Depression Score
a 0.14 (0.00, 0.43) 0.14 (0.00, 0.43)
(Watts)
b 
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Table 4.1 continued 
 
BMI (Body Mass Index), BP (Blood Pressure), MAP (Mean Arterial Pressure), IPAQ 
(International Physical Activity Questionnaire), CMV (Cytomegalovirus), CRP (C-
Reactive Protein), TNFα (Tumour Necrosis Factor α), IL (Interleukin), MIF 
(Macrophage Migratory Inhibitory Factor), GM-CSF (Granulocyte-Macrophage 
Colony Stimulating Factor), MCP-1 (Monocyte Chemotactic Protein 1), VEGF 
Male (n =100) Female (n =111)
Endocrine
Cortisol (nmol
.
L
-1
)
a 346 (301, 402)    292 (248, 358)***
DHEAs (nmol
.
L
-1
)
a 2743 (1848, 3811)    1782 (1141, 2455)***
Cortisol: DHEAs
a 0.13 (0.08, 0.19)    0.17 (0.11, 0.28)***
Inflammatory
CRP (mg
.
L
-1
)
a 0.89 (0.55, 1.68) 1.00 (0.51, 1.96)
TNFα (pg
.
ml
-1
)
a 0.00 (0.00, 0.28) 0.00 (0.00, 0.33)
IL-1β (pg
.
ml
-1
)
a 0.00 (0.00, 0.00) 0.00 (0.00, 0.00)
IL-6 (pg
.
ml
-1
)
a 0.00 (0.00, 0.47) 0.00 (0.00, 0.54)
IL-8 (pg
.
ml
-1
)
a 4.95 (3.24, 6.89)  6.02 (4.20, 7.59)*
IL-17 (pg
.
ml
-1
)
a 0.00 (0.00, 2.04) 0.00 (0.00, 0.00)
MIF (ng
.
ml
-1
)
a 0.62 (0.45, 2.20)  0.51 (0.32, 1.97)*
GM-CSF (pg
.
ml
-1
)
a 0.00 (0.00, 0.00) 0.00 (0.00, 0.00)
MCP-1 (pg
.
ml
-1
)
a 24.01 (17.73, 30.08) 22.48 (17.73, 30.77)
VEGF (pg
.
ml
-1
)
a 49.20 (29.85, 86.10) 58.65 (31.80, 106.70)
VCAM-1 (ng
.
ml
-1
)
a 334 (211, 475) 291 (202, 496)
ICAM-1 (ng
.
ml
-1
)
a 283 (159, 403) 247 (163, 438)
PAI-1 (pg
.
ml
-1
)
a 886 (528, 1708) 907 (502, 1573)
Endothelin-1 (pg
.
ml
-1
)
a 0.43 (0.31, 0.94) 0.49 (0.30, 1.08)
Anti-Inflammatory
IL-4 (pg
.
ml
-1
)
a 0.00 (0.00, 0.00) 0.00 (0.00, 0.00)
IL-10 (pg
.
ml
-1
)
a 0.00 (0.00, 0.00) 0.00 (0.00, 0.44)
IL-13 (pg
.
ml
-1
)
a 0.52 (0.22, 1.33) 0.76 (0.31, 1.54)
Metabolic
Fasting Blood Glucose (mmol
.
L
-1
)
a 5.6 (5.3, 6.1) 5.5 (5.1, 5.8)
Fasting Plasma Glucose (mmol
.
L
-1
)
b 5.3 (0.5) 5.2 (0.5)*
Fasting Plasma Insulin (µIU
.
ml
-1
)
a 14.0 (11.1, 19.2) 14.2 (10.2, 18.2)
HOMA-IR 
a,i 1.8 (1.4, 2.5) 1.8 (1.3, 2.3)
HOMA-β 
a,j 131.7 (107.3, 159.3) 133.9 (115.7, 153.3)
Leptin (ng
.
ml
-1
)
a 5.8 (3.8, 9.9) 17.2 (11.1, 25.0)***
Adiponectin (µg
.
ml
-1
)
a 2.9 (2.2, 3.9) 4.2 (3.4, 5.4)***
Leptin: Adiponectin
a 1.8 (1.1, 3.2) 4.4 (2.5, 7.1)***
Triglycerides (mmol
.
L
-1
)
a 1.05 (0.77, 1.36) 1.10 (0.87, 1.31)
Total Cholesterol (mmol
.
L
-1
)
a 5.1 (4.3, 5.8) 6.0 (5.4, 6.7)***
HDL (mmol
.
L
-1
)
a 1.4 (1.3, 1.7) 1.8 (1.5, 2.1)***
LDL (mmol
.
L
-1
)
a 3.7 (3.0, 4.4) 4.2 (3.6, 4.9)***
VLDL (mmol
.
L
-1
)
a 0.21 (0.15, 0.27) 0.22 (0.17, 0.26)
NEFA (mmol
.
L
-1
)
a 0.43 (0.34, 0.55) 0.53 (0.42, 0.69)***
Glycerol (µmol
.
L
-1
)
a 44.0 (35.0, 55.3) 64.0 (52.5, 84.5)***
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(Vascular Endothelial Growth Factor), VCAM-1 (Vascular Cell Adhesion Molecule 
1)ICAM-1 (Intracellular Adhesion Molecule 1), PAI-1 (Plasminogen Activator Inhibtor-
1), HDL (High Density Lipoprotein), LDL (Low Density Lipoprotein), VLDL (Very Low 
Density Lipoprotein), NEFA (Non-Esterified Fatty Acid). HOMA (Homeostatic Model 
Assessment). 
 
a Variable positively skewed, median (25th and 75th percentile). b Mean (SD). c 
Defined as total activity per hour of non-bedtime wear. d Population Number (% of 
population). e Composite score of alcohol consumption per week. f Defined as taking 
any prescribed medication for co-morbidity. g Those who take medication also take 
statins. h Having had the seasonal vaccination immediately prior to clinic. i Insulin 
resistance as defined by the Homeostatic Model Assessment . j Pancreatic β-cell 
function as defined by the Homeostatic Model Assessment. *p<.05, **p<.01, 
***p<.001 for women differing from men 
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4.3.2 Age Associated Systemic Inflammation 
In the previous chapter it was suggested that ageing is associated with increased 
systemic inflammation, this was re-examined herein this cross-sectional study of a 
very healthy and well characterised group of older adults. Within the group 
increasing age was associated with increased concentrations of cortisol (r =.264, 
p<.001), IL-6 (r = .172, p=.007) and a trend for raised CRP (r=.094, p=.091) and 
significantly reduced concentrations of DHEAs (r = -.169, p=.015) and IL-13 (r = -
.148, p=.017). These results are similar to the previous chapter suggesting that 
ageing is associated with elevated systemic inflammation. 
4.3.3 CMV Infection and Inflammatory Status 
CMV infection was present in 58% of men and 65% of women, however CMV titres 
were not associated with gender (p=.307) or age (r=0.07, p=.92) and there was no 
difference in age between CMV positive or negative groups (p=.653). Table 4.2 
highlights immune, inflammatory, anti-inflammatory and endocrine biomarker 
differences between CMV positive and negative individuals. CMV positive individuals 
had higher WCC (p=.022) than negative individuals which was driven by higher 
lymphocyte concentrations (p=.013), which is indicative of the T-cell response 
observed in CMV positive individuals. Of all the other measured biomarkers, only the 
growth factor VEGF (p=.014) was significantly higher in those infected with CMV. 
These findings are in agreement with the previous chapter confirming that CMV 
infection is not a driving force behind systemic inflammation in the elderly.  
4.3.4 Metabolic Health and Inflammation 
In light of recent suggestions that adipose tissue accounts for only 30% of circulating 
inflammatory mediators and that systemic inflammation can be driven by metabolic 
health (MH) regardless of obesity it was necessary to assess MH in this study [299]. 
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The Karelis and Meigs criteria were used to assess MH in this cohort (Table 4.3). 
Nine participants (4%) were identified as being metabolically unhealthy for both 
criteria but showed no differences between any of the inflammatory biomarkers 
measured (data not shown). There was a trend for the metabolically unhealthy 
individuals to have reduced physical activity levels (p = .085) than the healthy. These 
data highlight the homogeneity of the cohort in regard to health status and suggest 
that this cohort regardless of physical activity status and medication were very 
closely related in terms of overall health. 
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Table 4.2: CMV and inflammation. Median (IQR) of immune, inflammatory 
biomarkers, cortisol and DHEAs differences between CMV positive (n=128) and 
negative (n=83) participants. 
 
*p<.05 different from CMV negative participants 
Negative Positive
Immune
White Blood Cells (x10
9.
L
-1
) 4.6 (4.1, 5.6) 5.2 (4.2, 6.3)*
Neutrophils (x10
9.
L
-1
) 2.8 (2.4, 3.8) 3.2 (2.6, 4.1)
Monocytes (x10
9.
L
-1
) 0.35 (0.30, 0.45) 0.40 (0.30, 0.50)
Lymphocytes (x10
9.
L
-1
) 1.4 (1.2, 1.7) 1.5 (1.3, 2.1)*
Endocrine
Cortisol (nmol
.
L
-1
) 312 (256, 387) 330 (277, 380)
DHEAs (nmol
.
L
-1
) 2340 (1540, 3340) 2109 (1428, 3146)
Cortisol: DHEAs 0.14 (0.09, 0.23) 0.15 (0.10, 0.24)
Inflammatory
CRP (mg
.
L
-1
) 0.91 (0.46, 1.68) 1.00 (0.54, 1.87)
TNFα (pg
.
ml
-1
) 0.00 (0.00, 0.16) 0.00 (0.00, 0.41)
IL-1β (pg
.
ml
-1
) 0.00 (0.00, 0.00) 0.00 (0.00, 0.00)
IL-6 (pg
.
ml
-1
) 0.00 (0.00, 0.54) 0.00 (0.00, 0.47)
IL-8 (pg
.
ml
-1
) 5.82 (3.32, 7.74) 5.32 (3.32, 6.89)
IL-17 (pg
.
ml
-1
) 0.00 (0.00, 0.00) 0.00 (0.00, 0.48)
MIF (ng
.
ml
-1
) 0.54 (0.39, 1.81) 0.62 (0.36, 2.35)
GM-CSF (pg
.
ml
-1
) 0.00 (0.00, 0.00) 0.00 (0.00, 0.00)
MCP-1 (pg
.
ml
-1
) 23.55 (18.70, 30.50) 22.79 (17.32, 30.23)
VEGF (pg
.
ml
-1
) 46.89 (23.76, 83.17) 56.53 (36.90, 104.42)*
VCAM-1 (ng
.
ml
-1
) 292 (219, 453) 365 (202, 500)
ICAM-1 (ng
.
ml
-1
) 275 (158, 399) 295 (167, 453)
PAI-1 (pg
.
ml
-1
) 705 (465, 1412) 911 (544, 1718)
Endothelin-1 (pg
.
ml
-1
) 0.44 (0.31, 0.88) 0.47 (0.33, 1.03)
Anti-Inflammatory
IL-4 (pg
.
ml
-1
) 0.00 (0.00, 0.00) 0.00 (0.00, 0.00)
IL-10 (pg
.
ml
-1
) 0.00 (0.00, 0.00) 0.00 (0.00, 0.00)
IL-13 (pg
.
ml
-1
) 0.60 (0.22, 1.59) 0.67 (0.30, 1.33)
CMV Status
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Table 4.3: Metabolic Health Criteria 
 
 
4.3.5 Behavioural Lifestyle Choices and Inflammation 
In order to assess the impact of behavioural lifestyle choices on inflammatory 
biomarkers, linear regression analysis was conducted similar to the previous chapter 
(Table 4.4). The data revealed that a more inactive lifestyle was associated with 
increased systemic inflammation. Indeed having low physical activity levels was 
associated with significant increases in CRP (p=.005), TNFα (p=.002), PAI-1 
(p=.001), MCP-1 (p=.033) and a trend for increased soluble ICAM-1 (p=.07). Whilst 
having excess adipose tissue as measured by fat mass, BMI and percentage fat 
revealed associations with increased levels of CRP (p<.001), IL-8 (p=.015), IL-10 
(p=.046), IL-13 (p=.050), GM-CSF (p=.023), PAI-1 (p<.001), VEGF (p=.006), soluble 
ICAM-1 (p=.036) and cortisol: DHEAS ratio (p=.045). Mutual adjustment was 
conducted when both body composition and activity levels were influencing the 
inflammatory marker. In both instances body composition and not physical activity 
independently influenced the increased production of CRP (p=.007) and PAI-1 
(p<.001). These findings suggest that being physically inactive and/or having excess 
adipose tissue contribute significantly towards systemic inflammation. Interestingly 
Karelis Meigs
Blood Pressure (mmHg) SBP ≥ 130 or DBP ≤ 85 or treatment
Triglycerides (mmol
.
L
-1
) ≤ 1.70 ≥ 1.70
HDL (mmol
.
L
-1
) ≥ 1.30 & no treatment < 1.04 (M); < 1.30 (F)
LDL (mmol
.
L
-1
) ≤ 2.60 & no treatment
Total Cholesterol (mmol
.
L
-1
) ≥ 5.20
Fasting Plasma Glucose (mmol
.
L
-1
) ≥ 5.60 or treatment
HOMA-IR ≤ 1.95
Others Wasit > 102cm (M) or >88cm (F)
Criteria ≥ 4 of above < 3 of above
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the majority of inflammatory mediators were better predicted by measures of body 
fat. 
4.3.6 Relationships with Inflammation and Physical Function 
Analysis of physical functioning and thus progression towards frailty revealed effects 
for age and physical activity (Fig. 4.3) and were highly inter-correlated (r= -.216, 
p=.001), therefore multivariate ANOVA was conducted. There was a significant 
multivariate effect for age and activity on the prevalence of low physical functioning 
[F(4, 150) = 35.94, p<.001; η
2=.324]. Univariate analysis revealed that increasing age 
(Fig. 4.1A) was associated with heightened prevalence of poor physical functioning 
[F(2, 150) = 98.61, p<.001; η
2=.568] as those individuals who were high functioning 
were significantly younger than those with low or moderate physical function (both 
p<.001). In contrast, increased activity levels (Fig. 4.1B) were associated with 
reduced prevalence of low physical function [F(2, 150) = 11.94, p<.001; η
2=.137] with 
those individuals who were least frail being more active than the other two groups 
(both p<.001). Consequently, in this cohort low physical functioning was overall 
predicted best by age (β = .434, t(6.50), p<.001) and then physical activity levels (β = 
-.336, t(-5.03), p<.001). From the R2 value these independent variables accounted 
for 35.7% of the variance in physical function scores. 
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Table 4.4: Lifestyle and inflammation. Relationship between lifestyle factors and the level of serum inflammatory, anti-
inflammatory and endocrine biomarkers in 211 healthy elderly participants 
Linear regression analysis of the log-normalised data was used to test for significant associations between lifestyle factors and the level of inflammatory, anti-
inflammatory and endocrine biomarkers. Individual lifestyle components were entered individually as independent variables (model 1); following this, any 
significant related lifestyle factors were entered together (model 2) to assess their mutually adjusted associations with cytokine levels. 
 
Model Predictor β p R
2
β p R
2
β p R
2
β p R
2
β p R
2
β p R
2
β p R
2
β p R
2
β p R
2
β p R
2
β p R
2
1 BMI (kg/m
2
)  .295 <.001 .087 .370 <.001 .137 -.022 .756 .000 .112 .112 .013 .133 .056 .018 .143 .046 .020 -.001 .987 .000 .102 .143 .010 -.128 .065 .016 -.080 .253 .006 -.065 .355 .004
Body Fat (%)  .280 <.001 .078 .250 <.001 .062 .170 .015 .029 .017 .810 .000 .145 .036 .021 .081 .258 .001 .137 .050 .019 .192 .006 .037 .139 .045 .019 -.040 .571 .002 -.045 .524 .002
Visceral Fat (g)  .265   .001 .070 .484 <.001 .234 .057 .491 .003 .188 .023 .035 .089 .276 .008 .090 .286 .008 .059 .478 .003 .087 .295 .008 -.149 .068 .022 -.017 .841 .000 -.125 .131 .016
Waist: Hip Ratio  .018   .803 .000 .220 .001 .048 -.188 .007 .035 -.010 .886 .000 -.090 .197 .008 .042 .558 .002 -.148 .033 .022 -.104 .136 .011 -.133 .071 .021 -.029 .677 .001 -.020 .775 .000
Resting Heart Rate (bpm)  .134   .054 .018 .100 .150 .010 .010 .892 .000 -.058 .410 .003 .109 .166 .012 -.094 .189 .009 .023 .739 .001 .157 .024 .025 .091 .192 .008 -.043 .541 .002 -.155 .027 .024
Smoking  .066   .354 .004 .010 .886 .000 -.048 .499 .002 -.070 .329 .005 -.061 .386 .004 .081 .266 .006 -.093 .190 .009 .030 .670 .001 -.136 .053 .018 .077 .278 .006  .020 .782 .000
Alcohol Consumption -.127   .069 .016 .001 .992 .000 -.019 .782 .000 .041 .563 .002 -.050 .471 .003 -.137 .055 .019 -.070 .319 .005 -.070 .315 .005 -.165 .017 .027 .035 .620 .001 -.047 .500 .002
Quantitative Physical Activity
a
-.199   .005 .040 -.233 .001 .054 -.068 .342 .000 -.105 .145 .011 -.129 .070 .017 -.089 .227 .008 -.038 .594 .001 -.075 .296 .006 -.062 .383 .004 .082 .250 .007 - .222 .002 .049
Qualitative Physical Activity
b
-.194   .061 .038 -.132 .196 .018 -.117 .255 .014 .013 .898 .000 -.079 .444 .006 -.027 .799 .001 -.133 .192 .018 -.198 .052 .039 -.025 .804 .001 -.217 .033 .047 -.120 .246 .014
2 Body Composition .244 .001 .457 <.001
Physical Activity -.132 .067 .095 -.087 .279 .238
Body Composition and Physical Activity
GM-CSF ICAM-1 MCP-1 TNFα
Body Composition Physical Activity
VEGFCRP IL-8 IL-10 IL-13 Cortisol: DHEAsPAI-1
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Fig. 4.3: Physical Function, age and activity levels. Associations of age (A) and accelerometer derived steps per hour (B) on 
physical function. ***p<.001 different from the High Functioning individuals. 
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Linear regression (Table 4.5) was used to assess the associations of biological 
parameters including immune cell numbers, inflammatory cytokines and proteins, 
endocrine hormones and vitamin-D on composite physical function scores. 
Unadjusted analysis showed that increased white cell count (p=.048), neutrophils 
(p=.008), cortisol: DHEAs ratio (p=.017) and reduced Vitamin D3 concentrations 
(p=.006) were all associated with lower physical function scores.  Associations 
between white cell count (p=.119) and cortisol: DHEAs (p=.603) were attenuated 
following adjustment for age and gender (Model 2). Following further adjustment 
(Model 3) for smoking, drinking and medication associations with neutrophils 
(p=.067) were also attenuated leaving Vitamin D3 concentrations (p=.002) as the 
only biomarker associated with reduced physical function and thus potential for 
progression to frailty. It should be noted that there was an unadjusted association of 
reduced TNFα (p=.032) and reduced physical function which was attenuated 
following adjustment for age and gender (p=.069). Although these values may 
indicate TNFα as a poor predictor of poor health the concentrations within this cohort 
were extremely low and may not represent physiologically meaningful findings. 
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Table 4.5: Inflammation and physical function. Biomarker association with 
physical functioning capability 
 
Model 1: Unadjusted Model 
Model 2: Adjusted for Age  
Model 3: Adjusted for Age, Tobacco, Drinking, Medicated 
Biomarker β t p β t p β t p
Immune Composition
White Cell Count (x10
9.
L
-1
) .166 1.995 .048 .116 1.570 .119 .091 1.195 .234
Neutrophils (x10
9.
L
-1
) .223 2.706 .008 .167 2.261 .025 .140 1.845 .067
Monocytes (x10
9.
L
-1
) .078 .923 .358 .020 .271 .787 -.007 -.089 .930
Lymphocytes (x10
9.
L
-1
) -.032 -.375 .708 -.028 -.377 .707 -.035 -.464 .643
Inflammatory
CRP (mg
.
L
-1
) .115 1.406 .162 .106 1.486 .139 .088 1.195 .234
TNFα (pg
.
ml
-1
) -.176 -2.171 .032 -.130 -1.829 .069 -.117 -1.616 .108
IL-1β (pg
.
ml
-1
) -.059 -.722 .471 -.042 -.590 .556 -.037 -.495 .621
IL-6 (pg
.
ml
-1
) -.139 -1.711 .089 -.121 -.1.690 .093 -.129 -1.797 .075
IL-8 (pg
.
ml
-1
) .031 .379 .705 .029 .398 .691 .025 .346 .730
IL-17 (pg
.
ml
-1
) -.053 -.648 .518 .016 .224 .823 .020 .275 .783
MIF (ng
.
ml
-1
) -.044 -.544 .587 -.046 -.646 .519 -.044 -.607 .545
GM-CSF (pg
.
ml
-1
) .023 .277 .782 .076 1.045 .298 .063 .850 .397
MCP-1 (pg
.
ml
-1
) .075 .923 .357 .076 1.064 .289 .072 .993 .322
VEGF (pg
.
ml
-1
) .079 .968 .335 .097 1.353 .178 .103 1.426 .156
VCAM-1 (ng
.
ml
-1
) .089 1.094 .276 .050 .706 .481 .030 .418 .676
ICAM-1 (ng
.
ml
-1
) .094 1.156 .250 .061 .858 .392 .040 .554 .581
PAI-1 (pg
.
ml
-1
) -.004 -.055 .956 .055 .774 .440 .014 .183 .855
Endothelin-1 (pg
.
ml
-1
) .038 .468 .640 -.025 -.355 .723 -.031 -.426 .670
Anti-Inflammatory
IL-4 (pg
.
ml
-1
) .076 .931 .353 .148 2.061 .041 .160 2.226 .028
IL-10 (pg
.
ml
-1
) .047 .565 .573 .065 .899 .370 .081 1.104 .272
IL-13 (pg
.
ml
-1
) .092 1.133 .259 .136 1.913 .058 .138 1.927 .056
Endocrine
Cortisol (nmol
.
L
-1
) .060 .740 .461 -.039 -.518 .605 -.044 -.584 .560
DHEAs (nmol
.
L
-1
) -.186 -2.328 .021 -.072 -.869 .386 -.066 -.785 .434
Cortisol: DHEAs .192 2.405 .017 .041 .522 .603 .034 .423 .673
Clinical
Total Vitamin D (nmol
.
L
-1
) -.206 -2.558 .012 -.178 -2.504 .013 -.198 -2.781 .006
 Vitamin D2 (nmol
.
L
-1
) -.223 -2.769 .006 .041 .574 .567 .049 .673 .502
 Vitamin D3 (nmol
.
L
-1
) .044 .537 .592 -.197 -2.789 .006 -.218 -3.082 .002
Model 2Model 1 Model 3
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4.4 Results from the Recall Analysis 
 
4.4.1 Participant Characteristics 
These observations suggest heightened systemic inflammation is associated with a 
sedentary lifestyle and being overweight (Table 4.3). Although the participants in this 
study were not frail as defined by the ‘Fried Frailty Scale’ the progression towards 
frailty was associated with inflammatory markers as seen in the previous chapter, 
particularly elevated neutrophil concentrations, endocrine dysfunction and in this 
study, Vitamin D3 concentrations (Table 4.4). Additionally the most significant 
association with progression towards frailty was observed in those who were least 
physically active and as expected older. 
Therefore as heightened inflammation and frailty are associated with 
immunesenescence leading to increased risk of infection and morbidity it was 
necessary to determine the associations with physical activity status and immune 
function in this cohort.  The purpose of this section was to assess neutrophil and 
monocyte function in relation to physical activity status. Table 4.6 shows the 
participant characteristics and biomarker concentrations between those who had low 
and high physical activity levels (PAL). Ten males and ten females were recalled 
from each group. The high PAL group were on average 72% more active than the 
low PAL group when assessed by accelerometry and 120% more active from self 
reporting questionnaires. As expected the high PAL group had a lower BMI (p=.003), 
body fat percentage (p=.050) and visceral fat mass (p<.001). White blood cell counts 
(p=.009), driven by lymphocyte concentrations (p=.004) were lower in the high PAL 
group whilst Vitamin D3 (p=.027) concentrations were higher. The inflammatory 
cytokines IL-6 (p=.043) and IL-8 (p=.037) as well as the atherothrombotic risk factor 
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PAI-1 (p=.019) were all lower in the high PAL group. The anti-inflammatory cytokine 
IL-10 (p=.040) was higher in the low PAL active group. As shown previously these 
differences can be driven by body fat mass and upon re-assessment accounting for 
body fat percentage no differences were observed.  
The low PAL group had significantly worse metabolic profiles than the high PAL 
group as evidenced by increased plasma glucose (p=.021) and insulin (p=.011) 
concentrations resulting in increased insulin resistance (p=.013) and reduced 
pancreatic β-cell function (p=.040). Additionally the adipokine balance between leptin 
and adiponectin (p=.004) was elevated in the low PAL group as a consequence of 
increased leptin concentrations (p=.017) and a trend for reduced adiponectin 
concentrations (p=.070). Again, following adjustment for fat content these results 
were attenuated except for insulin (p=.022) and insulin resistance (p=.026) 
suggesting that physical activity independently improves insulin sensitivity.  
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Table 4.6: Characteristics of participants recalled for further analysis. 
 
Continued overleaf  
Low High
Social Characteristics
Gender (Males/Females) 10/10 10/10
Age (years)
a 65 (64, 69) 66 (64, 70)
BMI (kg
.
m
2
)
a 25.5 (23.5, 29.1) 23.0 (21.4, 24.2)**
Waist: Hip
a 0.89 (0.82, 0.96) 0.86 (0.81, 0.93)
Body Fat (%)
b 36.4 (6.7) 32.0 (7.6)*
Visceral Fat Mass (g)
a 1301 (875, 2246) 588 (376, 834)***
Bone Mineral Density (g
.
cm
2
)
b 1.17 (0.16) 1.13 (0.15)
Systolic BP (mmHg)
b 127 (13) 128 (16)
Diastolic BP (mmHg)
b 77 (7) 77 (6)
MAP (mmHg)
b 94 (9) 94 (9)
Resting HR (bpm)
a 61 (57, 71) 66 (62, 70)
Current Smoker
d 2 (10) 0 (0)***
Drink Alcohol
d 18 (90) 19 (95)
Alcohol Consumption
b,e 4.6 (2.6) 5.9 (2.8)
Activity Score
7-Day GT3X Accelerometer Wear
(Counts
.
hr
-1
)
b,c 43047 (11412) 74060 (15183)***
(Vector
.
hr
-1
)
b,c 25277 (6582) 43415 (9144)***
(Steps
.
hr
-1
)
b,c 345 (113) 599 (154)***
Physical Activity Score (IPAQ)
a 13.4 (11.3) 29.4 (16.9)*
Clinical
Medicated
d,f 11 (55) 7 (35)
Statin Use
d,g 4 (36) 1 (14)
Seasonal Vaccinated
d,h 9 (45) 11 (55)
White Blood Cells (x10
9.
L
-1
)
a 5.3 (4.8, 6.4) 4.5 (4.0, 5.2)**
Neutrophils (x10
9.
L
-1
)
a 3.2 (2.7, 3.9) 2.8 (2.7, 3.7)
Monocytes (x10
9.
L
-1
)
a 0.30 (0.20, 0.40) 0.25 (0.20, 0.30)
Lymphocytes (x10
9.
L
-1
)
a 1.6 (1.4. 2.1) 1.3 (1.1, 1.5)**
CMV Positive
d 8 (40) 11 (55)
CMV Titre (AU)
a 6.2 (2.1, 439.8) 35.3 (3.8, 2045.2)
Total Vitamin D (nmol
.
L
-1
)
a 39.5 (28.5, 48.0) 58.0 (39.3, 80.5)*
 Vitamin D2 (nmol
.
L
-1
)
b 0.00 (0.00, 0.00) 0.00 (0.00, 0.00)
 Vitamin D3 (nmol
.
L
-1
)
a 39.5 (28.5, 48.0) 58.0 (39.3, 80.5)*
Physical Functioning
Grip Strength (kg)
b 30 (25, 40) 27 (22, 36)
Two-Leg Jump Power (max
.
kg
-1
)
b 31.6 (25.5, 36.7) 32.1 (26.9, 36.4)
Berg Balance Score
a 55 (1) 55 (1)
Timed-Up-and-Go (sec)
b 8.5 (7.3, 9.3) 7.9 (7.0, 9.0)
Pittsburgh Sleep Quality Index
a 6 (1) 6 (2)
Hospital Anxiety Depression Score
a 0.29 (0.14, 0.50) 0.29 (0.14, 0.54)
Anxiety Score
a 0.36 (0.36, 0.57) 0.43 (0.18, 0.86)
Depression Score
a 0.29 (0.04, 0.40) 0.14 (0.00, 0.36)
Physical Activity Status
(Watts)
b 
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Table 4.6 continued: Characteristics of participants recalled for further analysis 
  
Low High
Endocrine
Cortisol (nmol
.
L
-1
) 340 (288, 391) 354 (291, 468)
DHEAs (nmol
.
L
-1
) 1777 (1128, 3450) 1793 (1128, 2887)
Cortisol: DHEAs 0.26 (0.25) 0.30 (0.30)
Inflammatory
CRP (mg
.
L
-1
) 1.32 (0.70, 2.42) 1.57 (0.57, 2.84)
TNFα (pg
.
ml
-1
) 0.00 (0.00, 1.37) 0.00 (0.00, 0.00)
IL-1β (pg
.
ml
-1
) 0.30 (0.19, 052) 0.19 (0.16, 0.29)
IL-6 (pg
.
ml
-1
) 1.72 (1.02, 2.33) 1.35 (0.63, 2.67)*
IL-8 (pg
.
ml
-1
) 7.57 (2.15) 6.49 (1.44)*
IL-17 (pg
.
ml
-1
) 0.00 (0.00, 18.82) 0.00 (0.00, 1.90)
MIF (ng
.
ml
-1
) 0.69 (0.39, 2.10) 0.49 (0.28, 1.26)
GM-CSF (pg
.
ml
-1
) 0.00 (0.00, 0.00) 0.00 (0.00, 0.00)
MCP-1 (pg
.
ml
-1
) 42.38 (15.94) 42.62 (18.41)
VEGF (pg
.
ml
-1
) 68.68 (25.94, 121.14) 47.67 (38.53, 74.56)
VCAM-1 (ng
.
ml
-1
) 311 (201, 474) 292 (172, 555)
ICAM-1 (ng
.
ml
-1
) 291 (143, 418) 310 (143, 412)
PAI-1 (pg
.
ml
-1
) 1733 (761, 2300) 581 (448, 891)*
Endothelin-1 (pg
.
ml
-1
) 0.49 (0.28, 1.26) 0.39 (0.31, 1.34)
Anti-Inflammatory
IL-4 (pg
.
ml
-1
) 0.00 (0.00, 0.00) 0.00 (0.00, 0.00)
IL-10 (pg
.
ml
-1
) 17.01 (6.36, 23.69) 10.22 (5.19, 16.51)*
IL-13 (pg
.
ml
-1
) 7.59 (4.93) 5.64 (3.69)
Metabolic
Fasting Blood Glucose (mmol
.
L
-1
)
a 5.4 (0.5) 5.2 (0.6)
Fasting Plasma Glucose (mmol
.
L
-1
)
b 5.4 (0.5) 5.0 (0.4)*
Fasting Plasma Insulin (µIU
.
ml
-1
)
a 21.2 (10.5, 27.3) 11.4 (9.5, 13.0)*
HOMA-IR 
a,i 2.7 (1.4, 3.6) 1.5 (1.3, 1.7)*
HOMA-β 
a,j 162.1 (120.0, 194.8) 129.8 (114.4, 142.2)*
Leptin (ng
.
ml
-1
)
a 15.0 (6.8, 24.1) 8.0 (3.5, 13.7)*
Adiponectin (µg
.
ml
-1
)
a 3.0 (2.3, 3.9) 3.5 (2.7, 5.5)
Leptin: Adiponectin
a 4.9 (2.5, 7.9) 2.3 (1.0, 3.1)*
Triglycerides (mmol
.
L
-1
)
a 1.05 (0.82, 1.41) 0.91 (0.69, 1.35)
Total Cholesterol (mmol
.
L
-1
)
a 5.3 (4.3, 6.0) 5.6 (5.3, 5.8)
HDL (mmol
.
L
-1
)
a 1.3 (1.3, 1.6) 1.6 (1.4, 2.0)*
LDL (mmol
.
L
-1
)
a 3.9 (3.1, 4.4) 3.9 (3.3, 4.4)
VLDL (mmol
.
L
-1
)
a 0.21 (0.16, 0.28) 0.18 (0.14, 0.27)
NEFA (mmol
.
L
-1
)
a 0.48 (0.24, 0.56) 0.40 (0.31, 0.61)
Glycerol (µmol
.
L
-1
)
a 47.5 (38.3, 61.5) 44.0 (29.0, 76.0)
Physical Activity Status
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4.4.2 Neutrophil Functional Dynamics and Physical Activity Status 
Neutrophil migration towards IL-8 was assessed in low and high PAL groups using 
an Insall chamber and time-lapse microscopy and Image-J to assess directional 
movement and speed [168]. Fig. 4.4 highlights the migration paths of neutrophils 
from one representative participant in each group; for the purpose of visualisation all 
cells are centred at a single co-ordinate and tracked according to their individual 
movements.  
Neutrophil migratory dynamics were highly correlated and intrinsically linked with 
each other, therefore multivariate ANOVA was utilised to assess the variance 
between the two activity groups. Homogeneity of covariance matrices of migratory 
dynamics was confirmed by Box’s M test (p=.735). There was a significant 
multivariate effect for physical activity status on neutrophil migration [F(4, 38)=5.50, 
p=.002; η2=.386]. Univariate analysis revealed that the chemotactic index (Fig. 4.5A) 
and chemotaxis (Fig. 4.5B) were greater in the highly active elders [F(1, 38)=11.80, 
p=.001; η2=.237] and [F(1, 38)=5.03, p=.031; η
2=.117], respectively. Neither 
chemokinesis (Fig. 4.5C) [F(1, 38)=2.54, p=.120; η
2=.063] or persistence (Fig. 4.5D) of 
migration [F(1, 38)=1.31, p=.260; η
2=.033] showed differences towards IL-8. These 
results suggest that neutrophil migratory dynamics are maintained in physically 
active elderly individuals. Indeed to assess whether migration was comparable to 
that of the young, neutrophils from ten young (23 ± 4 years) participants were 
assessed [mean (SEM); p]. Young participants had similar values for chemotactic 
index [0.41 (0.04); p=.985] and chemotaxis [1.68 (0.21); p=.891] to the physically 
active elders whilst being significantly greater than inactive elders, p=.001 and 
p=.021 respectively. Furthermore, to assess whether the body fat induced 
differences in inflammation were accounting for differences the individual 
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components IL-6, IL-8, PAI-1 and body fat percentage were entered as covariates. 
MANCOVA results revealed that neutrophil chemotactic differences were driven by 
physical activity status and not body fat or inflammatory mediators.   
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Fig. 4.4: Neutrophil migration and physical activity. Migration pathways of neutrophils from a representative low and high active 
elderly individual.  Figures represent migration paths of single cells following centralisation to point 0, 0 on the axis. Migratory 
dynamics towards IL-8 (y-axis) are presented. 
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Fig. 4.5: Neutrophil migratory characteristics and physical activity. Neutrophil migration parameters towards IL-8 from low 
active (black bars) and highly active (white bars) elders. Data are mean ± SEM. **p<.01, ***p<.001 compared to low PAL group 
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4.4.3 Neutrophil Receptor Expression Influencing Migratory Dynamics 
4.4.3.1 Neutrophil Chemokine Receptor Expression   
To determine whether the differences in migration were due to expression of the 
neutrophil IL-8 receptors CXCR1 (Fig. 4.6A) and CXCR2 (Fig. 4.6B), flow cytometric 
analysis of CD16+ neutrophils was conducted. No differences were observed for 
CXCR1 [F(1, 39) = .012, p=.913; η
2=.000] or CXCR2 [F(1, 39) = 1.03, p=.316; η
2=.029] 
expression. 
 
 
Fig. 4.6: Neutrophil surface expression of the IL-8 receptors CXCR1 (A) and 
CXCR2 (B) for low active (black bars) and highly active (white bars) elders. Data are 
mean ± SEM. 
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4.4.3.2 Neutrophil Adhesion 
Neutrophils were migrated on glass cover slips coated in 7.5% BSA which can mimic 
the properties of ICAM-1 [300]. Therefore to determine whether migration could be 
affected by the surface expression of the ICAM-1 receptors, CD11b and CD18 were 
measured. Fig. 4.7A shows a 62% increased expression of CD11b [F(1, 39) = 3.57, 
p=.035; η2=.109] on neutrophils from the high PAL group whilst no differences were 
observed for CD18 [F(1, 39) = .304, p=.585; η
2=.010; Fig. 4.7B]. Although CD11b 
expression differed between groups there were no significant associations with 
CD11b expression and migratory parameters suggesting CD11b expression may not 
be the primary contributor to migratory variances.  
Fig. 4.7: Neutrophil surface expression of adhesion molecules CD11b (A) and 
CD18 (B) for low active (black bars) and highly active (white bars) elders. Data are 
mean ± SEM. *p<.05 different from low PAL group. 
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4.4.4 Neutrophil Pathogen Recognition Receptors 
Upon arrival at the site of infection neutrophils are required to recognise bacterial 
components in order to begin resolution of infection. In order to determine whether 
physical activity status might affect the recognition of gram-negative and gram-
positive bacterial components, expression of TLR2 (Fig. 4.8A) and TLR4 (Fig. 4.8B) 
on CD16+ neutrophils was assessed. No differences were observed between groups 
for the expression of TLR2 [F(1, 39) = 1.44, p=.238; η
2=.039] or TLR4 [F(1, 39) = .401, 
p=.531; η2=.012] suggesting both groups are equally capable of recognition of 
bacterial cell components.  
Fig. 4.8: Neutrophil expression of bacterial recognition receptors TLR2 (A) and 
TLR4 (B) revealed no differences between low active (black bars) and highly active 
(white bars) elders. Data are mean ± SEM.  
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4.4.5 Neutrophil Bactericidal Activity 
In order to assess whether physical activity had an effect on neutrophil bacterial 
killing, assessment of phagocytosis of opsonised E.Coli (Fig. 4.9A) and superoxide 
production (Fig. 4.9B) in response to E.Coli was determined. Physical activity did not 
affect the ability of circulating neutrophils to uptake bacteria [F(1, 39) = .421, p=.521; 
η2=.012] however there was a small but significant reduction in the superoxide 
produced per cell in the highly active elders [F(1, 39) = 3.11, p=.044; η
2=.088]. As 
superoxide production has previously been reported to be reduced in the elderly, and 
subsequently may be an indicator of neutrophil senescence, the same analysis was 
conducted on 10 younger individuals. Mean superoxide production for the young (23 
± 4 years) participants was 104 ± 8 (SEM) which was significantly less than the least 
active elders (p=.032) but not the highest active elders (p=.509). Therefore it could 
be that the superoxide production towards E.Coli was hyper-responsive in the least 
active elders leading to abnormal production of superoxide radicals. 
 
Fig. 4.9: Neutrophil bactericidal activity. Neutrophil phagocytosis (A) of E.Coli and 
superoxide generation (B) towards E.Coli for low active (black bars) and highly active 
(white bars) elders. Data are mean ± SEM. *p<.05 different from low PAL group. 
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4.4.6 Monocyte Phenotype 
CD14+ monocytes consist of 3 distinct subtypes which are characterised by their 
expression of CD16 and are functionally distinct from each other. Although there was 
a trend for the highly active elders to have lower circulating numbers of monocytes 
(p=.056) there were no differences between the groups for the total numbers or 
percentages of the subtypes, Table 4.7.    
 
Table 4.7: Monocyte Subtypes and PAL.  
Median (IQR) monocyte subtype numbers and  
percentages in low and high active elders 
 
 
4.4.7 Monocyte Chemotaxis 
No differences were observed between the activity groups for monocyte migration 
(p=.494) towards MCP-1 (Fig. 4.10A) using the transwell method. There was a trend 
towards total monocyte expression of CCR2 (Fig. 4.10B) being higher in the active 
elders [F(1, 36)=3.48, p=.070; η
2=.088]. CCR2 expression on the classical [F(1, 
36)=4.51, p=.041; η
2=.111] and intermediate [F(1, 36)=4.92, p=.033; η
2=.120] 
monocytes was on average 33% (for both) greater in the high active group compared 
to the least active group. The secondary receptor for MCP-1 on monocytes, CCR4 
(Fig. 4.10C) was not different between groups and showed no differences for the 
monocyte subtypes. No differences were observed between activity groups for total 
Low High
Monocytes (x10
9.
L
-1
)
Classical 0.27 (0.18, 0.34) 0.18 (0.17, 0.26)
Intermediate 0.02 (0.01, 0.03) 0.02 (0.01, 0.02)
Non-Classical 0.03 (0.01, 0.04) 0.02 (0.01, 0.03)
Monocytes (%)
Classical 86.0 (84.1, 89.5) 86.7 (82.1, 89.7)
Intermediate 5.4 (4.1, 7.1) 5.4 (3.9, 6.6)
Non-Classical 7.8 (5.1, 9.4) 7.2 (6.2, 9.4)
Physical Activity Status
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monocyte expression of the adhesion markers CD11b (Fig. 4.10D) or CD18 (Fig. 
4.10E).  
 
Fig. 4.10: Monocyte function. Monocyte migration towards MCP-1 (A) and the 
expression of the MCP-1 receptors CCR2 (B) and CCR4 (C) and the adhesion 
molecules CD11b (D) and CD18 (E) on monocytes isolated from physically inactive 
(black bars) and active (white bars) elders. Data are mean ± SEM. 
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4.4.8 Monocyte Bactericidal function 
No differences were observed between groups for phagocytosis (Fig. 4.11A) of 
E.Coli or superoxide (Fig. 4.11B) production in response to E.Coli, (p=.814 and 
p=.421 respectively). There were no differences for TLR-2 (Fig. 4.11C) or TLR-4 
(Fig. 4.11D) expression between activity groups or monocyte subtypes. 
 
Fig. 4.11: Monocyte bactericidal activity. Monocyte phagocytosis of FITC-labelled 
E.Coli (A) and superoxide generation towards E.Coli after phagocytosis (B) as well 
as the bacterial recognition receptors TLR4 (C) and TLR2 (D) in cells isolated from 
physically inactive (black bars) and active (white bars) elders. Data are mean ± SEM. 
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4.4.9 Monocyte cytokine production 
It is possible that over expression of inflammatory cytokines from stimulated 
monocytes may contribute to general systemic inflammation. To assess the 
inflammatory response to bacterial infection, peripheral blood monocytes were 
stimulated with 10ng.ml-1 of LPS and assessed for the expression of the pro-
inflammatory cytokines IL-6 and TNFα. There was a trend (p=.070) for the highly 
active elders to produce less TNFα upon stimulation with LPS (Fig. 4.12A) but not for 
IL-6 (p=.290) production (Fig. 4.12B).  
 
 
Fig. 4.12: Monocyte cytokine production. Percentage increase from unstimulated 
to LPS stimulated total monocyte expression of TNFα (A) and IL-6 (B) in cells 
isolated from physically inactive (black bars) and active (white bars) elders. Data are 
mean ± SEM. 
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4.4.10 Monocyte Antigen Presentation Capacity  
Elderly individuals have previously been shown to have reduced antigen 
presentation capabilities. Therefore the expression of HLA-DR, the human analogue 
of MHC-II, was assessed on monocyte subtypes between groups. Analysis revealed 
there was a trend for highly active elders to have higher HLA-DR expression on 
classical monocytes (p=.080) but not intermediate (p=.275) or non-classical (p=.121) 
compared to less active elders, data not shown.  
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4.5 Discussion 
 
The previous chapter revealed that increased chronic systemic inflammation occurs 
over a number of years in healthy older adults and is directly associated with 
prevalence of frailty and risk of mortality. Furthermore inflammation was not 
dependent on adaptive immune responses to latent CMV infection as previously 
thought [256]. These results suggested that inflammageing may be determined to a 
greater extent by behavioural lifestyle choices such as being sedentary. However we 
were unable to assess immune function associations with inflammation or with 
lifestyle choices in the Hertfordshire Ageing Study as immune cells were not 
available. 
Innate immune dysfunction with age results in a number of severe modifications that 
can result in significantly impaired responses, but also basal activation of cells such 
as monocytes [162]. Impaired innate function can result in elongated and increased 
occurrence of infectious episodes. Aberrant responses such as reduced chemotaxis 
and increased reactive oxygen species production can contribute to this [168, 170].  
This chapter aimed to confirm the associations presented in chapter 3 such as the 
lack of relationship between CMV infection and inflammation, the association of a 
sedentary lifestyle and inflammation and the impact of systemic inflammation on 
progression towards physical impairment in older adults. In confirmation of the 
previous chapter the data showed that age was associated with increased 
inflammatory mediators and impaired endocrine function, in addition being positive 
for CMV in old age did not account for elevated inflammation. However accounting 
for age; body composition and physical inactivity were associated with elevated 
inflammatory status and inflammatory mediator levels were predictive of lower 
Page | 161  
 
physical functioning. As discussed in the previous chapter these findings are 
comparable to both the previous study and those of others. 
In addition metabolic biological variables including leptin, adiponectin, cholesterol, 
triglycerides and insulin sensitivity were assessed. Increased glucose and insulin 
content in conjunction with systemic inflammation were associated with insulin 
sensitivity which can lead to tissue damage resulting in increased risk of type-2 
diabetes [301]. Furthermore, cholesterol and lipid by-products are associated with a 
number of health conditions such as atherosclerosis [130]. Supporting other reports 
in the literature the data showed that men and women differ significantly in their 
metabolic profiles such as leptin and adiponectin as well as cholesterol [302]. 
Similarly physical activity is associated with a number of metabolic differences 
including improved insulin sensitivity and approximated β-islet function, reduced 
leptin and increased HDL cholesterol [303]. However the metabolic health of all of 
the participants as assessed using the Karelis and the Meigs criteria showed that 
only nine were metabolically unhealthy and none of these were included in the recall 
analysis [299, 304].  
As immune function is reduced with age and is intrinsically linked with increased 
systemic inflammation it is likely that the effects of physical activity on inflammation 
and endocrine dysfunction may parallel immune function [294]. Therefore this 
chapter aimed to assess the relationship of physical activity with innate immune cell 
function in this cohort and its relationship with systemic inflammation. To do this the 
top and bottom 20% of each physical activity group was age, gender and clinically 
matched as best as possible and recalled for assessment of neutrophil and 
monocyte functional capacity.  
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Neutrophil dysfunction is well documented with ageing particularly with respect to 
bactericidal capacity and migration [168, 172]. The consequences of this are 
profound and increase the risk of infection in the elderly, especially bacterial infection 
which is one of the leading causes of mortality in the elderly [172]. Our group 
recently showed that neutrophils from the elderly migrated less accurately than those 
from young subjects [168]. Here it is confirmed that neutrophils from the elderly have 
reduced chemotactic ability, however it is clear that the elderly are not a 
homogenous group but consist of individuals who in effect appear younger than their 
age. Thus isolated neutrophils from physically active elderly individuals migrated 
more accurately than physically inactive elders.  
Systemic inflammation with ageing is intertwined with immunesenescence with each 
factor potentially contributing to the severity of the other. Elevated inflammatory 
mediators, both locally and systemically have been suggested to reduce immune cell 
function. However, Sapey and colleagues assessed isolated peripheral neutrophil 
function from the elderly following incubation with plasma from young and old donors 
[168]. They determined that removing neutrophils from an old environment and 
placing it into a new one does not restore function. Therefore differences in the 
elderly neutrophils are likely to be cell intrinsic and not necessarily due to systemic 
inflammatory exposure, although it cannot be ruled out that the bone marrow 
inflammatory environment is not driving these cell changes [305]. To address this a 
very healthy cohort of elderly active and inactive individuals were studied here and 
the data show that any differences in inflammation were attenuated by adjusting for 
body fat. However neutrophil migration remained statistically different between 
physical activity groups adjusting for both inflammatory state and fat mass, 
suggesting that systemic inflammation may not be exclusively driving neutrophil 
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defects such as altered chemotaxis. Instead low physical activity appears to be the 
primary determinant of reduced neutrophil migration which may lead to poorer 
infection control and subsequently increased mortality often associated with 
sedentary behaviour [306].  
These findings are comparable to animal studies suggesting neutrophil migration 
towards sites of infection is improved following exercise [307]. Few studies have 
assessed the impact of exercise on neutrophil migration in humans.  Wolach and 
colleagues suggested neutrophil migration was impaired 24 hours after an acute 
bout of exercise in young healthy adults suggesting an exercise induced defect 
[308]. Although the exact mechanism of this impairment remains elusive it was 
observed that chemotaxis was restored 48 hours after exercise and highlights that 
exercise sessions are able to transiently alter neutrophil function. Additionally Syu 
and colleagues showed an increased chemotactic ability immediately after an acute 
bout of exercise [246]. Furthermore, it was shown that neutrophil chemotaxis was 
improved following 4 months of moderate exercise sessions in young adults. These 
findings are compatible with the findings in this chapter that regular bouts of 
moderate activity have the potential to improve neutrophil migratory dynamics.  
This study is the first to assess neutrophil migration using an accurate tool in healthy 
active and inactive elders. The data suggest that neutrophils from physically active 
elders have the potential to reach sights of infection both quicker and with improved 
accuracy (chemotactic index). The consequences for health of this are two-fold; first 
the neutrophils in theory can engage and deal with infection quicker causing 
improved resolution. Secondly the accuracy of migration can reduce non-specific 
tissue damage caused by neutrophils migrating inaccurately through tissue and 
causing excessive protease mediated damage.  
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In order to assess whether the effects of physical activity on migration were achieved 
by chemokine receptor expression, CXCR1 and CXCR2 was assessed. Sapey and 
colleagues suggested there were no differences for CXCR1 and CXCR2 expression 
in neutrophils from young and old donors or following stimulation [168]. Furthermore 
in their study, Sapey and colleagues suggest that neutrophil migratory defects are 
associated with increased intracellular PI3K expression [168]. Therefore it was not 
surprising that no differences in chemokine receptor expression on quiescent 
neutrophils were seen in our active and inactive elders. However, the data did show 
that the physically active participants had increased basal expression of CD11b but 
not CD18 suggesting that MAC-1 formation overall was unaltered. This is in 
agreement with a number of other studies which have suggested MAC-1, one of the 
ligands for ICAM-1, is unaffected by either age or physical activity status [309]. It is 
unclear whether increased CD11b was associated with improved adherence to the 
glass cover slip or indicative of increased activation. Interestingly neutrophil 
expression of CD11b has been shown to be increased in response to muscle 
damaging exercise and may reflect an inherent activation status in order to repair 
muscle [310]. However CD11b has been shown to be unaffected following aerobic 
exercise sessions [311]. Additionally no differences have been observed between 
basal CD11b expression in young and elderly individuals[172]. Therefore the role of 
elevated CD11b expression in the physically active elders remains unclear. Future 
work should attempt to replicate this and assess in vitro what the relation is with 
migratory function. 
Neutrophil bactericidal activity has been shown to be consistently impaired in the 
elderly and so if neutrophil migration was maintained in the physically active elders it 
was possible that the same may apply for bacterial killing. Bacterial killing was 
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assessed by incubating whole blood with opsonised E.coli and assessing the 
percentage of cells capable of ingesting fluorescently labelled bacteria and the 
relative amount each cell was capable of ingesting. Additionally one of the killing 
mechanisms, superoxide production, was assessed in a similar manner this time 
superoxide production was determined fluorescently following ingestion of opsonised 
E.coli. No differences were observed between the activity groups for each of the 
bactericidal functions suggesting that regular physical activity is unable to modify 
these responses. Butcher and colleagues suggested that phagocytosis is reduced in 
the elderly due in part to a reduced expression of CD16 on the cell surface [172]. 
There were no differences in CD16 expression between the activity groups 
suggesting that phagocytosis would be unaltered. Furthermore there were no 
differences in bacterial recognition receptors TLR4 or the gram-positive bacteria 
specific TLR2. However this is in contrast to others who have shown that older adults 
are able to improve bacterial killing following acute exercise as well as following 
longer term exercise interventions [226, 246]. These studies were unable to 
determine the mechanism by which physical activity can improve bactericidal 
functions. One difference between this study and others in the literature is perhaps 
the degree of difference in activity levels between the participants. Yan and 
colleagues assessed elderly participants with over a 5 fold increase in activity 
compared to the inactive group and showed only a moderate effect on immune 
function [226]. Therefore as our active participants had barely double the activity 
levels of the inactive group it is likely that bactericidal activity is more sensitive to 
physical activity than migration and if we had more disparate levels of activity the 
same differences could have been observed. 
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In light of the neutrophil data it is likely that the lack of effect for physical activity 
status on monocyte function was also due to the two groups not being different 
enough in their activity level. Monocyte function in response to physical activity has 
received a great deal more attention than neutrophils recently and is often 
associated with improved chemotaxis and inflammatory phenotype [312]. Monocyte 
migration to the chemokine MCP-1 and the expression of the MCP-1 receptors 
CCR2 and CCR4 were assessed here, but no differences were found. This is in 
contrast to some studies reported for younger adults and exercise [313]. In these 
studies monocyte migration was assessed in younger adults but using pooled 
peripheral blood mononuclear cells (PBMCs) containing T, B and NK-cells, whereas 
in this chapter isolated monocytes were used. Any effects seen in young adults could 
therefore be indirect and mediated by other cells in the PBMC fraction. 
Furthermore, inflammatory phenotype has been reported to be improved in elderly 
individuals participating in physical activity interventions [237]. Reduced CD16+ 
expression and reduced TLR expression have been associated with improved 
monocyte inflammatory status due to reduced LPS-induced TNFα production [238]. 
However it remains unclear whether these are beneficial to the host due to the 
necessity for the monocyte to direct immune responses by its inflammatory actions. 
CD16+ monocytes on the other hand are capable of basally producing more 
inflammatory cytokines such as TNFα and as the elderly have a greater proportion of 
CD16+ cells reduced numbers may lower systemic inflammation. In contrast to 
studies which show a reduced CD16 expression following training or in active elders 
here no differences were seen in receptor expression between activity groups [238, 
314].  
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Monocyte and macrophage phagocytosis is suggested to be impaired in the elderly 
due in part to cellular dysregulation such as increased inflammatory state and 
reduced telomere length [158]. Here no difference was seen in TLR or CD16 
expression and so it was not surprising that monocyte bactericidal functions were not 
different. To date the only other study to assess monocyte phagocytosis in the 
elderly in response to any form of exercise revealed no effect for exercise 
interventions [243]. In addition, there were no differences in basal or LPS stimulated 
TNFα or IL-6 production from monocytes in the active and inactive elders, ruling out 
an effect on monocyte function as a mediator of reduced inflammation. Therefore it 
can be concluded that in the group studied here physical activity did not have a 
significant impact on monocyte function.  
 
4.6 Limitations and Future Work 
 
There were some major limitations to this study which are inherent in all cross-
sectional investigations. Firstly this study adopted very rigorous inclusion criteria that 
were similar to the Seniuer Protocol and in doing so there may have been 
recruitment bias [315]. As each of the participants had to be free from a number of 
age-associated chronic conditions and be able to walk to the clinic for assessment it 
was not possible to include truly sedentary individuals in the analysis. However had 
the study recruited such individuals it would have been impossible to determine 
whether measured differences were due to underlying morbidities. Therefore 
although it is admirable that effects for physical activity were seen, future studies 
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should attempt to screen activity levels even further to determine the lowest healthy 
limit of activity and assess similar measures. 
In respect to biological measures the study was limited by what could be assessed 
on the blood available and therefore it may have missed intrinsically different 
variables. This was evident in the assessment of neutrophil migration. Although 
Sapey and colleagues determined neutrophil migration to be associated with 
dysregulated PI3K activity it was not possible to assess this here. Therefore it 
remains unclear whether physical activity is altering the PI3K as a means to improve 
migration or whether there is another pathway responsible. Future studies assessing 
neutrophil migration should consider intrinsic cellular pathway analysis as a means 
to determine the mechanisms of action and identify potential novel therapeutic 
targets. In addition to this it would be beneficial to assess migration in the groups to 
a number of other neutrophil targets such as gram-positive S.aureus to ensure that 
the migratory differences are not limited to one chemokine.  
 
4.7 Conclusions 
 
In summary the findings from the previous chapter that ageing is associated with 
increased systemic inflammation which is not being driven by latent viral CMV 
infection were confirmed. Physical activity lifestyle choices and body composition 
were associated with elevated inflammation and endocrine dysfunction and these 
increases were associated with greater physical impairment. Therefore being 
physically active in later life may offer protection against many age associated 
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inflammatory conditions such as Alzheimers and type 2 diabetes and protect from 
physical frailty.  
Neutrophil function, specifically chemotaxis, was enhanced in physically active 
individuals suggesting improved infection control and resolution and reducing the risk 
of morbidity and mortality associated by age induced immune dysfunction. Although 
neutrophils could kill bacteria equally well there is no doubt that improving migration 
to the site of infection could ultimately limit the infectious episode. There were no 
differences in monocyte function between active and inactive elders and this may be 
due primarily due to the lack of truly sedentary participants. 
In conclusion, inflammation, endocrine and immune function show modest 
improvements in physically active elderly individuals and may reduce the risk of 
morbidity and mortality in later life.  
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Chapter 5: Inflammatory 
and Immune Responses 
to Acute Exercise in 
Physically Active and 
Inactive Elders 
 
  
Page | 171  
 
5.0 Introduction 
 
The interactions of immunesenescence and systemic inflammation drive the elderly 
towards morbidity and mortality. With an ageing population already currently 
accounting for 30% of the NHS budget despite making up 16% of the population, 
there is a pressing need to investigate economical, non-invasive methods to counter 
the impact of immunesenescence and inflammageing in the elderly. Participation in 
regular periods of moderate-intensity exercise has been associated with a number of 
health benefits including reduced risk of cardiovascular disease, increased longevity 
and a reduced risk of infectious episodes [316]. Furthermore, exercise offers a cost-
effective and easy to implement tool with often little need for equipment and can be 
effectively performed in the home or clinic [294]. 
Chronic sub-clinical systemic inflammation is associated with increased fat mass, 
genetic predisposition and immunesenescence. Both chronic and acute exercise 
sessions have been shown to modulate the inflammatory phenotype of the 
individual. In particular circulating CRP has been consistently shown to be lower in 
physically trained individuals [317], those who have undertaken a moderate intensity 
exercise intervention, non-obese individuals and the young. Subsequently as 
exercise alters the metabolic profile and adipocyte mass, there is a reduced 
inflammatory milieu. In addition to alterations in inflammation there is an exercise 
induced change in adipose resident macrophages from inflammatory M1 to anti-
inflammatory M2 [236].  
A major consideration of acute exercise is the susceptibility of the participant to 
infection following exercise if exercise is excessive [211]. Known as the ‘open 
window’ hypothesis of infection there is an increased susceptibility to contracting 
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infection due to the lymphopenia and reduced function of T-cells and NK-cells in the 
hours following exercise [318]. These effects are often associated with the intensity 
of exercise and nutritional status of the participant [319, 320]. As the elderly are at an 
increased risk of infection due to immunesenescence it is pertinent to ensure that the 
intensity of exercise will reduce infection susceptibility whilst improving immune 
function and inflammatory status in this population. 
With increased age, the immune system is remodelled with reduced specific 
responses to pathogens, increased basal inflammation and reduced immune 
tolerance. Therefore understanding the effects of acute exercise on innate immunity 
in the aged is highly pertinent. Few studies have assessed the impact of acute 
exercise sessions on the innate immune system, and of them monocyte analysis is a 
majority. However both neutrophils and monocytes represent innate cells that are 
capable of modulating the immune response and severity of the inflammatory 
response. 
Greater neutrophil phagocytosis has been observed in middle aged participants who 
regularly exercised compared to non-exercisers [226]. Although few studies have 
shown reduced absolute circulating numbers of neutrophils in response to exercise, 
those that have assessed elderly patients with chronic low-grade inflammation 
suggest a link with inflammation, neutrophil function and exercise [244]. Studies 
assessing acute exercise effects on neutrophils are few and predominantly in the 
young. Young to middle aged trained (38 ± 4 years) males have been shown to 
increase neutrophil phagocytic capacity following 45 minutes cycling compared to 
sedentary males [245]. In young individuals (20-24 years) a short maximal ergometer 
test resulted in increased chemotaxis but not percentage of phagocytic cells [246].  
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These data increase the prospect that neutrophil function can be modified with 
exercise, however the effects remain to be determined in the elderly. 
Monocytes are key mediators of infection resolution by not only aiding clearance of 
bacteria but also communicating and directing the adaptive response via cytokine 
production and antigen presentation. Monocyte responses to chronic and acute 
exercise training have received more attention in the elderly than neutrophils. As toll-
like receptor (TLR) activation is reduced with age [144] the majority of studies have 
focused on TLR changes with exercise. TLR activation and monocyte sub-type 
composition, particularly the CD16+ subsets are associated with increased 
inflammation potential. Elderly trained individuals have been shown to have reduced 
TLR4 expression on CD16+ monocytes and reduced stimulated monocyte 
production of TNFα [321]. Although others have shown no differences in TLR4 
expression or phagocytic capacity following 12-weeks training, there was an 
increase in co-stimulatory ability of T-cells by increased expression of CD80 in one 
study [322]. These results suggest that exercise has the ability to modify the pro-
inflammatory and functional capacity of monocytes dependent on intensity and 
duration of exercise sessions. The general consensus being that shorter duration, 
moderate intensity exercise offers physiological benefits whilst reducing the risk of 
causing immune and inflammatory dysfunction 
It is clear that there is a complex relationship between training status, immune 
function and inflammation which offers an explanation of the beneficial effects of 
habitual physical activity and exercise on the health of the elderly. To date no studies 
have comprehensively assessed the combined effects of an acute bout of exercise 
on immune function and inflammation in elderly men and women who are either 
physically active or inactive. The purpose of the current study was to assess whether 
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predicated aerobic capacity as a result of habitual physical activity in older (>60 
years) life was associated with altered inflammatory state and phagocyte function. 
Specifically the aims of this chapter were: 
 To determine whether the activity status of the individuals influenced 
inflammation and neutrophil/monocyte function at rest.  
 To assess whether a short moderate bout of walking could alter inflammatory 
status and immune function in a protective manner, and if levels of habitual 
physical activity influenced the response. 
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5.1 Acute Intervention Exercise Study Methods 
5.1.1 Participants 
Participants were 31 elderly adults who were recruited from the local Birmingham 
community, aged between 60 and 77 years. Inclusion criteria were: no current 
immune and no known hormonal disorder, no eating disorder, no psychiatric 
disorder, no acute illness and should not be taking medication specifically known to 
alter the immune system or hormone balance. Participants were also recruited on 
the basis that they were either regularly physically active or physically inactive and 
could walk continuously for 20 minutes unaided. Participants were either physically 
inactive (n=15) or physically active (n=16). Inactive participants were recruited locally 
and not involved in any regular structured physical activity currently, or in the 
previous 5 years. Physically active participants were recruited from local activity 
groups such as rambling, keep fit classes and local running clubs. As is typical with 
‘healthy’ elderly participants, 22% suffered conditions such as hypertension and 48% 
were taking medications such as an antihypertensive and/or gastrointestinal 
medication. No significant differences were observed for socio-economic status, 
chronic illness or medications taken between the exercise groups. All participants 
gave written informed consent prior to commencement of the study, which was 
approved by the University Research Ethics Committee (West Midlands, UK).  
5.1.2 Exercise Diary 
Confirmation of participant activity levels was determined from the completion of a 
14-day consecutive exercise diary. Variables recorded were activity type, duration 
and intensity. Exercise intensity was determined using a 0–10 RPE scale with 0 as 
rest and 10 as maximal effort [323]. Time spent in moderate and vigorous intensity 
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activities was based on metabolic equivalents (MET) for given activities [324] and 
RPE. Minutes spent in moderate and vigorous activities were averaged for the 14-
day period and from this an exercise score created using the 0–5 categorical scoring 
system from the Whitehall Study [325]. Combined scores were determined by weight 
adjusting the categorical score by multiplying by moderate activities by 2 and 
vigorous activities by 3. 
5.1.3 Experimental Protocol 
Participants were informed not to drink alcohol and to abstain from exercise in the 24 
hours prior to testing and consume only water on the morning of testing. Testing was 
conducted between 8 and 9 am and upon arrival participants were informed of the 
testing timeline for the morning. Following anthropometric (height and weight) 
characterisation participants completed an incremental submaximal treadmill walk 
test using Douglas Bag (Cranlea, Birmingham, UK) gas analysis to measure aerobic 
capacity. Participants were fitted with a heart rate (HR) monitor around the chest and 
HR measured continuously by telemetry (Polar Electro, Kempele, Finland) and 
recorded every 15 seconds. Familiarisation of the treadmill, Douglas bag mouthpiece 
and nose-clip was completed prior to testing. Following 15 minutes of seated rest for 
venous blood collection participants began walking on the treadmill with the speed 
gradually increased until a self-rated level of ‘brisk walk’ was achieved. Every 4 
minutes, gradient increments of 2% and 3.5%, depending on HR, were applied. 
During the final minute of each stage expired air samples were collected into 
Douglas bags for oxygen consumption analysis. Ratings of perceived exertion (RPE) 
were determined during the final minute of each stage. The test was terminated once 
the participant had reached 75% of their predicted maximum HR or an RPE rating of 
‘hard’ in participants who’s HR did not increase proportional to the exercise intensity. 
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75% of predicted maximum HR was determined by the formula [208 – (age in years 
x 0.7)] [326]. Following cessation of exercise participants were immediately seated 
and venous blood samples taken before remaining seated for the final blood sample 
1 hour later. 
Oxygen (O2) consumption and carbon dioxide (CO2) production were assessed from 
the Douglas bag samples using a 1440-infrared CO2 analyser and paramagnetic O2 
analyser (Servomex, Crowborough, UK). Expired air volume was measured using a 
standard dry gas meter (Harvard Apparatus, Edenbridge, UK) and corrected to 
current temperature and air pressure. Maximal O2 consumption (VO2max) was 
predicted by plotting HR and O2 consumption during the final 3 stages of exercise 
and regression analysis using age-adjusted maximum HR. 
This study was completed with the collaborations of Dr Anna Phillips of Sport and 
Exercise Sciences who conducted sections 5.1.1 – 5.1.3. 
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5.1.4 Biological Analyses 
Peripheral blood samples were taken from a vein in the antecubital fossa before the 
commencement of exercise but after 15 minutes of seated rest (Pre), immediately 
upon cessation of exercise (Post) and 1 hour after cessation of exercise (1 Hour 
Post). The following biological analysis was completed and described in section 2.2. 
Inflammatory and anti-inflammatory cytokines were measured by magnetic XMap 
technology. CRP, cortisol and DHEAs were measured by ELISA. Neutrophil and 
monocyte bactericidal function was assessed using phagotest and phagoburst kits, 
monocyte and neutrophil phenotype were assessed by flow cytometry. 
5.1.5 Statistical Analysis 
Statistical analyses were performed similar to previous chapters.  Individuals were 
grouped into low and high active groups based on their predicted VO2max and 
Exercise Diary results. Univariate ANOVA was conducted to assess differences of 
anthropometric characteristics between the two groups taking into account gender. 
Following this repeated measure ANOVA and ANCOVA were conducted to assess 
the changes in biological variables over the three time points and whether physical 
activity status influenced the effects with BMI included in the analysis as a covariate. 
The assumption of sphericity was tested using Mauchley’s method and any 
violations corrected for using the Greenhouse-Geisser method. Partial η2 is reported 
as a measure of effect size. Post-hoc pairwise analysis with Bonferroni correction 
was conducted to assess biological variable differences over time in each activity 
group. Statistical significance was accepted at p<.05. 
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5.2 Results 
5.2.1 Group Characteristics and Exercise Test 
Group characteristics and exercise test data for the activity groups is presented in 
Table 5.1. BMI [F(1, 29)=19.48, p<.001, η2=.402] and estimated VO2max [F(1, 
29)=34.61, p<.001, η2=.601] differed significantly with VO2max withstanding 
adjustment for age. There were no differences between groups for any of the data 
collected during the incremental walk test. Mean duration of the incremental walk 
test was 22.83 ± 0.94 minutes with final HR at the end of the exercise 133 ± 10 bpm 
which was equivalent to 76.7 ± 5.5 % of their predicted maximal HR. This HR value 
suggests that the majority if not all of the exercise session was conducted in an 
aerobic state. Final RPE score at the end of the test was 5.1 ± 1.2 which was 
equivalent to a rating of ‘Hard’. 
 
Table 5.1: Participant characteristics and exercise test data. Data are Mean ± 
SD. 
 
**p<.001, ***p<.001 compared to the Low Active group 
  
Low Active (N=16) High Active (N=15)
Sex (M/F) 7/9 9/6
Age (years) 68.0 ± 4.7 65.1 ± 4.4
BMI (kg
.
m
2
) 26.0 ± 2.8       22.2 ± 2.0***
Estimated VO2max (ml
.
kg
-1.
min
-1
) 31.2 ± 6.1       45.6 ± 5.9***
Estimated VO2max (L
.
min
-1
) 2.3 ± 0.6       3.1 ± 0.6**
Exercise Duration (min) 22.7 ± 1.3 23.0 ± 0.3
Final HR (bpm) 134 ± 11 132 ± 10
Final HR (% of max) 77.9 ± 5.7 75.4 ± 5.2
Final RPE 5.2 ± 1.2 5.0 ± 1.2
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5.2.2 Inflammatory and Endocrine Responses to Acute Exercise 
5.2.2.1 Inflammatory Mediators 
Table 5.2 outlines the effect of the exercise protocol, split by basal activity level 
groups, on circulating pro and anti-inflammatory cytokines, growth factors and acute 
phase proteins. There was a significant main effect of exercise for the pro-
inflammatory cytokines IL-1β [F(2, 60)=5.95, p=.004, η2=.166], IL-6 [F(2, 60)=5.04, 
p=.009, η2=.144] and IL-8 [F(2, 60)=8.69, p<.001, η2=.225] which were significantly 
increased from Pre to 1 Hour Post exercise. Similarly there was a significant main 
effect of exercise for GM-CSF, an inflammatory protein which stimulates growth and 
differentiation of neutrophils and monocytes [F(2, 60)=58.63, p<.001, η2=.701]. The 
acute phase protein CRP showed a significant main effect of exercise [F(2, 
60)=11.24, p<.001, η2=.286], which was driven by a reduced concentration at 1 Hour 
Post exercise in the low active group and was the only inflammatory marker which 
was significantly different at all time-points between groups (p=.002 for all). However, 
after adjustment for BMI the differences between groups for CRP were attenuated 
(p>.05 for all times). Furthermore, correlation analysis revealed that both BMI 
[r(29)=.48, p=.004] and estimated relative VO2max [r(29)= -.40, p=.029] were 
associated with CRP whilst absolute VO2max [r(29)= -.22, p=.161] was not. This 
suggests that body composition and not aerobic fitness is driving differences in CRP 
concentrations between groups. Of the anti-inflammatory cytokines there was a 
significant main effect of exercise for IL-13 which increased from Pre to 1 Hour Post 
[F(2, 60)=9.02, p<.001, η2=.231].  
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5.2.2.2 Endocrine Responses  
There was a significant main effect of exercise for cortisol (Fig. 5.1A), which 
decreased from Pre to 1 Hour Post [F(2, 60)=20.67, p<.001, η2=.408]. Males had 
higher cortisol levels than females at all time-points [F(1, 29)=5.21, p=.03, η2=.152]. 
There was a significant main effect of exercise for DHEAs (Fig. 5.1B), which 
increased slightly Post exercise [F(2, 60)=4.27, p=.018, η2=.125], however males 
had higher levels of DHEAs than females at all time-points [F(1, 29)=4.63, p=.04, 
η2=.138]. Due to the effects of the exercise on cortisol and DHEAs there was a 
significant main effect of exercise for the cortisol: DHEAs ratio (Fig. 5.1C), which 
decreased from Pre to 1 Hour Post exercise [F(2, 60)=12.76, p<.001, η2=.298].  
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Table 5.2: Acute exercise effects on inflammation. Cytokine, growth factor and acute phase protein concentrations in response 
to the exercise protocol for physical activity groups. Data are Mean ± SEM. 
 
* p<.05, **p<.01, ***p<.001 compared to within group Pre exercise values. 
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Fig. 5.1: Adrenal response to acute exercise. Cortisol (A), DHEAs (B) and the cortisol: DHEAS (C) response to acute exercise in 
low and high active elderly individuals. Data are mean ± SEM. *p<.05, ***p<.001 different from Pre exercise values for both groups. 
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5.2.3 Immune Function Responses to Exercise 
5.2.3.1 Immune Cell Composition 
The intensity of the exercise test was sufficient to produce a biphasic response in 
circulating leukocyte numbers (Table 5.3). Exercise caused an increase of 49% in 
circulating lymphocytes (p<.001), 34% for neutrophils (p<.001) and 28% for total 
monocytes (p=.001). Within the monocyte population the CD16bright population 
increased by 44% (p=.005) and 28% in CD16neg (p=.004), no difference was 
observed at Post exercise for CD16dim monocytes. This highlights the preferential 
mobilisation of CD16bright monocytes into the peripheral blood compartment following 
acute exercise. Lymphocytes fell below Pre values 1 Hour Post exercise (p<.001) 
whilst neutrophils remained above Pre (p=.002) values but below Post (p=.009) at 1 
Hour Post exercise. Monocyte numbers were not significantly different from Pre 
values at 1 Hour Post exercise which was the same for the CD16bright and CD16neg 
populations. The CD16dim population was reduced from Post to 1 Hour Post exercise 
(p=.018). There was a trend for the Low Active group to have more CD16+ 
monocytes than the High Active group at Pre exercise (p=.078). 
5.2.3.2 Neutrophil Bactericidal Activity 
There was a moderate but significant main effect of exercise for the percentage of 
neutrophils ingesting bacteria (Fig. 5.2A), which increased ~2% from Pre to Post 
exercise and remained above Pre 1 hour later [F(2,58)=3.12, p=.050, η2=.097]. The 
amount of bacteria ingested on a per cell basis by neutrophils remained the same 
throughout (Fig. 5.2B), although there was a trend for the high active group to be 
able to ingest more bacteria than the low active group at Pre (p=.053), Post (p=.063) 
and 1 Hour Post (p=.058) exercise as seen by on average 20% greater MFI. There 
was a significant main effect of exercise for percentage of neutrophils producing 
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superoxide (Fig. 5.2C) towards ingested bacteria, which increased ~1.5% from Pre 
to Post exercise and again 1 Hour Post exercise [F(2, 56)=8.60, p=.001, η2=.235]. 
No effect for exercise was observed for the amount of superoxide being produced by 
neutrophils towards bacteria (Fig. 5.2D). 
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Table 5.3: Exercise induced immune cell composition. Immune cell number changes in response to exercise for low and high 
active elders 
 
Data are mean ± SD. **p<.01, ***p<.001 compared to Pre exercise values and # p<.05 less than Post exercise within groups. 
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Fig. 5.2: Neutrophil bactericidal activity in response to acute exercise. Neutrophil phagocytosis of FITC-labelled E.Coli (A, B) 
and superoxide generation towards E.Coli after phagocytosis (C, D) in active and inactive elders. Data are mean ± SEM. *p<.05, 
**p<.01 different from Pre exercise for both groups.    
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5.2.3.3 Neutrophil Phenotype 
CD16 is the Fc receptor (FcγRIII) responsible for IgG1 and IgG3 binding and previous 
work from our group has shown that low CD16 expression is related to reduced 
phagocytosis of E. coli[172]. Low CD16 is also a marker of immature neutrophils that 
may be released prematurely from the bone marrow[327, 328]. There is an on-going 
debate as to where the exercise induced increased numbers of neutrophils 
circulating in the blood come from. Some researchers argue that demargination from 
the endothelium is responsible and others that these cells are released in larger 
numbers from the bone marrow[329, 330]. CXCR2 is the chemokine receptor for IL-
8, however it is also a marker of newly emigrated cells from the bone marrow. 
Mature neutrophils released from the bone marrow have higher expression of 
CXCR2 and lower expression of CXCR4 with this relationship reversing as the cell 
becomes senescent and prepares to be cleared from the system [177].  
CD16 expression was unaffected by exercise (Fig. 5.3A). There was a significant 
main effect of exercise for CXCR2 expression (Fig. 5.3B), with expression 
decreasing by 17% in response to exercise before returning to Pre exercise values 1 
hour later [F(2, 58)=7.12, p=.001, η2=.210]. There was also a small but significant 
main effect of exercise for CXCR4 expression (Fig. 5.3C) with a 2.5% reduced 
expression of CXCR4 from Pre to 1 Hour Post exercise [F(2, 56)=3.81, p=.028, 
η2=.120]. There was a significant main effect of exercise for the CXCR2:CXCR4 ratio 
[F(2, 56)=4.41, p=.017, η2=.136] which was driven by an increased proportion of 
CXCR2 and reduced CXCR4 positive neutrophils at the 1 Hour time point. These 
results suggest that in response to exercise circulating neutrophils consist of a lower 
proportion of a senescent phenotype. There was a correlation between the 
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expression of CXCR2 and the percentage of neutrophils ingesting bacteria at the 1 
Hour Post exercise [r(29)=.33, p=.038].  
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Fig. 5.3: Neutrophil phenotype in response to acute exercise. Neutrophil CD16 (A), CXCR2 (B), CXCR4 (C) and the ratio of 
CXCR2 to CXCR4 (D) expression in response to acute exercise in active and inactive elders. Data are mean ± SEM. *p<.05, 
**p<.01 different from Post exercise in both groups. 
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5.2.3.4 Monocyte Bactericidal Activity 
There was a significant main effect of exercise for the percentage of monocytes 
ingesting bacteria (Fig. 5.4A), which increased 2.5% from Pre to 1 Hour Post 
exercise [X2(2) = 7.55, p=.023]. The amount of bacterial uptake by monocytes was 
unchanged over the exercise (Fig. 5.4B). There was a significant main effect of 
exercise for the percentage of monocytes producing superoxide (Fig. 5.4C) towards 
ingested bacteria, which increased 5% from Pre to 1 Hour Post exercise [X2(2) = 
8.87, p=.012]. There was also a significant main effect of exercise for the superoxide 
production against bacteria (Fig. 5.4D), which increased 10% from Pre to 1 Hour 
Post exercise [X2(2) = 10.41, p=.005].  
Monocyte populations consist of 3 distinct types which have been identified as 
functionally distinct. As the exercise bout caused a redistribution of the monocyte 
subtypes (Table 5.3) the relationships between monocyte CD16 expression and 
function was assessed. Total number of circulating CD16bright monocytes was 
associated with increased uptake of E. coli at Pre exercise [r(30) = .299, p=.05]. 
Similar to neutrophil function and the exercise induced redistribution of functionally 
distinct cells; there was a redistribution of monocytes so that they are more 
functional towards microbial infection 1 hour after cessation of exercise.  
5.2.3.5 Monocyte Phenotype  
In order to assess the relationship between altered monocyte bactericidal activity 
and phenotype TLR4 expression was assessed (Fig. 5.5A) in response to exercise. 
There were no activity group differences for TLR4 expression at any time points and 
so figures are presented as the whole group. TLR4 expression was on average 21% 
and 16% (p<.001 for both) higher at all times on the CD14+/CD16dim and 
Page | 192  
 
CD14+/CD16bright populations respectively compared to CD14+/CD16neg. There was a 
significant main effect of exercise for expression of TLR4 on total CD14+ monocytes 
[F(2,56)=26.39, p<.001, η2=.704] which was driven by expression of TLR4 on the 
CD14+/CD16bright monocytes [F(2,56)=23.34, p<.001, η2=.692]. In both activity 
groups there was a 4% increased expression Post exercise (p<.001) before falling to 
4% lower than Pre levels 1 Hour Post exercise (p<.001). No significant associations 
were observed for TLR4 expression on monocyte subtypes and monocyte 
bactericidal function.   
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Fig. 5.4: Monocyte bactericidal activity in response to acute exercise. Monocyte phagocytosis of FITC-labelled E.Coli (A,B) 
and superoxide generation towards E.Coli after phagocytosis (C,D) in active and inactive elders. Data are mean ± SEM. *p<.05, 
**p<.01 different from Pre exercise for both groups.   
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There were no activity group differences for TLR2 expression at any time points and 
so figures are presented as the whole group (Fig. 5.5B). TLR2 expression was on 
average 30% higher at all times on CD14+/CD16neg (p<.001) and 38% higher on 
CD14+/CD16dim (p<.001) compared to CD14+/CD16bright populations. There was a 
significant main effect of exercise for expression of TLR2 on total CD14+ monocytes 
[F(2,56)=122.80, p<.001, η2=.814] which was driven by changes in expression of 
TLR2 on the CD14+/CD16dim monocytes [F(2,56)=35.48, p<.001, η2=.559]. In both 
groups there was a 4% reduced expression Post exercise (p<.001) which again 
reduced 3% 1 Hour Post exercise (p<.001). No significant associations were 
observed for TLR2 expression on monocyte subtypes and monocyte function. 
Coupled with the small associations between monocyte CD16 expression and 
bacterial uptake, it is likely that changes in monocyte function due to exercise are 
independent of TLR4 and TLR2 expression.  
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Fig. 5.5: Monocyte phenotype response to acute exercise. Monocyte expression 
of TLR4 (A) and TLR2 (B) on CD14+ monocyte subtypes in response to acute 
exercise. Data are mean ± SEM. ***p<.001 compared to Pre exercise levels for that 
subtype. 
 
  
A 
B 
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5.3 Discussion 
 
5.3.1 Inflammatory Response to Acute Exercise 
Transient controlled inflammatory responses are critical to the success of immune 
responses against infection through recruitment and activation of immune cells. 
However chronic inappropriate inflammation can lead to diseases such as 
cardiovascular disease and rheumatoid arthritis [31]. As ageing is associated with a 
dysfunctional inflammatory status (inflammageing) there is an increased risk of 
inflammation-related disease in the elderly. Similar to many other studies the results 
here show that physical inactivity is associated with heightened systemic 
inflammation and that acute exercise bouts can transiently modify the systemic 
inflammatory status [120, 273, 317, 331].  Indeed the effects of exercise on 
inflammation in various conditions in the elderly have received considerable attention 
in recent years. 
CRP is an acute phase protein which is intrinsically linked to heightened risk of 
cardiovascular disease and in the present study it was significantly reduced in the 
physically active group before adjustment for BMI. Physical activity has been 
associated with reduced CRP concentrations in a number of studies following 
adjustment for BMI. In particular, Henson and colleagues and Pischon and 
colleagues both observed relationships with sedentary lifestyles and CRP even after 
adjustment for body fat [332, 333].  However in contrast to these findings, in this 
chapter following adjustments for BMI the group differences in CRP were attenuated. 
Furthermore, correlative analysis revealed that body composition was associated 
with CRP concentration more so than estimated aerobic capacity. This is in contrast 
to the previous chapter where regression analysis with mutual adjustment for body 
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composition and quantitative physical activity levels in over 200 participants revealed 
body fat as the primary driving force behind increased systemic CRP concentrations.  
A number of studies have revealed similar patterns of associations with CRP, activity 
status and BMI in both young and old individuals. However it is difficult to fully 
separate the effects of BMI and aerobic fitness in smaller cohorts of participants like 
this and previous studies. Recently Stewart and colleagues revealed a 58% 
reduction in CRP concentrations following 12-weeks of combined aerobic and 
resistance training in both young and older participants [282]. Interestingly there 
were no changes in body fat percentage following training but importantly there were 
increases in aerobic capacity and muscle mass. This suggests that CRP 
concentrations may be associated with both muscle and fat composition suggesting 
an anti-inflammatory effect for muscle. Indeed Petersen and colleagues have 
suggested the role of muscle as an anti-inflammatory tissue for a number of years 
and suggest that exercise training should encompass both aerobic and resistance 
modes [197]. 
In support of this the acute inflammatory response to exercise can reveal to some 
extent the capacity of working muscle to reduce systemic inflammation and improve 
overall health capacity [275]. In this study small but significant increases in 
circulating concentrations of IL-1β, IL-6, IL-8, GM-CSF and IL-13 were seen following 
1 hour of seated rest. Importantly at no point were any of the cytokines produced at a 
dangerous level indicating infection or damage. These findings are comparable to 
others who have shown acute transient responses in both pro and anti-inflammatory 
cytokines [239]. There is no doubt that the intensity, duration and mode of exercise 
can determine the degree and type of cytokine production as well as the longevity of 
its presence in the circulation [197, 204, 277]. High intensity long duration exercise is 
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usually accompanied by systemic increases in a number of pro-inflammatory 
cytokines including IL-1β, IL-6 and occasionally TNFα [334]. Until recently these 
increases, especially in at risk populations have been suggested to be detrimental 
and potentially damaging [335]. However recent studies have shown that the 
inflammatory response is needed for muscle anabolic responses and muscle protein 
synthesis after exercise is abolished in the presence of anti-inflammatory drugs 
[336]. So the pro-inflammatory response effect seen here is in fact a positive one, 
potentially helping to maintain and build muscle. 
Recently it has been shown that cytokine dynamics following acute exercise is 
indicative of a tissue protective role including improved insulin sensitivity, immune 
function and muscle vascular angiogenesis [196]. Exercise stimulated muscle 
derived IL-6 is known to stimulate insulin sensitivity through activation of AMPK 
rather than SOCS3 at the same time as reducing endotoxin mediated TNFα 
production [203]. Muscle damage has been shown to increase local and systemic 
inflammation and although we cannot discount such damage even at relatively low 
intensities the inflammatory signs of muscle adaptation were present.  
The chemokine IL-8 is a chemoattractant but has also been recently shown to 
enhance muscle microvascular angiogenesis following exercise [209, 337]. 
Therefore it is likely the increased IL-8 observed here was indicative of adaptive 
processes required for muscle repair and growth. Additionally following resistance 
exercise training muscle receptor expression for IL-4 and IL-13 are increased 
suggesting a potential role in muscle adaptation and hypertrophy as well as an anti-
inflammatory response [338]. In confirmation with this we observed an increase in IL-
13 production 1 hour after exercise and although the exercise session was not 
resistance based it is likely that IL-13 was enhancing muscle adaptation. 
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Furthermore, IL-1β is often cited as a pro-inflammatory cytokine capable of 
enhancing the inflammatory response and having the potential to cause tissue 
damage. However recently it has been shown to be a necessary intermediary in the 
synthesis and production of IL-6 from muscle cells [339, 340]. Therefore as 
mentioned previously IL-1β stimulated IL-6 can act in a pleiotropic way to repair and 
adapt muscle in response to stress such as exercise. Although we are unable to 
assess stimulatory dynamics of IL-1β and IL-6 the concomitant increase observed in 
both suggests a synergist role which is likely to benefit muscle adaptation via IL-6.  
GM-CSF expression is often found in exercising muscle and plasma from athletes 
and is thought to play a pleiotropic role in muscle repair and adaptation by 
stimulating growth of neutrophils and monocytes which aide  in the response [341]. 
These cells are integral to cellular and damaged tissue repair therefore it is likely 
GM-CSF increases observed in this study were aiding tissue adaptation. Taken 
together our findings are suggestive of a protective and adaptive role for what are 
typically pro-inflammatory cytokines and growth factors following a short bout of 
acute exercise in healthy elderly individuals.  
To date no study has fully explored the mechanisms of muscle induced cytokine 
responses acting in a pleiotropic manner in either the young or elderly. However by 
assessing larger numbers and types of cytokines, chemokines and growth factors 
the study here has shown the potential for a pleiotropic muscle enhancing effect from 
a simple walking procedure in the elderly. Future work should include muscle 
biopsies from the elderly at different time points during exercise to determine the 
exact dynamics of these typical pro-inflammatory mediators. 
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5.3.2 Endocrine Response to Acute Exercise 
Improving the endocrine status, particularly the ratio of cortisol to DHEAs offers 
potential therapeutic benefits to the elderly in respect to overall reductions in 
systemic inflammation and reduced frailty prevalence as cortisol is immune 
suppressing and catabolic with respect to muscle and bone [134]. The 
cortisol:DHEAs ratio was reduced in response to an acute bout of walking at a 
predominantly moderate intensity in elderly individuals. Reductions were mainly 
driven by reduced concentrations of cortisol rather than increased DHEAs. Cortisol 
decreased during the exercise bout and further reduced 1 hour after cessation 
compared to baseline levels. These findings are comparable to Kemmler and 
colleagues who have shown reduced cortisol in response to exercise during the 
morning in postmenopausal women [342] and also in men [343]. Circulating cortisol 
concentrations are dependent on diurnal variations with the highest levels being 
found during the early hours of the morning during sleep phase [344]. Therefore as 
with the current study and those of Kremmler it is difficult to assess whether the 
reductions were independent of exercise and in fact being controlled by diurnal 
rhythms. In the present study the elderly individuals were assessed around 3 hours 
after awakening suggesting that diurnal variations were minimal. Also as the 
intervention was carried out at the same time each day for all participants and lasted 
only 20 minutes, the diurnal effects therefore should be minimal.  
Others have assessed elderly participants with higher intensity exercise bouts in the 
morning and shown significant increases in cortisol [345]. Relative intensity of 
exercise has been suggested to be a controlling factor on the cortisol response in 
young and older individuals with higher intensities (>60% of VO2max) causing 
activation of the HPA-axis and subsequent increased concentrations [346]. In the 
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current study the intensity was for the majority of time very low and only reached 
moderate and hard during the final stages suggesting time spent above 60% VO2max 
was not sufficient to cause an altered increased HPA response. In light of these data 
it is likely that intensity of exercise and not time of day modulates cortisol responses 
greater and the current study cortisol reductions were in response to the exercise 
bout, although further analysis to confirm this is warranted. Encouragingly the level 
of exercise was moderate and only lasted for 23 minutes and thus may be easy to 
implement in the elderly population. 
Unlike cortisol, DHEAs concentrations are not diurnally controlled and increased 
slightly in response to the exercise session; furthermore although not significant 
there was a clear pattern for the high active elders to have increased DHEAs 
concentrations at all time-points. DHEAs associations with exercise, especially in the 
elderly are limited, with the majority of studies assessing the un-sulphated form 
DHEA [248, 343, 347]. DHEAs is positively associated with muscle mass and is 
utilised by the body as a precursor to a number of anabolic mediators [348]. 
Although the present study did not assess overall muscle mass, the differential 
pattern of DHEAS between active and inactive has been shown previously [349]. 
Regardless of muscle mass, Li and colleagues recently suggested that a walking 
session was sufficient to increase DHEAs in middle aged men and Kremmler 
showed increased DHEAs concentrations in women following exercise [342]. 
Although others have not shown increases there are methodological variances that 
may account for no effect. In particular, when assessing strength trained individuals, 
DHEAs concentrations may be at their peak for that individual and to induce an 
exercise dependent response would be near impossible [350]. Additionally gender 
differences are apparent with DHEAs, with males having higher concentrations than 
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females due to DHEAs utilisation in sex steroid synthesis and muscle metabolism 
[351, 352]. Therefore exercise induced increases of DHEAs may be more likely in 
elderly females than men due to the menopause and reduced muscle mass. 
Although the increases in DHEAs in the present study were seen in females there 
was a trend towards a difference for males (p=.089). Thus acute exercise induced 
changes to circulating DHEAs in the elderly may be gender specific and rely on the 
mode and duration of the exercise bout. 
5.3.3 Immune Response to Acute Exercise 
The findings of this study suggest the inflammatory and endocrine responses to 
acute exercise are well placed to direct an enhanced immune response. The 
increased IL-8 may be contributing to muscle adaptation, but in conjunction with 
increased GM-CSF can stimulate the production and release of new neutrophils and 
monocytes from the bone marrow, suggesting an enhanced innate immune response 
[353]. Increased ratio of DHEAs to cortisol and elevated inflammatory to anti-
inflammatory cytokines can prime the immune system for detection of and clearance 
of pathogens [79]. In the present study a short bout of walking moderately improved 
neutrophil and monocyte function in both low and highly active elders which was 
paralleled by immune enhancing inflammatory mediator production and endocrine 
responses. Specifically the percentage of neutrophils and monocytes able to uptake 
and produce superoxide to bacteria was increased, particularly during the recovery 
phase. Although the amount of bacterial uptake by both cell types was unaffected by 
exercise, monocytes produced significantly more superoxide towards bacteria during 
the recovery phase.  
  
Page | 203  
 
5.3.4 Neutrophil Response to Acute Exercise 
Neutrophil numbers increased in response to the exercise and did not increase any 
further during the recovery phase. Neutrophil number responses to exercise are well 
documented with intensity and duration of exercise directing whether numbers keep 
increasing during recovery (high intensity long duration) or start to fall back to 
baseline levels (low intensity short duration) [245]. Neutrophil superoxide production 
and uptake of E.coli on a per cell basis was unaffected by acute exercise. In younger 
sedentary and trained individuals moderate short duration exercise has been shown 
to cause a transient increase in neutrophil phagocytosis and bactericidal killing [245, 
354, 355] while longer higher intensity exercise causes reduced function [356]. As 
this study is the first to assess an acute walking bout in elderly men and women it is 
possible that the exercise bout may not have the capacity to alter neutrophil function 
at the cellular level. However there was a trend (p=.058) for the active elders to have 
increased uptake of bacteria per cell suggesting habitual training has the ability to 
modify neutrophil function over a longer period of time. Sedentary men aged below 
60 years have been previously shown to have reduced neutrophil function over 
trained individuals [226, 245, 357] and here we show a trend for similar differences in 
our elderly cohort, confirming the potential benefit of regular exercise on bacterial 
uptake by neutrophils. Exercise intensities over 75% of VO2max and 60 minutes 
duration are often associated with an increase in circulating neutrophil numbers post 
exercise and again during the recovery phase and subsequently neutrophil 
dysfunction [294]. Because our exercise protocol was relatively short (~23 minutes) 
and stopped at 75% of maximum predicted heart rate it is unlikely to have been 
sufficient to cause transient cellular changes in bactericidal function similar to other 
studies.  
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The percentage of circulating neutrophils capable of E.coli phagocytosis and 
production of a superoxide response was increased 1 Hour Post exercise. Although 
these increases were relatively small, total numbers of circulating cells did not reflect 
the observed pattern. Instead total circulating neutrophil numbers decreased 1 Hour 
Post exercise in the present study while percentage of cells increased at the same 
time point. This was interesting in that the inflammatory and endocrine milieu at this 
time point was such that it could enhance neutrophil function, particularly by 
releasing newer potentially more functional or proportionally more functional cells 
from the bone marrow. Thus these findings suggest that exercise caused a 
redistribution of functionally and potentially phenotypically distinct neutrophils, similar 
to what is often seen in lymphocyte subpopulations [214, 358]. Neutrophils are often 
considered a homogenous terminally differentiated population of professional 
phagocytes; however it was revealed recently that neutrophil populations have 
different expression of adhesion molecules causing some to migrate better than 
others [327]. Therefore, it is plausible that exercise can redistribute functionally 
distinct neutrophils and benefit the elderly who have reduced neutrophil function and 
modify the risk of infection.  
To investigate this further and to determine whether phenotype could identify 
functional neutrophils we investigated the acute exercise dependent expression of 
CXCR2 and CXCR4 on neutrophils for the first time. CXCR2 has previously been 
reported to be increased, while CXCR4 is non-detectable on newly released mature 
neutrophils from the bone marrow [359]. Consequently, CXCR2 was reduced while 
CXCR4 is elevated on older ‘senescent’ neutrophils preparing to be cleared from the 
system. We observed a significant reduction of CXCR2 and CXCR4 expression 
immediately and 1 hour after, respectively, exercise cessation in both groups with 
Page | 205  
 
CXCR2 returning to basal values 1 Hour Post exercise. CXCR2 expression at 1 Hour 
Post exercise was also positively correlated with percentage of cells capable of 
bacterial phagocytosis. Interestingly the ratio of CXCR2 to CXCR4 expressing 
neutrophil may give an indication of proportions of functional to less functional 
neutrophils in the circulation [177, 360]. We show here that the ratio with more 
functional neutrophils is increased at 1 hour post exercise which parallels the 
observations we see with percentage of neutrophils capable of ingesting bacteria 
and producing a superoxide killing mechanism. These data are novel and suggest 
that exercise can redistribute functionally distinct neutrophils with altered 
phenotypes. Furthermore, the increased concentration of GM-CSF during the 
recovery has the potential to allow migration of newly matured neutrophils from the 
bone marrow, which would be consistent with CXCR2 expression changes [341, 
361]. Studies in younger individuals have shown increases for neutrophil adhesion 
and activation molecules CD11b and CD62L in response to exercise [362, 363]. In 
light of this exercise may not only alter the activation status of neutrophils but also 
preferentially redistribute newer neutrophils in order to mobilise them in response to 
stress. 
In summary neutrophil function with acute exercise was only slightly modified and 
although no differences between activity groups was apparent, there was a trend for 
the highly active individuals to have improved phagocytic capacity compared to 
inactive elders. Acute low level exercise can redistribute and de-marginalise 
functionally distinct cells as evident by their phenotype. Whether regular exercise 
can improve neutrophil function remains to be determined however this is likely 
considering previous research and the trends observed in this study between active 
and inactive elders.  
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5.3.5 Monocyte Response to Acute Exercise 
Monocyte dysfunction with age is well documented including reduced chemotaxis, 
phagocytosis and respiratory burst [364]. To date few studies have assessed 
monocyte function and phenotype modifications in response to acute bouts of 
exercise in the elderly. Monocyte bactericidal capacity was improved in response to 
acute exercise in the elderly, with an increased percentage of monocytes able to 
uptake bacteria, produce superoxide killing burst and more superoxide generation 
per monocyte. These findings paralleled those of neutrophils and further suggest the 
inflammatory milieu may be able to modify immune function. No differences were 
observed between activity groups for any of the bactericidal functions. This is in 
agreement with the only other study to assess monocyte phagocytosis in later life. 
Schaun and colleagues [243] showed no improvements in bactericidal activity in a 
group of middle aged men (mean age of 54 years old) following 12 weeks of 
exercise training. Although they did not assess differences between habitual activity 
levels of their subjects as there were no improvements following training it may be 
that monocyte phagocytosis is less responsive to exercise induced modifications in 
the elderly. Furthermore, the responses to an acute exercise bout have not been 
reported previously.  
In young individuals phagocytosis has been shown to increase following exercise 
whilst superoxide killing is often reduced. LaVoy and colleagues [365] recently 
showed an increase in phagocytosis following a strenuous 75 km cycle time trial in 
young trained athletes . These findings are in contrast to this study and suggest 
intensity and duration may play a role in differences observed between young and 
elderly. Furthermore the shift towards a myeloid lineage in the elderly may account 
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for differences between young and old, although further work is required to assess 
this.  
Ageing is associated with an increased proportion of pro-inflammatory CD16+ 
monocytes yet the production of cytokines following pathogen stimulation is reduced 
suggesting a reduced immune surveillance capacity. Here a preferential mobilisation 
of CD16+ monocytes into the peripheral blood was seen following acute exercise 
before a return to baseline 1 hour after cessation. Although not statistically significant 
there was a trend (p=.079) towards the low active group having more CD16 on the 
surface of their monocytes. Monocytes in the sedentary elderly have been previously 
shown to express more CD16 on their surface than monocytes from active 
individuals [163, 366]. CD16 expression on monocytes has been associated with 
increased risk of atherosclerosis due to their adhesive and pro-inflammatory nature 
[367]. The data shown here are in concurrence with a number of others studies in 
younger individuals following acute bouts of exercise. It is unclear where the cells go 
following cessation of exercise however it is possible that the pro-inflammatory 
monocytes are preferentially removed from the peripheral blood, perhaps to other 
immune compartments such as the spleen for homeostatic clearance [368]. This has 
the potential to ultimately improve monocyte function, especially in the elderly and 
reduce the risk of adverse health conditions.  
To investigate whether this biphasic redistribution of monocytes affected function, 
cell surface phenotype in response to exercise was also investigated. Acute 
resistance exercise in the elderly does not affect the expression of TLR4 on 
monocytes however it can augment the LPS induced production of TNFα [321]. 
Other studies have also assessed the expression of surface molecules responsible 
for pathogen recognition (TLR2 and TLR4) inflammation and antigen presentation 
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(HLA-DR) to adaptive cells and concluded that acute exercise is capable of altering 
the immune potential by removing pro-inflammatory monocytes from the circulation 
during the recovery phase of exercise [156]. Simpson and colleagues suggested the 
redistribution of monocytes may impact on the anti-inflammatory effects of exercise 
and immune surveillance [156, 369]. In agreement with this, increases in TLR4 
expression immediately post exercise were seen before falling back to baseline 
levels during the recovery phase, whilst TLR2 was reduced post exercise and 
reduced further during the recovery phase.  
 
The inflammatory potential of monocytes is essential for pathogen recognition and 
clearance and subsequently it is essential to assess whether this was impaired in 
response to the exercise bout. This study shows for the first time that in elderly 
individuals the percentage of monocytes capable of phagocytosis and producing a 
superoxide burst plus the amount of superoxide on a per cell basis towards E. Coli is 
increased during the recovery phase after an acute exercise bout.  These findings 
paralleled those of neutrophils and the alterations to immune enhancing cytokine and 
endocrine constituents. Thus acute exercise in the elderly of a moderate nature has 
the potential to modify the innate immune response by redistributing phenotypically 
distinct cells into the periphery. These cells are capable of enhanced bacterial 
clearance and may indicate why young and elderly individuals who participate in 
regular bouts of moderate exercise have enhanced immune function over those who 
are sedentary and do not exercise. 
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5.4 Limitations and Future Work 
 
This study is not without limitations. First, although we did not follow the participants 
for longer than one hour after exercise cessation others have followed participants 
for a number of days and observed exercise induced changes returning to baseline 
levels. It is therefore likely that our participants’ immune parameters also returned to 
baseline levels. It is this mechanism of small stressors, which can cause tissue 
modifications if repeated regularly, that is likely responsible for the exercise training 
improvements in inflammatory mediators and immune function. Second, we did not 
observe any difference in inflammatory mediators between the low and high habitual 
activity groups which is in contrast to a number of other studies [197, 198]. These 
studies consist mostly of either truly sedentary and/or highly active individuals and 
represent the extremes of suggested health. In the present study, although groups 
were determined to be either active or inactive the fact that they could attend the 
laboratory and complete the walking test suggests that the inactive group were not 
truly sedentary. Indeed their estimated VO2max levels are above that of previously 
published sedentary levels and guidelines provided by the American College of 
Sports Medicine. Future studies should therefore assess the cytokine, chemokine 
and growth factor dynamics during exercise and in at least the 24 hours following 
cessation. 
Third, we associated an immune enhancing inflammatory and endocrine milieu with 
enhanced innate immune function. These are observations and do not imply cause 
and effect. Simpson and colleagues recently attempted to address this issue with 
baseline monocyte incubation with autologous plasma from the varying exercise time 
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points. They concluded that serological constituents were unable to alter the surface 
phenotype of the monocytes but did not consider function [369]. Therefore future 
studies should focus on the functional changes of immune cells in response to 
autologous serum from varying time points.  
  
5.5 Conclusions 
 
In summary, acute exercise of a low to moderate intensity and relatively short 
duration can modify inflammation, endocrine status and immune function in a 
manner which may offer protection from infection as well as promoting beneficial 
physiological adaptation. Alterations in inflammatory mediators can stimulate not 
only muscle adaptation but here we suggest also have immune enhancing effects 
which can offer protection against pathogenic infection. Physical inactivity status was 
associated with increased basal CRP; however these effects were lost upon 
adjustment for BMI. Both the inactive and active groups elicited a similar 
inflammatory mediator response to exercise suggesting that if the severely inactive 
become more active they will promote an immune enhancing condition and offer 
improved protection from infection. In conclusion the data suggest that short walking 
bouts may benefit the elderly by enhancing the immune response to a potential 
bacterial challenge.   
Page | 211  
 
 
 
Chapter 6: Inflammation 
and Immune Function 
Response to  
High Intensity Interval 
Training (HIT) 
 
  
Page | 212  
 
6.0 Introduction 
 
It is well established that regularly physical activity is effective in reducing the risk of 
age-related conditions such as type-2 diabetes and cardiovascular disease.  In this 
respect, leading a physically active lifestyle reduces several risk factors for chronic 
disease, including a low exercise capacity, greater central adiposity, reduced insulin 
sensitivity and low-grade systemic inflammation [190].  Nevertheless, the majority of 
the population remain physically inactive, citing a lack of time as the primary barrier 
to exercise participation [187].  Therefore, it is of key importance that exercise 
strategies are developed to maximise the beneficial adaptations of exercise in a 
time-efficient manner, and that are acceptable to the general population including the 
elderly. 
One emerging approach to combat physical inactivity focuses on the use of high 
intensity interval training (HIT) [370].  Recent interest in HIT originates from its time-
efficient nature, in which short bouts of high intensity exercise (up to 60 seconds) are 
combined with periods of low intensity recovery or rest (1 to 2 minutes), providing an 
exercise session lasting around 20 minutes.  A number of well-controlled studies 
provide evidence for the effectiveness of HIT (when performing three sessions per 
week), reporting improvements in exercise capacity, blood pressure, blood vessel 
function and insulin sensitivity in young sedentary individuals following six weeks of 
HIT training [371, 372].  Furthermore, many of the beneficial adaptations to HIT 
appear to be similar to those induced by more traditional endurance-type exercise 
interventions that require a much longer time commitment (a minimum of 30 minutes 
moderate-intensity exercise per day, five times per week).  Therefore, evidence is 
accumulating to suggest that HIT provides a time-efficient and effective alternative to 
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traditional moderate-intensity exercise-based interventions as a tool to improve 
health.   
However, a major limitation is the lack of assessment of immune, endocrine and 
inflammatory mediators which are inherently linked to and an underlying cause of 
insulin resistance, vascular function and disease risk. Furthermore, all but one of the 
studies to date have assessed the impact of HIT in young healthy cohorts failing to 
assess the impact of ageing, a major contributor to the severity of the above 
pathologies [373]. Finally, the majority of studies to date have assessed the effects 
of HIT in a laboratory-based environment and have not determined whether it is 
transferrable to the real world, i.e. a gym setting.  The primary measure of the 
effectiveness of any intervention program is the adherence to the prescribed 
intervention, in this case an exercise training program. Furthermore, unlike 
laboratory based interventions, group based interventions are regularly cited as 
having superior overall adherence [374, 375]. 
Therefore in light of this the aims of this chapter were: 
1) Assess the physiological modifications offered by high intensity interval 
training compared to an endurance training program. 
2) Determine inflammatory, endocrine and immune responses to each training 
intervention. 
3) Determine the impact of age on exercise induced changes provided by 
exercise interventions. 
4) Assess the adherence to exercise interventions in a real world instructor led 
group based environment. 
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6.1: High Intensity Interval Training Study Methods 
 
6.1.1 Participants 
Participants were 90 healthy sedentary individuals recruited from the University of 
Birmingham, University Hospital Birmingham and localised area, aged 20 – 60 years 
old. Exclusion criteria were: known metabolic or cardiovascular diseases and 
engagement in more than 150 minutes of physical activity per week in the preceding 
year. All participants were subjected to a 12-lead electrocardiogram examination and 
verification of no underlying cardiovascular abnormalities provided by a research 
nurse. All participants gave written informed consent prior to commencement of the 
study, which was approved by the University Research Ethics Committee (West 
Midlands, UK). 
6.1.2 Pre-Training Experimental Procedures 
Anthropometric characteristics were taken and included assessment of body 
composition using a single frequency bioimpedence analyser (Tanita BC 418 MA 
Segmental Body Composition Analyser, Tanita, Japan). This device uses an 
algorithm incorporating age, height and impedance values to estimate relative fat 
and muscle mass across different segments of the body. Participants were fitted with 
a HR monitor around the chest and HR measured continuously by telemetry (Polar 
Electro Ltd., Kempele, Finland) and recorded every 15 seconds. VO2max was 
assessed from a progressive exercise test to volitional exhaustion on an 
electronically braked cycle ergometer (Lode BV, Groningen, Netherlands). O2 
consumption and CO2 production was quantified using a breath-by-breath on-line 
gas collection system (Oxycon Pro, Jaeger, Germany). Following familiarisation 
protocols participants began cycling at 25 Watts (W) with cadence required to be 
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above 50 revolutions per minute (rpm), followed by sequential increments of 35 W 
every 3 minutes until cadence was reduced to less than 50 rpm. VO2max was 
determined as the average value obtained in the last 30 seconds of the test and 
validated when HR was greater than 90% of the age-predicted maximal HR 
(calculated as 220 – age in years) and respiratory exchange ratio (RER) was greater 
than 1.1.  
A subset of the 90 participants (n=27) agreed to have blood samples taken 
immediately before the aerobic capacity test and immediately after for immune 
analysis. Participants were supine for at least 15 minutes before commencement of 
the test after which blood was taken from a vein in the antecubital fossa. Peripheral 
blood (40 ml) was collected into evacuated vaccutainers (Becton-Dickinson, Oxford, 
UK) containing lithium heparin or EDTA anticoagulants or clotting factor for serum 
isolation. Upon voluntary cessation of the aerobic capacity test, participants were laid 
down and the same blood sampling performed. 
At least 48 hours following the VO2max test, participants reported to the laboratory 
after an overnight fast (> 10 h). Participants were instructed to refrain from 
performing vigorous activity in the preceding 48 hour period, and were asked to 
avoid consuming caffeine or alcohol in the previous 24 hours.  In addition, 
participants completed a diet diary outlining their food intake in the preceding 24 
hour period which was collected upon arrival to the laboratory. Brachial artery blood 
pressure measurements were first made in triplicate using an automated 
sphygmomanometer (Omron 7051T, Omron Corp., Kyoto, Japan) following 15 
minutes of supine rest. Immediately following these measures a 20G cannula was 
inserted into a vein in the antecubital fossa of one arm and a 3-way stop cock 
attached to permit multiple blood sampling.  A 20 ml baseline blood sample was 
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obtained and distributed into vacutainers containing EDTA, sodium fluoride (NaF) or 
clotting factor, after which participants consumed a beverage containing 75 g 
glucose (Fisher Scientific, UK) dissolved in water and made up to 300 ml.  Further 5 
ml blood samples were obtained after 30, 60, 90 and 120 minutes, and collected into 
vacutainers containing either EDTA or NaF.  Isotonic saline (~5 ml) (B Braun, UK) 
was used to keep the cannula patent every 15 minutes during the 2 h test.   
On completion of the pre-training experimental procedures, participants were 
randomly assigned to either HIT or endurance training (ET), taking gender, age and 
BMI into consideration.  In this way it was expected that the two groups would be 
well-matched for exercise capacity (VO2max) and serological measures. 
6.1.2 Exercise Training 
Exercise sessions took place at the University of Birmingham sports centre in the 
cycle suite in groups of 10-15 participants.  Exercise was carried out on 
mechanically-braked spinning bikes (Star Trac UK Ltd., Buckinghamshire, UK) that 
permitted the participant to manually adjust the braking resistance, and thereby 
control the exercise intensity at which they were working.  All exercise sessions at 
the University of Birmingham sports centre were led by an instructor who was 
experienced in delivering exercise classes.  Before starting the training intervention, 
each participant was provided with an individual heart rate target value (determined 
from the results of the VO2max test) to achieve during the exercise sessions.  Both 
training groups (HIT or ET) were asked to attend 3 supervised exercise sessions per 
week for 10-weeks, although 5 sessions (Monday-Friday) were available in order to 
maximise attendance.  A record of subject attendance at the exercise sessions was 
maintained throughout the 10 weeks by an investigator.   
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6.1.2.1 High intensity interval training (HIT) 
For each HIT training session participants were provided with a HR monitor that 
transmitted HR to a central unit (Polar Team 2, Polar Electro Ltd., Warwick, UK) and 
individual HR values were subsequently projected on to a screen at the front of the 
room.  In this way, participants could track their heart rate throughout the exercise 
session.  Each HIT training session began with a short (5 minute) warm up of low 
intensity cycling, after which participants performed repeated high intensity sprints of 
between 15 and 60 seconds in duration, interspersed with periods of active recovery 
(60 to 120 seconds in duration), Table 6.0.  For the high intensity sprints, participants 
were instructed to adjust the resistance of the bike such that they achieved a heart 
rate greater than that equivalent to 80% of VO2max.  After each high intensity sprint 
this resistance was removed and participants cycled with minimal resistance.  Each 
session concluded with a 5 minute cool down.  Participants were instructed to 
maintain their habitual physical activity levels, but were asked not to engage in 
additional exercise training throughout the 10 week training period.     
6.1.2.2 Moderate intensity endurance training (ET)  
All participants randomised to the ET group were provided with a HR monitor 
(RS400, Polar Electro Ltd., Warwick, UK) for the 10-week training period which was 
used to record HR throughout each exercise training session.  Each ET session 
began with a short (5 minute) warm up of low intensity cycling, after which 
participants performed moderate-intensity steady state cycling for 20 to 40 minutes, 
Table 6.0.  During the steady state period, participants were instructed to adjust the 
resistance of the bike such that they achieved a HR equivalent to 65% of VO2max.  
Each session concluded with a 5 minute cool down.  In addition to attending 3 
supervised exercise sessions per week, participants were asked to perform 2 
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unsupervised moderate-intensity exercise sessions, such that a total of 5 exercise 
sessions were performed each week.  HR monitors were also worn for unsupervised 
exercise sessions, thereby providing a monitoring system for participation in the 
additional sessions, together with completion of training diaries.   
Table 6.0: Overview of HIT and ET training protocols 
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6.1.3 Post-training experimental procedures   
Post-training VO2max was assessed at least 48 hours following the last training 
session.  At this visit, participants were provided with the diet diaries that they 
completed before training, and were asked to replicate their diet in the 24 hours 
preceding the next visit. Furthermore, participants were required to visit the 
laboratory at the same time of day for testing as baseline. More than 48 hours 
following the post-training VO2max test, participants reported to the laboratory after an 
overnight fast (> 10 h), and underwent identical assessments to those outlined in 
‘Pre-training experimental procedures’.  Body composition was assessed on a 
separate day following this.   
6.1.4 Biological Analysis 
The following biological analysis was completed and described in section 2.2. 
Inflammatory and anti-inflammatory cytokines were measured by magnetic XMap 
technology. CRP, cortisol and DHEAs were measured by ELISA. Neutrophil and 
monocyte bactericidal function was assessed using phagotest and phagoburst kits, 
monocyte and neutrophil phenotype were assessed by flow cytometry. 
6.1.5 Statistics 
Statistical analyses were performed similar to Chapter 5. Individuals were 
randomised to either HIT or ET accounting for age and gender to ensure both groups 
were characteristically similar. Univariate ANOVA was conducted to assess 
differences of anthropometric characteristics between the two groups taking into 
account gender. Following this repeated measure ANOVA and ANCOVA were 
conducted to assess the changes in biological variables over either: 1) The two times 
of baseline and follow-up or 2) The times between Pre and Post VO2max testing at 
baseline and follow-up in consideration of the training group. Following this statistical 
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analysis was repeated to include assessment of whether individuals in each group 
who were aged below or above 40 years old showed any biological and training 
effects. Body fat percentage was significantly higher in the over 40 year olds and 
was subsequently included as a covariate. The assumptions of sphericity were 
assessed, partial η2 reported and Bonferroni post-hoc pairwise analysis conducted 
as in previous chapters. Statistical significance was accepted at p<.05. 
This study was completed with the collaborations of Dr Chris Shaw of Sport and 
Exercise Sciences who conducted sections 6.1.1 – 6.1.3. 
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6.2 Results 
 
6.2.1 Participant Characteristics in Response to Training and Intervention 
Table 6.1 outlines the main physiological changes with each of the training 
interventions.  Adherence to the training intervention was on average 22% greater (p 
<.001) in the HIT group than the ET group. Subsequently despite the lower 
adherence, the ET group performed significantly (p<.001) more exercise sessions 
than the HIT group (33 ± 2 versus 25 ± 1). Thus the average weekly total time 
commitment for the ET group (128 ± 7 minutes) was more than twice that of the HIT 
group (55 ± 2 minutes; p<.001). Heart rate data revealed that the HIT group had an 
average heart rate at the end of each bout of high intensity exercise equivalent to 91 
± 2% of their VO2max whilst the average HR for the ET group was equivalent to 64 ± 
2% of their VO2max. 
HIT caused similar modifications to body composition and aerobic capacity as ET. 
There were significant main effects of exercise training but not between exercise 
groups for reduced weight [F(1, 88)=13.31, p<.001, η2=.131] which equated to a 
similar effect on BMI [F(1, 88)=12.54, p=.001, η2=.125]. Changes in BMI were 
associated with reduced body fat percentage [F(1, 88)=14.25, p<.001, η2=.143] and 
not increased muscle mass although there was a trend for the ET group to have a 
small increase post training (p =.081). Similarly there was a main effect of exercise 
training for aerobic capacity increases [F(1, 88)=79.80, p<.001, η2=.476]. 
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Table 6.1: Group characteristics. Participant characteristics for the high intensity (HIT) and endurance (ET) training groups before 
(Pre) and after (Post) 10-weeks of training. Data are mean ± SEM. 
  
***p<.001 compared to HIT group. 
Training 
effect
Training x 
group
Pre Post Pre Post (p ) (p )
Gender (males/females)
Adherence (%)
Age (years)
Body composition
Weight (kg) 78.7 ± 2.7 77.9 ± 2.6 77.5 ± 2.4 76.6 ± 2.4 <.001 .884
BMI (kg
.
m
-2
) 27.7 ± 0.7 27.3 ± 0.7 27.7 ± 0.7 27.4 ± 0.7    .001 .939
Fat mass (%) 31.7 ± 1.2 30.8 ± 1.1 32.0 ± 1.2 30.9 ± 1.3 <.001 .421
Muscle mass (%) 65.0 ± 1.2 65.6 ± 1.1 64.7 ± 1.1 65.8 ± 1.3    .714 .074
Exercise capacity
VO2 max (ml
.
min
-1.
kg
-1
)   32.0 ± 1.0   34.8 ± 1.0   31.5 ± 1.0   33.9 ± 1.1 <.001 .899
VO2 max (L.min
-1
)     2.5 ± 0.1     2.7 ± 0.1     2.4 ± 0.1     2.6 ± 0.1 <.001 .331
15/31 15/29
83 ± 3    61 ± 4***
HIT ET
42 ± 2 43 ± 2
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6.2.1.1 Inflammatory, Endocrine and Metabolic Alterations in Response to 
Training 
Participation in the HIT intervention was associated with similar endocrine, 
inflammatory and metabolic modifications as the ET intervention. There were 
significant main effects of exercise training but not between exercise groups for 
reduced cortisol [F(1, 88)=129.81, p<.001, η2=.637] and increased DHEAs [F(1, 
88)=34.80, p<.001, η2=.349] which equated to a reduction in the cortisol:DHEAs ratio 
[F(1, 88)=46.29, p<.001, η2=.416]. Similar main effects were observed for reduced 
concentrations of the pro-inflammatory CRP [F(1, 88)=5.71, p=.019, η2=.069] , IL-6 
[F(1, 88)=3.99, p=.047, η2=.051], IL-8 [F(1, 88)=22.93, p<.001, η2=.252]  and MCP-1 
[F(1, 88)=11.31, p=.001, η2=.143] and a trend for increased GM-CSF [F(1, 88)=3.96, 
p=.051, η2=.055]. Additionally exercise training was associated with an improved 
metabolic profile through reduced concentrations of leptin [F(1, 88)=4.91, p=.030, 
η2=.066], increased adiponectin [F(1, 88)=5.07, p=.027, η2=.064] and a subsequent 
reduced ratio of leptin to adiponectin [F(1, 88)=14.91, p<.001, η2=.176]. 
6.2.1.2 Neutrophil and Monocyte Bactericidal Activity 
Neutrophil and monocyte capacity to ingest bacteria and produce a superoxide killing 
response were modified by ten weeks of ET and HIT, Table 6.3. There was a 
significant main effect of training for an increased amount of bacterial uptake per cell 
(MFI) for neutrophils [F(1, 22)=7.99, p=.009; η2=.250] and monocytes [F(1, 
22)=18.54, , p<.001; η2=.457]. No effect for training was observed for the percentage 
of neutrophils and monocytes able to uptake bacteria. Similarly there was a 
significant main effect of exercise training for an increased amount of superoxide 
generation per cell (MFI) for neutrophils [F(1, 22)=11.62, p=.003; η2=.346] and 
monocytes [F(1, 22)=4.83, , p=.039; η2=.187]. Additionally the percentage of 
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neutrophils [F(1, 22)=37.69, , p<.001; η2=.653] and monocytes [F(1, 22)=11.63, , 
p=.002; η2=.336] producing superoxide killing capabilities was increased following 
ten weeks of ET training. Taken together both HIT and ET can improve neutrophil 
and monocyte bactericidal capacity.  
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Table 6.2: Biomarker response to training. Endocrine, inflammatory and metabolic characteristics for the high intensity (HIT: 
n=46) and endurance (ET: n=44) training groups before (Pre) and after (Post) 10-weeks of training. Data are Mean ± SEM. 
 
Training 
effect
Training x 
group
Pre Post Pre Post (p ) (p )
Endocrine
Cortisol (nmol
.
L
-1
) 390 ± 14 290 ± 13 351 ± 15 274 ± 14 <.001 .128
DHEAs (nmol
.
L
-1
) 3261 ± 309 3861 ± 331 3615 ± 332 4319 ± 357 <.001 .640
Cortisol: DHEAs   0.16 ± 0.02   0.09 ± 0.01   0.15 ± 0.02   0.09 ± 0.01 <.001 .457
Inflammatory
CRP (mg
.
L
-1
) 1.35 ± 0.40 0.97 ± 0.14 1.43 ± 0.31 0.96 ± 0.11 .019 .211
TNFα (pg
.
ml
-1
) 0.24 ± 0.06 0.18 ± 0.05 0.97 ± 0.08 1.04 ± 0.12 .770 .756
IL-1β (pg
.
ml
-1
) 0.49 ± 0.02 0.47 ± 0.01 0.72 ± 0.08 0.72 ± 0.09 .473 .989
IL-6 (pg
.
ml
-1
) 1.02 ± 0.17 0.89 ± 0.12 0.83 ± 0.20 0.47 ± 0.11 .047 .259
IL-8 (pg
.
ml
-1
) 3.48 ± 0.16 3.10 ± 0.15 4.10 ± 0.22 3.74 ± 0.21 <.001 .654
IL-17 (pg
.
ml
-1
) 0.37 ± 0.37 0.00 ± 0.00 0.01 ± 0.01 0.02 ± 0.02 1.000 .307
GM-CSF (pg
.
ml
-1
) 18.79 ± 6.23 23.47 ± 8.03 19.13 ± 4.91 26.97 ± 5.59 .051 .663
MCP-1 (pg
.
ml
-1
) 22.56 ± 0.94 21.42 ± 1.05 26.01 ± 0.96 24.22 ± 1.08 .001 .460
VEGF (pg
.
ml
-1
) 2.67 ± 0.47 2.35 ± 0.41 3.31 ± 0.39 3.43 ± 0.46 .686 .936
Anti-Inflammatory
IL-4 (pg
.
ml
-1
) 0.02 ± 0.01 0.01 ± 0.01 0.02 ± 0.01 0.03 ± 0.01 .696 .823
IL-10 (pg
.
ml
-1
) 0.39 ± 0.31 0.88 ± 0.74 0.71 ± 0.64 0.05 ± 0.05 .739 .172
IL-13 (pg
.
ml
-1
) 0.10 ± 0.04 0.03 ± 0.02 0.11 ± 0.07 0.11 ± 0.05 .951 .767
Metabolic
Leptin (ng
.
ml
-1
) 18.83 ± 1.78 16.12 ± 1.68 15.61 ± 1.78 14.59 ± 1.68 .030 .319
Adiponectin (µg
.
ml
-1
) 2.24 ± 0.18 2.73 ± 0.20 2.21 ± 0.19 2.29 ± 0.21 .027 .107
Leptin: Adiponectin 10.13 ± 1.42 6.61 ± 0.91 9.84 ± 1.42 7.89 ± 0.91 <.001 .270
HIT ET
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Table 6.3: Immune function response to training. Neutrophil and monocyte 
bactericidal function for the high intensity (HIT: n=13) and endurance (ET: n=11) 
training groups before (Pre) and after (Post) 10-weeks of training. Data are Mean ± 
SEM. 
 *p<.05 significantly different from corresponding HIT time point  
 
  
Pre Post Pre Post (p ) (p )
Phagocytosis
Neutrophil (%) 97.3 ± 0.4 97.0 ± 0.4 96.5 ± 0.5 97.3 ± 0.3 .734 .185
Neutrophil (MFI) 130.6 ± 4.4 152.0 ± 7.9 126.2 ± 3.6 145.5 ± 13.0 .009 .890
Monocyte (%) 94.5 ± 0.7 93.3 ± 0.5 93.6 ± 0.7 93.1 ± 0.6 .058 .451
Monocyte (MFI) 99.3 ± 2.9 113.3 ± 3.9 92.9 ± 3.7 110.4 ± 5.8 <.001 .633
Superoxide Production
Neutrophil (%) 93.1 ± 12.0 98.4 ± 0.2 95.6 ± 0.7 98.5 ± 0.2 <.001 .089
Neutrophil (MFI) 69.0 ± 6.5 84.6 ± 7.0 77.6 ± 5.8 104.8 ± 10.7 .003 .355
Monocyte (%) 74.4 ± 2.7 81.6 ± 1.6 74.4 ± 4.1 85.6 ± 1.9* .002 .480
Monocyte (MFI) 22.8 ± 0.9 27.5 ± 2.3 27.8 ± 2.0 30.9 ± 3.7 .039 .730
Training 
Effect
Training x 
Group
HIT ET
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6.2.1.3 Monocyte Phenotype  
CD16 expression on CD14 positive monocytes is indicative of a pro-inflammatory 
phenotype. There was a significant main effect of time on the increased percentage 
of CD14+/CD16neg monocytes [F(1,25)=11.34, p=.004, η2=.311] suggesting a 
reduced inflammatory phenotype (Table 6.4). This was confirmed by significant 
reductions in the percentage of the CD16dim (p=.009) and CD16bright (p=.011) 
populations. Differences were similar across the two intervention groups. 
TLR expression on monocytes is an indication of inflammatory potential. TLR4 (Fig. 
6.1A) and TLR2 (Fig 6.1B) were assessed on the three monocyte subsets, classical 
(CD14+/CD16neg), intermediate (CD14+/CD16dim) and non-classical 
(CD14+/CD16bright). No differences were observed between the HIT and ET groups 
for expression of TLR4 or TLR2 on any of the subsets or in response to training. 
There was a significant main effect of time for expression of TLR4 on total CD14+ 
monocytes [F(1,25)=18.45, p<.001, η2=.302] which was driven by expression of 
TLR4 on the CD14+/CD16bright monocytes [F(1,25)=16.54, p<.001, η2=.257]. TLR2 
expression was higher at all times on CD14+/CD16neg and CD14+/CD16dim compared 
to CD14+/CD16bright populations (p<.05). There was a significant main effect of time 
for expression of TLR2 on total CD14+ monocytes [F(1,25)=21.40, p<.001, η2=.257] 
which was driven by changes in expression of TLR2 on the CD14+/CD16dim 
monocytes [F(1,25)=19.42, p<.001, η2=.199]. These data suggest that HIT exercise 
training is comparable to ET in reducing the pro-inflammatory potential of monocytes 
by reducing TLR2 and TLR4 expression on CD16 positive monocytes. 
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Table 6.4: Monocyte response to training. Percentage of CD14+ monocytes 
expressing CD16 in the high intensity (HIT: n=14) and endurance (ET: n=13) training 
groups before (Pre) and after (Post) 10-weeks of training. Data are Mean ± SD. 
   
Pre Post Pre Post (p ) (p )
Monocyte (%)
CD14+/CD16neg 87.2 ± 4.7 91.1 ± 2.9 86.9 ± 5.8 89.8 ± 5.2 .004 .449
CD14+/CD16dim 4.4 ± 2.8 3.1 ± 1.7 4.7 ± 2.4 3.8 ± 2.1 .009 .566
CD14+/CD16bright 8.1 ± 4.4 5.8 ± 3.6 8.4 ± 3.1 7.1 ± 4.2 .011 .487
HIT ET Training 
Effect
Training x 
Group
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Fig. 6.1: Monocyte phenotype responses to exercise training. Monocyte 
expression of TLR4 (A) and TLR2 (B) on CD14+ monocyte subtypes in response to 
10-weeks of HIT or ET exercise training. Data are mean ± SEM. ***p<.001 compared 
to Pre baseline measures levels for that subtype. 
A 
B 
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6.2.2 Participant Characteristics in Response to Training and Age 
The cohort tested consisted of an age range spanning 40 years. Therefore as ageing 
has a significant impact on inflammation, endocrine function and immune function 
the relationship between age and training was assessed. Participant data was split 
into two groups, those aged below 40 years (young) and those aged 40 years and 
above (middle aged). Table 6.5 outlines the similar variables assessed in Table 6.1, 
split for age. No differences were observed between groups for gender, adherence 
or the intervention group they were placed in. No differences were observed 
previously for effects of intervention group and no differences were observed with 
age groups, therefore all participants in the age groups were analysed together 
having completed an exercise intervention.  
As before, there were main effects of exercise training for reduced weight (p<.001), 
BMI (p=.001), body fat percentage (p<.001) and VO2max (p<.001). Although no 
interactions were observed for a training x group effect the middle aged participants 
had a significantly higher BMI at both Pre (p=.033) and Post (p=.037) training plus 
body fat percentages at the same times than the young (p=.049 and .031 
respectively). Furthermore the middle aged group had lower VO2max values at both 
Pre and Post training (both p<.001) than the young. 
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Table 6.5: Group characteristics for ageing. Participant characteristics for the young and middle aged groups before (Pre) and 
after (Post) 10-weeks of training. Data are mean ± SEM. 
 
*p<.05, ***p<.001 significantly different between the below 40 age group and above 40 age group at the corresponding times 
Training 
effect
Training x 
group
Pre Post Pre Post (p ) (p )
Gender (males/females)
Adherence (%)
Age (years)
Exercise Group (HIT/ET)
Body composition
Weight (kg) 77.9 ± 2.7 77.0 ± 2.7 78.4 ± 2.4 77.5 ±2.3 <.001 .906
BMI (kg
.
m
-2
) 26.9 ± 0.7 26.6 ± 0.7 28.5 ± 0.7* 28.2 ± 0.7*    .001 .959
Fat mass (%) 30.1 ± 1.1 29.8 ± 1.1 33.8 ± 1.3* 33.3 ± 1.3* <.001 .730
Muscle mass (%) 66.3 ± 1.1 66.7 ± 1.1 63.0 ± 1.3 63.1 ± 1.3    .714 .414
Exercise capacity
VO2 max (ml
.
min
-1.
kg
-1
)   35.1 ± 0.9   38.0 ± 0.9   28.4 ± 0.9***   30.6 ± 0.9*** <.001 .250
VO2 max (L.min
-1
)     2.8 ± 0.1     2.9 ± 0.1     2.1 ± 0.1***     2.3 ± 0.1*** <.001 .331
17/29 13/31
33 ± 5 52 ± 5***
77 ± 2
Young Middle Aged
74 ± 3
24/22 22/22
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6.2.2.1 Age Associated Inflammatory, Endocrine and Metabolic Alterations in 
Response to Training 
Anti-inflammatory and endocrine effects of exercise were driven by larger overall 
changes in the older participants than the young (Table 6.6). As before there were 
main effects of exercise training for reduced cortisol (p<.001), increased DHEAs 
(p<.001) and a reduced cortisol:DHEAs ratio (p<.001). DHEAs as expected was 
significantly lower in the middle aged group at both Pre (p=.004) and Post (p=.017) 
training compared to the young group. Subsequently changes in cortisol were driven 
to a greater extent in the middle aged participants who had on average a 26% 
overall reduction compared to 20% in the young group. Similarly DHEAs increased 
on average by 31% in the middle aged group compared to 24% in the young group. 
This equated to an average reduction in the cortisol:DHEAs ratio of 38% in the 
middle aged group compared to 29% in the young.  
Similarly exercise training was associated with reduced concentrations of CRP 
(p=.019), IL-6 (p=.047), IL-8 (p<.001) and MCP-1 (p=.001). Changes in IL-6 were 
driven to a greater extent in the middle aged group who had on average a 15% 
change compared to 3% in the young group. Changes in CRP, IL-8 and MCP-1 were 
similar between ages. Interestingly, at both time points the concentrations of GM-
CSF were higher in the middle aged group (both p<.01) than the young group. There 
was a trend for the young group to have increased GM-CSF concentrations (p=.058) 
but not the middle aged group (p=.385) following training.  
As before leptin (p=.030) was reduced whilst adiponectin (p=.027) was increased in 
response to training. There were no interactions with age and changes were not 
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driven by either age group suggesting adipokine levels may be independent of age 
and dependent solely on adipocyte content. 
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Table 6.6: Biomarker responses with ageing. Endocrine, inflammatory and metabolic characteristics for the young (n=46) and 
middle aged (n=44) groups before (Pre) and after (Post) 10-weeks of training. Data are mean ± SEM. 
 
*p<.05, **p<.01 significantly different between the below 40 age group and above 40 age group at the corresponding times 
Training 
effect
Training x 
group
Pre Post Pre Post (p ) (p )
Endocrine
Cortisol (nmol
.
L
-1
) 370 ± 12 295 ± 14 373 ± 17 270 ± 14 <.001 .078
DHEAs (nmol
.
L
-1
) 4051 ± 359 4636 ± 370   2779 ± 224**  3494 ± 282* <.001 .556
Cortisol: DHEAs   0.13 ± 0.02   0.08 ± 0.01   0.17 ± 0.02   0.10 ± 0.01 <.001 .180
Inflammatory
CRP (mg
.
L
-1
) 1.84 ± 0.50 1.17 ± 0.19 1.03 ± 0.15 0.77 ± 0.11 .019 .310
TNFα (pg
.
ml
-1
) 0.58 ± 0.09 0.70 ± 0.14 0.56 ± 0.10 0.49 ± 0.08 .770 .193
IL-1β (pg
.
ml
-1
) 0.61 ± 0.02 0.60 ± 0.02 0.60 ± 0.03 0.58 ± 0.03 .473 .596
IL-6 (pg
.
ml
-1
) 0.75 ± 0.17 0.69 ± 0.10 1.13 ± 0.23 0.68 ± 0.13 .047 .172
IL-8 (pg
.
ml
-1
) 3.67 ± 0.22 3.31 ± 0.23 3.88 ± 0.20 3.51 ± 0.15 <.001 .944
IL-17 (pg
.
ml
-1
) 0.17 ± 0.02 0.17 ± 0.02 0.00 ± 0.00 0.00 ± 0.00 1.000 .307
GM-CSF (pg
.
ml
-1
) 33.73 ± 7.22 40.73 ± 8.40    7.87 ± 3.65**    9.60 ± 3.71** .051 .542
MCP-1 (pg
.
ml
-1
) 23.91 ± 0.80 22.61 ± 0.81 24.56 ± 1.15 22.95 ± 1.31 .001 .734
VEGF (pg
.
ml
-1
) 3.16 ± 0.47 3.26 ± 0.41 2.76 ± 0.39 2.51 ± 0.43 .686 .613
Anti-Inflammatory
IL-4 (pg
.
ml
-1
) 0.01 ± 0.01 0.03 ± 0.01 0.02 ± 0.01 0.01 ± 0.01 .696 .177
IL-10 (pg
.
ml
-1
) 0.34 ± 0.31 0.96 ± 0.74 0.89 ± 0.73 0.00 ± 0.00 .739 .083
IL-13 (pg
.
ml
-1
) 0.05 ± 0.03 0.11 ± 0.05 0.12 ± 0.08 0.03 ± 0.05 .951 .152
Metabolic
Leptin (ng
.
ml
-1
) 16.29 ± 1.73 14.67 ± 1.63 18.21 ± 1.85 16.09 ± 1.73 .030 .767
Adiponectin (µg
.
ml
-1
) 2.24 ± 0.21 2.58 ± 0.21 2.20 ± 0.16 2.45 ± 0.19 .027 .743
Leptin: Adiponectin 9.68 ± 1.22 6.82 ± 0.86 10.31 ± 1.61 7.71 ± 0.97 <.001 .858
Young Middle Aged
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6.2.2.2 Age-Associated Bactericidal Activity in Response to Exercise 
There were significant interactions between exercise training and the age of the 
participants for monocyte and neutrophil function suggesting that the two groups 
produced different responses to training (Table 6.7). The main interaction was 
observed for the amount of bacterial uptake (MFI) by monocytes [F(1, 22)=5.47, 
p=.029; η2=.187] which was driven by significant increases in values following ten 
weeks training in the middle aged group (p=.007) suggesting an immune enhancing 
effect of exercise with older age. Similarly there was an interaction for the 
percentage of neutrophils producing a superoxide killing burst [F(1, 22)=4.58, 
p=.045; η2=.186] which was driven by a larger magnitude of change in the young 
(p<.001) than in the middle aged group (p=.020). Additionally the middle aged group 
had a small but significantly higher percentage of superoxide producing cells at Pre 
training (p=.048). Taken together, exercise training can improve neutrophil and 
monocyte bactericidal function in both young and middle aged individuals, however it 
appears that the middle aged individuals improve to a greater degree. These data 
would suggest that exercise training can reverse some of the functional immune 
reductions observed with ageing. 
6.2.2.3 Monocyte Phenotype  
With regard to monocyte phenotype, increased CD16 expression on CD14 positive 
monocytes are indicative of a pro-inflammatory phenotype is associated with 
increased age. There was a significant main effect of time on the increased 
percentage of CD14+/CD16neg monocytes [F(1,25)=13.21, p=.007, η2=.385] 
suggesting a reduced inflammatory phenotype (Table 6.8). This was confirmed by 
significant reductions in the percentage of the CD16dim (p=.002) and CD16bright 
(p=.024) populations. Differences were similar across the two age groups. 
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TLR expression on monocytes in the elderly has been suggested to decrease 
following exercise training periods. TLR4 (Fig. 6.2A) and TLR2 (Fig 6.2B) expression 
were assessed on the three monocyte subsets, classical (CD14+/CD16neg), 
intermediate (CD14+/CD16dim) and non-classical (CD14+/CD16bright). No differences 
were observed between the age groups for expression of TLR4 or TLR2 on any of 
the subsets. There was a significant main effect of time for expression of TLR4 on 
total CD14+ monocytes but only in the middle-aged participants [F(1,25)=38.45, 
p<.001, η2=.651] which was driven by expression of TLR4 on the CD14+/CD16bright 
monocytes [F(1,25)=42.35, p<.001, η2=.711]. There was a significant main effect of 
time for expression of TLR2 on total CD14+ monocytes from both young and middle-
aged participants [F(1,25)=99.61, p<.001, η2=.723] which was driven by changes in 
expression of TLR2 on the CD14+/CD16dim monocytes [F(1,25)=102.31, p<.001, 
η2=.823]. 
 
Table 6.7: Immune function responses with ageing. Neutrophil and monocyte 
bactericidal function for the young (n=11) and middle aged (n=13) groups before 
(Pre) and after (Post) 10-weeks of training. Data are Mean ± SEM. 
 
*p<.05 significantly different from corresponding Young time point assessed using 
repeated measures ANOVA. 
Pre Post Pre Post (p ) (p )
Phagocytosis
Neutrophil (%) 96.8 ± 0.4 96.9 ± 0.3 97.3 ± 0.4 97.4 ± 0.5 .734 .973
Neutrophil (MFI) 126.9 ± 4.4 155.2 ± 9.8 130.3 ± 3.9 145.4 ± 9.9 .009 .283
Monocyte (%) 94.89 ± 0.4 93.4 ± 0.4 94.2 ± 0.8 93.1 ± 0.7 .058 .194
Monocyte (MFI) 98.9 ± 4.5 109.5 ± 5.3 96.8 ± 3.1 114.7± 4.1 <.001 .583
Superoxide Production
Neutrophil (%) 93.1 ± 1.1 98.4 ± 0.2  95.0 ± 0.7* 98.5 ± 0.2 <.001 .045
Neutrophil (MFI) 65.5 ± 5.7 96.0 ± 9.6 75.4 ± 6.8 86.5 ± 8.3 .003 .067
Monocyte (%) 69.9 ± 3.1 83.6 ± 2.0  77.5 ± 2.9* 83.1 ± 1.7 .002 .068
Monocyte (MFI) 25.5 ± 1.5 26.2 ± 2.0 22.1 ± 1.0 30.2 ± 2.9 .039 .029
Young Middle-Aged Training 
Effect
Training x 
Group
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Table 6.8: Monocyte responses with ageing. Percentage of CD14+ monocytes 
expressing or not CD16 for the young (n=14) and middle-aged (n=13) groups before 
(Pre) and after (Post) 10-weeks of training. Data are mean ± SD. 
 
  
Pre Post Pre Post (p ) (p )
Monocyte (%)
CD14+/CD16neg 88.9 ± 4.9 90.3 ± 3.9 85.4 ± 5.1 88.4 ± 4.7 .007 .188
CD14+/CD16dim 4.8 ± 3.1 3.9 ± 2.1 5.7 ± 4.0 4.2 ± 2.8 .002 .418
CD14+/CD16bright 7.6 ± 4.1 5.2 ± 3.2 7.9 ± 3.8 7.1 ± 3.8 .024 .113
Young Middle-Aged Training 
Effect
Training x 
Group
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Fig. 6.2: Monocyte phenotype responses to exercise and age. Monocyte 
expression of TLR4 (A) and TLR2 (B) on CD14+ monocyte subtypes in response to 
10-weeks exercise training. ***p<.001 compared to Pre baseline measures for that 
subtype. Data are mean ± SEM.  
A 
B 
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6.3 Discussion 
 
Regular bouts of structured exercise sessions are associated with a number of 
health benefits including reduced risk of chronic diseases mainly through 
modification of aerobic capacity, muscle mass, adiposity, insulin sensitivity and low 
grade systemic inflammation. Although it seems obvious that everyone, young and 
old should participate in some form of regular exercise one of the main cited reasons 
for not exercising is a lack of available time, especially in those who are middle aged 
and older [187]. Therefore it is no surprise that the majority of these age groups are 
physically inactive and unable to adhere to the current health guidelines of at least 
150 minutes of moderate exercise per week plus two sessions per week undertaking 
muscle strengthening exercises [272]. High Intensity Interval Training (HIT) offers an 
alternative exercise method which incorporates short intense bouts over a reduced 
period of time which has been shown to elicit similar physiological responses as 
regular endurance training (ET). 
This study compared the effects of ten weeks of high intensity interval training (HIT) 
at ~91% of VO2max three times per week to that of five weekly sessions of endurance 
training (ET) at ~64% of VO2max on systemic inflammation, endocrine function and 
immune function in healthy but sedentary men and women. Ageing has been shown 
to impair certain adaptations to exercise training, such as the muscle anabolic 
response, therefore it was important to assess whether HIT could improve 
adaptation or mimic that of ET in a slightly older cohort [376]. The participants of this 
study were aged between 20 and 60 years old and as ageing has an impact on all of 
the above measured variables it was our aim to assess the effects of age.  
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Not only is this the first study comparing HIT and ET effects on systemic 
inflammation, endocrine function and immunity, it is also the first to assess the 
impact of age as well. The main findings of this study were that ten weeks of high 
intensity interval training elicited comparable reductions in inflammatory and 
endocrine biomarkers whilst improving innate immune function in a group of healthy 
but sedentary individuals. Furthermore, HIT was as efficacious as ET in improving 
the same parameters following stratification of participants into young (20 – 39 year 
old) and middle aged (40 – 60 years old) individuals. 
6.3.1 Fitness improvements and adherence 
It is well established that aerobic exercise interventions can improve 
cardiorespiratory fitness with responses being dependent on duration and intensities 
of the program [377]. This study confirms findings from other studies that both HIT 
and ET improved absolute (L.min-1) and relative (ml.min-1.kg-1) maximal aerobic 
capacity and reduced body fat percentage in a group of sedentary but healthy 
individuals [370].  Although in this study the ET group had significantly lower 
adherence to the training, they actually exercised on average twice as long as the 
HIT group. Adherence to exercise interventions is problematic in all those who 
undertake them, especially sedentary individuals. Group based instructor led 
exercise interventions have been shown to improve adherence and give health 
benefits especially in at-risk populations such as the elderly and sedentary [378, 
379]. Here adherence to HIT was greater than ET even when both were in groups 
and led by experienced instructors. This opens up the possibility that high-risk 
groups such as the elderly and diseased may be able to improve health parameters 
to an even greater extent than previously thought and would adhere to the HIT 
program.  
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Typical submaximal aerobic training is characterised by continuous duration activity 
of a relatively constant intensity whilst HIT is typically interval sessions of varying 
durations of high and low intensities, usually above or at the anaerobic threshold. 
Therefore adaptation to HIT involves a number of energy utilisation changes such as 
fat oxidation and muscle substrate metabolism. Indeed as shown here with an 
equivalent reduction in body fat we can assume that fat oxidation was increased 
comparably in both groups. Indeed, Essen and colleagues have previously shown 
that sedentary individuals used more lipids than stored glycogen following 1 hour of 
HIT (15 second exercise at maximal capacity followed by 15 second rest) when 
compared to 1 hour of continuous exercise at 50% maximal capacity [380]. 
Furthermore, HIT for 6 weeks has been shown to improve intramuscular triglyceride 
breakdown via cellular alteration of expression of lipolytic proteins as well as glucose 
uptake proteins [371, 372].  
In addition, aerobic capacity is dependent on mitochondrial function allowing energy 
production in the form of ATP to be increased by oxidative phosphorylation. Unlike 
ET however, HIT can also increase energy production by upregulation of anaerobic 
glycolysis as well as aerobic glycolytic enzymes [370]. This does not occur to a 
significant level in endurance training interventions. Therefore as the duration of total 
HIT in this study was less than that of ET the comparable aerobic capacity 
improvements are likely due to improved energy substrate utilisation. 
6.3.2 Inflammatory Responses 
Alterations in fat oxidation and energy substrate utilisation are associated with 
protection from chronic diseases with an inflammatory phenotype. Corroborating 
findings from other studies we show here that ten weeks of exercise training reduces 
systemic inflammation [334]. CRP and IL-6 are the most commonly measured 
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inflammatory markers of training interventions [334]. CRP concentrations are 
consistently shown to be reduced by both aerobic exercise training and resistance 
training. It remains unclear the mechanism driving exercise induced CRP reductions 
however it is thought to be primarily due to reduced body fat percentage [25, 280, 
381]. Conversely, Stewart and colleagues recently suggested that other mechanisms 
than fat reduction may drive reduced CRP concentrations as they observed no 
change in body fat percent but reduced CRP following 12 weeks of training [282]. 
However, a number of studies have shown that physically active individuals have 
lower CRP concentrations than physically inactive but also have lower BMI’s [239]. 
In support of this, CRP and body composition were positively related in this study 
whilst relative but not absolute aerobic fitness was negatively associated suggesting 
body composition was driving changes in CRP.  
IL-6 is the main cytokine responsible for hepatic production of CRP which suggests 
that changes in circulating inflammatory cytokine concentrations may lead to 
reduced CRP. Ahmadi and colleagues, Stewart and colleagues and Donges and 
colleagues amongst others have shown systemic reductions in CRP following 
training but not IL-6, IL-1β or TNFα [282, 382, 383]. In agreement with this literature, 
HIT or ET did not show reduced IL-1β or TNFα concentrations in this study, though a 
small but significant reduction in IL-6 (p=.047) was seen. As mentioned previously IL-
6 plays a dual role in inflammation, if produced in response to infection or from 
adipocytes it is inflammatory by nature whilst if produced by muscle during exercise 
it is anti-inflammatory and tissue protective [196]. As there was no large change in 
IL-6 the reduced CRP is likely being driven primarily by reduced body fat percentage. 
The cytokine network and indeed the adipokine network are extremely complex and 
not fully understood. To understand the inflammatory phenotype of adipose tissue 
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and the response to exercise training adipokine levels were assessed in response to 
HIT and ET. Leptin and adiponectin production are directly associated with adipose 
tissue mass and the ratio of the two may therefore be a reliable measure of 
adipocyte function and adipose tissue induced inflammation [384]. When the ratio of 
leptin to adiponectin is high it is indicative of a pro-inflammatory phenotype whereby 
cells produce more TNFα and IL-6 which can inhibit the production of adiponectin. 
Increased adiponectin is thought to be cardio-protective in that it can increase nitric 
oxide content allowing improved vascular function as well as improving fat oxidation 
[32]. A number of studies have shown that both weight loss and exercise can alter 
the production of leptin and adiponectin [385]. In agreement with this, the data here 
show that the leptin:adiponectin ratio was significantly reduced following training 
which was mediated by an increase in adiponectin and a reduction in leptin. In light 
of this we suggest that reduced IL-6 and CRP following exercise training is primarily 
due to reduced and altered function of adipocyte mass as evident by altered leptin 
and adiponectin production.  
Few studies comprehensively assess cytokine changes in response to exercise and 
of those that do the majority are in response to acute exercise but tell us little about 
the overall impact of the exercise. Therefore in order to determine further health 
enhancing benefits of the exercise training this study measured a total of 12 different 
cytokines. Similar to a number of other studies the typical anti-inflammatory 
cytokines IL-4, IL-10 and IL-13 were unaffected by exercise training [386]. 
Interestingly we show here that MCP-1 and IL-8 are altered with exercise training. 
MCP-1 is responsible primarily for attracting monocytes to sites of infection however 
it is also expressed on vascular endothelial cells and is thought to play a significant 
role in development of atherosclerosis by tethering monocytes and promoting 
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differentiation into foam cells and atheroma plaques [387]. Indeed MCP-1 is 
consistently shown to be elevated in both the peripheral blood and carotid plaques of 
patients with advanced carotid disease [388].  Both resistance and aerobic training 
have been shown to reduce circulating MCP-1 suggesting a reduced risk of 
developing atheroma. Although it is unclear the mechanism by which MCP-1 
reductions occur it is thought to be from either reduced immune cell production or 
reduced endothelial cell production or a combination of both and not likely reduced 
infectious episodes, although this cannot be ruled out [389]. Importantly, elevated 
MCP-1 is representative of pro-inflammatory macrophage (M1) differentiation in 
atherosclerosis suggesting that monocyte differentiation and subsequently function is 
altered [41, 390]. Therefore reduced MCP-1 concentrations observed here may 
account for altered macrophage phenotype resident in tissues as well as monocyte 
phenotype and function. 
In addition to this neutrophil immune function may be altered due to changes in 
immune modulators, in particular GM-CSF was increased in response to ten weeks 
of training. GM-CSF is typically associated as a pro-inflammatory growth factor 
stimulating production of neutrophils and monocytes from the bone marrow [391]. 
Indeed in patients with chronic conditions such as chronic heart failure it is typically 
elevated and with training there is a significant reduction [392]. However with healthy 
ageing GM-CSF may be reduced and contribute to impaired neutrophil and 
monocyte function [393]. Therefore increased GM-CSF after ET and HIT is likely a 
good factor, improving immune function and reducing risk of disease and infection.  
Finally, the data in this thesis has previously suggested that the cortisol:DHEAs ratio 
may be an important indicator of immune cell function as it acts to suppress when 
elevated and enhance function when reduced. A number of studies have shown that 
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sedentary or overweight individuals have a reduced cortisol:DHEAs ratio following 
exercise training. Izzicupo and colleagues showed that reduced cortisol:DHEAs ratio 
following 13 weeks training in post-menopausal women reduced their risk of chronic 
disease [394]. Here 10 weeks of training not only reduced the ratio it did so by 
reducing cortisol and increasing DHEAs suggesting an extremely favourable 
alteration to the HPA-axis and ultimately inflammation and immune function.  
Taken together, it is likely that exercise induced alterations of inflammatory 
biomarker levels are indicative of modifications of systemic tissue function. Reduced 
body fat is contributing to reduced hepatic burden as evidence by reduced IL-6 and 
CRP levels. This is evident by the altered adipokine concentrations highlighting 
modified tissue size and function. Reduced MCP-1 and IL-8 are indicative of reduced 
cardiovascular disease and other chronic disease risks. Furthermore, in combination 
with increased GM-CSF and reduced cortisol:DHEAs there is potential to improve 
immune function and further reduce risk of infection and disease. 
6.3.3 Immune Function 
Both HIT and ET improved neutrophil and monocyte responses to bacteria as well as 
reducing the inflammatory phenotype of monocytes. The previous chapter suggested 
that an acute bout of walking can transiently alter neutrophil and monocyte 
bactericidal capacity as well as cell phenotype and potential inflammatory capacity. 
This finding suggests that innate immune cell function can be modulated in response 
to exercise training programs. However few studies have assessed the impact of 
training interventions on neutrophil function. Cross-sectional studies have revealed 
that neutrophil phagocytosis is improved in trained compared to untrained individuals 
across an age range of 20 to 60 years [226, 246]. Furthermore, increased training 
status in men has been associated with increased neutrophil phagocytosis [245]. 
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More recently, neutrophil chemotaxis and phagocytosis was improved following 2 
months of moderate exercise training [246]. In agreement with these studies, this 
study showed that following 10 weeks of training neutrophil phagocytosis was 
increased in respect to increased cellular uptake of bacteria and increased cellular 
production of oxidative killing. These findings were consistent across exercise 
groups and ages, although improvements appeared to be larger in the young.  
 
Additionally, similar effects on bactericidal activity of monocytes were seen following 
10 weeks of training. This is in contrast to Schaun et al who observed no change in 
monocyte bactericidal following 12 weeks of aerobic and strength training [243]. This 
study did however assess effects in slightly older men than the present study 
suggesting ageing may attenuate any exercise induced changes. To address the 
data from this study were stratified in to a young and middle-aged group and this 
revealed that monocytes produced a greater degree of change for superoxide killing 
in the middle aged than the younger group. Although the improved bacterial uptake 
was similar across the two ages it is possible that our conflicting findings from 
Schaun and colleagues were due to methodological differences. In particular they 
used isolated monocytes incubated with opsonised zymosan whilst here a whole 
blood assay was used which reduces handling artefacts.  
 
Monocyte phenotype as previously shown in this thesis (chapter 5) was altered by 
acute exercise with monocyte expression of CD16, TLR4 and TLR2 all reduced. This 
would suggest that the monocyte phenotype is shifting from a pro-inflammatory state 
capable of perpetuating systemic inflammation to a less inflammatory state with 
improved anti-inflammatory capabilities. In this chapter it is shown that in sedentary 
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healthy individuals’ monocyte phenotype was also altered in response to HIT and ET 
exercise training. In particular, the percentage of pro-inflammatory CD16 positive 
monocytes was reduced whilst the expression of TLR2 and TLR4 was slightly 
reduced on the pro-inflammatory subtypes. This suggests that not only is exercise 
training improving bactericidal capacity but it is doing so on a developmental 
component of monocyte biology.  
 
Although we cannot determine the exact mechanism causing these innate cell 
changes it is possibly due to the alterations in inflammatory status impacting cell 
differentiation or improved clearance of dysfunctional cells. Incubation of neutrophils 
and monocytes with various inflammatory or anti-inflammatory mediators has been 
shown to modulate cell function [395, 396]. Neutrophils isolated from highly inflamed 
rheumatoid joints exhibit severe dysfunctional properties including elevated and 
abnormal reactive oxygen species production [397-399]. Furthermore, patients with 
chronic obstructive pulmonary disorder (COPD) have elevated inflammatory cytokine 
production and have recently been shown to have impaired neutrophil chemotaxis 
[170]. Similar patterns are observed in monocytes from chronic inflammatory 
conditions. Hulsmans and colleagues suggested that individuals with chronic heart 
conditions have reduced monocyte function but an elevated pro-inflammatory 
phenotype which contributes to atheroma plaque formation [400]. Therefore as we 
have shown a reduced inflammatory milieu as well as an immune enhancing 
endocrine response it is likely that this study not only altered intrinsic cellular function 
but also maintained correct differentiation in the circulation. 
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6.3.4 Effects of Age 
The one study that has assessed some form of HIT in the elderly and/or middle aged 
have shown that even when the training is intermittent walking, aerobic capacity, fat 
oxidation, muscle strength, glucose utilisation and risk factors for cardiovascular 
disease are attenuated [373].  These findings show that HIT can be adapted for a 
group of individuals not likely to be able to perform typical exercise sessions such as 
cycling or running. However, to date no study has assessed whether HIT can 
improve inflammatory and immune function in an older cohort which are directly 
associated with disease progression.  
Although others have suggested that adaptation to training is impaired with age [376, 
401], especially musculoskeletal and cardiorespiratory adaptations, this study did not 
see any effect for age on physiological improvements following training. Others have 
shown differences between younger and older cohorts; however the age difference 
tends to be greater. Here we show that even in middle aged cohorts physiological 
improvements are evident by both ET and HIT. However, the older group had more 
body fat and had a lower aerobic capacity, lower levels of DHEAs and GM-CSF and 
a slightly higher baseline percentage of neutrophils and monocytes producing 
superoxide responses towards E.Coli. In effect both HIT and ET training caused 
similar alterations regardless of age. In the case of DHEAs which has been 
suggested to be tissue protective and GM-CSF which can stimulate improved innate 
immune responses, training initiated a restoration of levels to almost that of younger 
participants.  
As time may play such a significant role in reduced adherence for exercise training, 
HIT offers a new paradigm which can elicit health improvements in both young and 
middle-aged individuals. Furthermore, as others have shown physiological 
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improvements in elderly HIT participants it is likely that HIT can improve 
inflammation and immune function in those most at risk of chronic disease and 
infection. 
 
6.4 Limitations & Future Work 
 
This study is not without limitations. It has been assumed that modifications 
observed in the middle-aged group are translatable to an elderly cohort, however to 
date no such study assessing inflammation or immune function has been conducted. 
As the exercise may stress the body to a greater degree than regular training it is 
possible that the elderly may over-stress and therefore cause heightened damaging 
inflammation as well as immune suppression. Over training has been previously 
shown to exhibit such changes; however the work coming from the Japanese groups 
suggests no adverse effects [373]. Therefore future work should carefully assess the 
implementation of HIT in the elderly and aim to assess comprehensive inflammatory 
and immune function. 
 
In addition adaptive immune cell function was not considered. Low aerobic capacity 
has been associated with increased prevalence of senescent T-cells in the 
peripheral blood which indicates a functional decrement and may allow infection 
propagation [402]. Furthermore as exercise can mobilise and alter function of T-cells 
[294] it is likely that HIT may be able to elicit a similar result. Future work should 
therefore also assess T-cell phenotype and function in order to semi-quantify such 
things as thymic function, vaccine response and infection control. 
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Finally, as was shown in the previous chapter acute exercise transiently alters 
inflammation and immune function. It would be worthwhile to assess the impact of 
transient changes in the HIT group to assess a) whether the acute modifications are 
greater and b) what the dynamics of change are over the training period to attempt 
and narrow down adaptation dynamics. This would allow for better quantification of 
the type, duration and intensities of training which would be needed to elicit 
beneficial improvements and thus personalise exercise prescription. 
 
6.5 Conclusions  
 
In conclusion it is shown here for the first time that high intensity interval training is 
as effective at modifying inflammation and immune function as regular endurance 
type training. Furthermore, the effects of HIT are transferable across ages, from 
young to middle-aged at least. This suggests that with modification and planning, 
HIT training could be an effective therapeutic intervention to delaying or preventing 
inflammatory mediated chronic disease and infections in the elderly.  
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Chapter 7: General 
Discussion  
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7.0 General Discussion 
 
Physiological ageing has long been associated with an increased risk of chronic 
disease and infection. An underlying contributing factor is the increase in low-grade 
chronic systemic inflammation in the absence of infection (inflammageing) [31, 127]. 
It remains unclear the exact factors driving inflammageing but include 
immunesenescence, obesity, loss of anti-inflammatory sex steroids, hyperactivation 
of the HPA-axis and reduced levels of physical activity [251].  Taken together 
obesity, sedentary behaviour and immune mediated inflammation contributes to the 
majority of morbidities and mortality observed in the elderly [31, 403]. Physical 
activity and exercise offers a mechanism by which immune dysfunction, obesity and 
subsequently inflammation can be attenuated in the elderly [190, 294]. Exercise both 
acute and chronic is energy demanding and subsequently utilises adipose tissue as 
an energy source reducing the risk of obesity. Similarly exercise can modify the 
number and function of circulating immune cells to reduce the risk of infection and 
modify cytokine output by muscle and adipose tissue. However, until recently few 
studies have assessed the impact of physical activity on inflammation and immune 
function in the elderly. The aims of this thesis were therefore to identify the 
consequences and causes of inflammageing and assess the effects of physical 
activity as an intervention on inflammation and immunesenescence in healthy elderly 
individuals. 
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7.1 Summary 
 
Chapter 3 investigated the effects of persistent infection by cytomegalovirus (CMV) 
on inflammageing over a ten year period and the consequences inflammageing 
presents in later life. Over 700 elderly participants were recruited, had a number of 
assessments completed including blood taken in 1994 before over 250 returned ten 
years later for a follow-up analysis. To our surprise, CMV was not driving the 
increased production of inflammatory mediators in our cohort which was in contrast 
to suggestions by a number of studies [89, 95, 222]. Furthermore in contrast to other 
studies CMV infection was not predictive of frailty or mortality over a ten year period 
[404, 405]. However systemic inflammatory markers including cytokines, endocrine 
mediators and immune cells were predictive of frailty and mortality suggesting 
mortality associated with inflammation and CMV infection are independent of each 
other. Interestingly, measurements of behavioural lifestyle choices reflective of a 
sedentary behaviour revealed that body fat and physical functioning were influencing 
inflammageing more than other measures such as CMV infection and social class.  
In light of the previous findings, Chapter 4 investigated the impact of physical activity 
levels on systemic inflammation and immune function in over 200 very healthy 
elderly participants. Confirming findings from the previous chapter, CMV infection 
was not predictive of systemic inflammation but physical activity levels and body fat 
were predictive of inflammation. Therefore as the previous chapter indicated frailty 
and mortality being associated with immune components it was necessary to assess 
immune function concurrently. Additionally, CMV is dominated by the adaptive arm 
and showed no effects. As the immune system with age shifts from a lymphoid to a 
myeloid dependent state and innate cells are capable of influencing inflammation we 
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assessed neutrophil and monocyte function in response to physical activity levels. In 
comparison to findings from others [168] ageing was associated with neutrophil 
dysfunction, however being physically active in old age attenuated the functional 
decline. Maintenance of neutrophil function was independent of body fat suggesting 
that physical activity was influencing intrinsic cell mechanisms. No differences were 
observed for monocyte function suggesting neutrophils may be more sensitive to 
physical activity status. 
As physical activity was influencing inflammation and innate cell function, Chapter 5 
aimed to determine the impact of a short acute bout of exercise in healthy elders. 
Elderly participants were either grouped as high or low active and completed an 
incremental walking test. Exercise caused an increase in inflammatory biomarkers 
and improved endocrine response during the recovery period following exercise 
cessation. These effects were paralleled with small improvements in neutrophil and 
monocyte bactericidal function suggesting altered inflammatory mediators can 
modulate immune function. Interestingly, the low active group had similar 
inflammatory profiles but also a trend for reduced immune function compared to the 
active group suggesting regular exercise can improve immune function. 
It is clear from previous chapters that physical activity could modify inflammation and 
immune function in the elderly, however getting them to exercise voluntarily is a 
significant social issue. Middle-aged and elderly individuals state a lack of time for 
participating in regular exercise sessions [406]. Therefore the final chapter (Chapter 
6) aimed to assess whether a novel high intensity interval training (HIT) intervention 
with a reduced time commitment could elicit similar results as ‘regular’ exercise 
interventions. In particular we aimed to determine for the first time whether 10-weeks 
of HIT could modify inflammatory state and immune function in young and middle-
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aged sedentary individuals. HIT was as effective as ‘regular’ training at reducing 
systemic inflammation, through adipose tissue modification whilst improving 
neutrophil and monocyte bactericidal function. Interestingly, although the results 
tended to be more pronounced in the younger participants effects were also 
observed in the older cohort. Additionally those individuals in the HIT group had a 
higher adherence to the study than ‘regular’ training. These findings suggest that HIT 
may provide an effective therapeutic intervention to delaying or preventing 
inflammatory mediated chronic disease and infections in the elderly. 
In light of the findings from this PhD a striking observation can be made. With age 
there is a pronounced increase in systemic inflammation and marked reduction in 
immune function. These observations have been attributed previously to chronic 
repeated infectious episodes [85, 251]. However, ageing is an inherent process and 
not a pathological condition. Therefore to confidently characterise functional 
decrements as attributed to ageing they must be independent of pathologies. The 
findings throughout this thesis suggest that those individuals who maintain a 
physically active lifestyle have improved immune function and reduced systemic 
inflammation with no major pathologies. This suggests that as regular exercise is 
known to reduce the risk of age related pathologies, the ageing process could be 
better characterised in extremely active elders over time. 
Recently master athletes have been suggested as a model of successful ageing, or 
‘positive’ control, to study inherent ageing, due to their lack of confounding 
pathologies [407, 408]. Master athletes are typically defined as being over 50 years 
old and actively taking part in exercise training [409]. Indeed a 13-year study of 
elderly competitive runners (>50 years old) versus non-runners suggested that the 
active group were at a lower risk of disability and mortality [410]. Although the rate of 
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decline in physiological variables such as VO2max is similar between trained and 
untrained, the high starting point in master athletes appears to aid protection [409]. 
Therefore as it is difficult to define minimum exercise requirements to prevent 
pathological changes with age [411] the master athlete represents an excellent 
control group for ageing studies. Although master athletes still succumb to infection 
and inflammatory related disease [412], it is clear that the severity and incidence are 
less than the general population.  
Subsequently, this thesis has shown that differences in immune function and 
systemic inflammation are evident in elderly individuals who do not have a large gap 
in physical activity levels. Therefore, future research assessing immune and 
inflammatory function in the elderly should consider utilising extremely active 
individuals to fully determine the age related decline in function. 7.5 Elucidating 
Potential Mechanisms 
The exact mechanisms driving sterile chronic systemic inflammation in the elderly 
remain elusive. During this thesis some of the mechanisms could be elucidated, 
however one of the key limitations of all of these studies was the apparent good 
health of our participants. What is clear is that physical activity and body composition 
are intrinsically linked but not mutually dependent for inflammatory associations.  
7.5.1 Inflammation, Immunesenescence and Physical Activity 
 
One of the key observations seen here is that habitual activity leads to reduced 
systemic inflammation and that acute exercise can promote an inflammatory 
response most likely in order to promote tissue adaptation. Although accounting for 
body fat many observations were attenuated however it is unlikely that adipose 
tissue is the principle source of inflammatory mediators. We were unable to assess 
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the dynamics of inflammation and the interaction each component has with each 
other is incompletely understood. Figure 7.1 highlights the cytokine response to 
exercise and sepsis and shows that disease is in fact a different type of pro-
inflammatory situation [196, 197]. This raises the question that perhaps the line 
between pro and anti-inflammatory is not so clear.  In light of the recent findings that 
IL-6 can block production of TNFα and IL-1β can stimulate cortisol production it is 
likely that exercise promotes a blurred inflammatory environment which is likely 
acting against natural ageing with tissue adaptation. 
 Fig 7.1: Differences between cytokine dynamics during infection and exercise. 
Taken from Petersen et al. [197]  
What is clear is that no single factor can account for the exercise induced 
improvements observed, however systemic inflammation is the likely cause. 
Improvements are a tightly intertwined network of physiological systems working 
together, Fig. 7.2. For example we did not account for the potential capacity of 
exercise to reduce the frequency of senescent cells which promote inflammation. 
Recent work has shown that physical activity is associated with reduced senescent 
T-cells therefore it is likely that other senescent cells may be cleared or prevented 
from accumulating [217, 413]. If this is the case then the inflammatory environment 
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created by exercise is promoting clearance of dysfunctional cells. This is particularly 
evident when assessing exercise induced improvements in vaccine efficacy [414]. 
Not only does systemic inflammation promote efficacy it can also impair it, therefore 
the impact of exercise on adaptive inflammatory environment most likely aides in 
vaccine efficacy. 
 
Fig. 7.2: Physical activity and inflammation. Systemic effects of physical activity 
showing physiological changes which promote an anti-inflammatory environment.  
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7.5.2 CMV Infection, Inflammation and Mortality 
 
CMV infection has been linked with increased risk of mortality in a number of other 
studies however, whether CMV infection is directly responsible for mortality remains 
unclear. The fact we observed no effect on mortality or inflammageing does not rule 
out the impact this virus has on morbidity and mortality in later life. In our study the 
cohort were all relatively healthy compared to the general population and were from 
a considerably more affluent area which is in contrast to others. It has been shown 
that CMV infection is more prevalent in groups from lower socioeconomic 
populations and is likely therefore to undergo increased intermittent reactivation. This 
would undoubtedly lead to premature or quickened immunesenescence leading to 
increased risk of infection and disease. Subsequently the inflammatory status of 
these individuals may be different from CMV negative individuals. Additionally, 
evidence is appearing which suggests low socioeconomic groups participate less in 
structured and habitual physical activity. 
In the acute exercise study (Chapter 5) we observed some interesting trends 
developing between the high and low active elders who were CMV seropositive. The 
high active elders appeared to have lower titre’s, reduced numbers of monocytes 
and improved monocyte bactericidal functions. Although these findings were 
moderate and non-significant it raises the question of whether regular exercise 
reduces the viral load and subsequently improves the immune capacity of the 
individual. Recently it was suggested that physical active could reduce the frequency 
of CMV specific T-cells following findings that physical activity was related to the 
frequency of senescent T-cells in the peripheral blood compartment [402]. Although 
it is unlikely that exercise can cause clearance of CMV specific T-cells it is likely that 
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exercise can limit the movement and seeding of the virus as well as enhancing the 
immune response against its reactivation. This may not be apparent in young healthy 
CMV positive individuals but is likely to be more evident in elderly individuals. Recent 
studies have suggested that CMV utilises innate immune cells in order to migrate to 
tissue and propagate infection [158]. Monocytes appear to be key mediators of this 
by promoting differentiation in to pro-inflammatory non-classical monocytes where 
they migrate to tissue, aided by their adhesive and migratory properties [158, 415].  
Whether CMV therefore modifies innate immune function in order to survive remains 
unknown. Recently LaVoy and colleagues showed no difference in innate 
bactericidal function in response to exercise or between CMV positive and negative 
individuals. These participants were all relatively young and may not represent a true 
reflection of longitudinal CMV infection. Although we saw no direct effect of CMV on 
systemic inflammation in any of the studies its impact on immunity cannot be 
ignored. Subsequently it is likely that systemic inflammation may be integral to CMV 
related mortality as is likely for all underlying morbidities. 
7.6 Conclusions and future research into physical activity and 
inflammation and immune function 
 
In conclusion inflammageing is responsible for the majority of age related tissue 
dysfunctions including sarcopenia, cardiovascular function and immune function. 
Thus this thesis reveals that the phenomenon of inflammageing is driven primarily by 
behavioural sedentary lifestyle choices and less so by immune responses. This was 
confirmed by the findings that habitual physical activity and a ten-week exercise 
intervention were associated with reduced inflammatory mediators. These reductions 
were inherently linked with reduced body fat, a consequence of increased physical 
fitness suggesting the metabolic alteration benefits of habitual exercise.  
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Future research will endeavour to assess the most economical and efficacious way 
of reducing systemic inflammation in the elderly. Our findings from the HIT study 
offers hope that not only healthy elderly participants can contribute but also those 
with underlying morbidities. Clearly more research needs to be conducted to tease 
out the fine interplay between exercise, inflammation and disease in the elderly. 
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